amendment list, 24 April 2026
Europe’s Beating Cancer Plan
Document SANT-AM-787665 · (2025/2139(INI))
Committee on Public Health
Full text
Jump to an amendment (719)
- Amendment 1
- Amendment 2
- Amendment 3
- Amendment 4
- Amendment 5
- Amendment 6
- Amendment 7
- Amendment 8
- Amendment 9
- Amendment 10
- Amendment 11
- Amendment 12
- Amendment 13
- Amendment 14
- Amendment 15
- Amendment 16
- Amendment 17
- Amendment 18
- Amendment 19
- Amendment 20
- Amendment 21
- Amendment 22
- Amendment 23
- Amendment 24
- Amendment 25
- Amendment 26
- Amendment 27
- Amendment 28
- Amendment 29
- Amendment 30
- Amendment 31
- Amendment 32
- Amendment 33
- Amendment 34
- Amendment 35
- Amendment 36
- Amendment 37
- Amendment 38
- Amendment 39
- Amendment 40
- Amendment 41
- Amendment 42
- Amendment 43
- Amendment 44
- Amendment 45
- Amendment 46
- Amendment 47
- Amendment 48
- Amendment 49
- Amendment 50
- Amendment 51
- Amendment 52
- Amendment 53
- Amendment 54
- Amendment 55
- Amendment 56
- Amendment 57
- Amendment 58
- Amendment 59
- Amendment 60
- Amendment 61
- Amendment 62
- Amendment 63
- Amendment 64
- Amendment 65
- Amendment 66
- Amendment 67
- Amendment 68
- Amendment 69
- Amendment 70
- Amendment 71
- Amendment 72
- Amendment 73
- Amendment 74
- Amendment 75
- Amendment 76
- Amendment 77
- Amendment 78
- Amendment 79
- Amendment 80
- Amendment 81
- Amendment 82
- Amendment 83
- Amendment 84
- Amendment 85
- Amendment 86
- Amendment 87
- Amendment 88
- Amendment 89
- Amendment 90
- Amendment 91
- Amendment 92
- Amendment 93
- Amendment 94
- Amendment 95
- Amendment 96
- Amendment 97
- Amendment 98
- Amendment 99
- Amendment 100
- Amendment 101
- Amendment 102
- Amendment 103
- Amendment 104
- Amendment 105
- Amendment 106
- Amendment 107
- Amendment 108
- Amendment 109
- Amendment 110
- Amendment 111
- Amendment 112
- Amendment 113
- Amendment 114
- Amendment 115
- Amendment 116
- Amendment 117
- Amendment 118
- Amendment 119
- Amendment 120
- Amendment 121
- Amendment 122
- Amendment 123
- Amendment 124
- Amendment 125
- Amendment 126
- Amendment 127
- Amendment 128
- Amendment 129
- Amendment 130
- Amendment 131
- Amendment 132
- Amendment 133
- Amendment 134
- Amendment 135
- Amendment 136
- Amendment 137
- Amendment 138
- Amendment 139
- Amendment 140
- Amendment 141
- Amendment 142
- Amendment 143
- Amendment 144
- Amendment 145
- Amendment 146
- Amendment 147
- Amendment 148
- Amendment 149
- Amendment 150
- Amendment 151
- Amendment 152
- Amendment 153
- Amendment 154
- Amendment 155
- Amendment 156
- Amendment 157
- Amendment 158
- Amendment 159
- Amendment 160
- Amendment 161
- Amendment 162
- Amendment 163
- Amendment 164
- Amendment 165
- Amendment 166
- Amendment 167
- Amendment 168
- Amendment 169
- Amendment 170
- Amendment 171
- Amendment 172
- Amendment 173
- Amendment 174
- Amendment 175
- Amendment 176
- Amendment 177
- Amendment 178
- Amendment 179
- Amendment 180
- Amendment 181
- Amendment 182
- Amendment 183
- Amendment 184
- Amendment 185
- Amendment 186
- Amendment 187
- Amendment 188
- Amendment 189
- Amendment 190
- Amendment 191
- Amendment 192
- Amendment 193
- Amendment 194
- Amendment 195
- Amendment 196
- Amendment 197
- Amendment 198
- Amendment 199
- Amendment 200
- Amendment 201
- Amendment 202
- Amendment 203
- Amendment 204
- Amendment 205
- Amendment 206
- Amendment 207
- Amendment 208
- Amendment 209
- Amendment 210
- Amendment 211
- Amendment 212
- Amendment 213
- Amendment 214
- Amendment 215
- Amendment 216
- Amendment 217
- Amendment 218
- Amendment 219
- Amendment 220
- Amendment 221
- Amendment 222
- Amendment 223
- Amendment 224
- Amendment 225
- Amendment 226
- Amendment 227
- Amendment 228
- Amendment 229
- Amendment 230
- Amendment 231
- Amendment 232
- Amendment 233
- Amendment 234
- Amendment 235
- Amendment 236
- Amendment 237
- Amendment 238
- Amendment 239
- Amendment 240
- Amendment 241
- Amendment 242
- Amendment 243
- Amendment 244
- Amendment 245
- Amendment 246
- Amendment 247
- Amendment 248
- Amendment 249
- Amendment 250
- Amendment 251
- Amendment 252
- Amendment 253
- Amendment 254
- Amendment 255
- Amendment 256
- Amendment 257
- Amendment 258
- Amendment 259
- Amendment 260
- Amendment 261
- Amendment 262
- Amendment 263
- Amendment 264
- Amendment 265
- Amendment 266
- Amendment 267
- Amendment 268
- Amendment 269
- Amendment 270
- Amendment 271
- Amendment 272
- Amendment 273
- Amendment 274
- Amendment 275
- Amendment 276
- Amendment 277
- Amendment 278
- Amendment 279
- Amendment 280
- Amendment 281
- Amendment 282
- Amendment 283
- Amendment 284
- Amendment 285
- Amendment 286
- Amendment 287
- Amendment 288
- Amendment 289
- Amendment 290
- Amendment 291
- Amendment 292
- Amendment 293
- Amendment 294
- Amendment 295
- Amendment 296
- Amendment 297
- Amendment 298
- Amendment 299
- Amendment 300
- Amendment 301
- Amendment 302
- Amendment 303
- Amendment 304
- Amendment 305
- Amendment 306
- Amendment 307
- Amendment 308
- Amendment 309
- Amendment 310
- Amendment 311
- Amendment 312
- Amendment 313
- Amendment 314
- Amendment 315
- Amendment 316
- Amendment 317
- Amendment 318
- Amendment 319
- Amendment 320
- Amendment 321
- Amendment 322
- Amendment 323
- Amendment 324
- Amendment 325
- Amendment 326
- Amendment 327
- Amendment 328
- Amendment 329
- Amendment 330
- Amendment 331
- Amendment 332
- Amendment 333
- Amendment 334
- Amendment 335
- Amendment 336
- Amendment 337
- Amendment 338
- Amendment 339
- Amendment 340
- Amendment 341
- Amendment 342
- Amendment 343
- Amendment 344
- Amendment 345
- Amendment 347
- Amendment 348
- Amendment 349
- Amendment 350
- Amendment 351
- Amendment 352
- Amendment 353
- Amendment 354
- Amendment 355
- Amendment 356
- Amendment 357
- Amendment 358
- Amendment 359
- Amendment 360
- Amendment 361
- Amendment 362
- Amendment 363
- Amendment 364
- Amendment 365
- Amendment 366
- Amendment 367
- Amendment 368
- Amendment 369
- Amendment 370
- Amendment 371
- Amendment 372
- Amendment 373
- Amendment 374
- Amendment 375
- Amendment 376
- Amendment 377
- Amendment 378
- Amendment 379
- Amendment 380
- Amendment 381
- Amendment 382
- Amendment 383
- Amendment 384
- Amendment 385
- Amendment 386
- Amendment 387
- Amendment 388
- Amendment 389
- Amendment 390
- Amendment 391
- Amendment 392
- Amendment 393
- Amendment 394
- Amendment 395
- Amendment 396
- Amendment 397
- Amendment 398
- Amendment 399
- Amendment 400
- Amendment 401
- Amendment 402
- Amendment 403
- Amendment 404
- Amendment 405
- Amendment 406
- Amendment 407
- Amendment 408
- Amendment 409
- Amendment 410
- Amendment 411
- Amendment 412
- Amendment 413
- Amendment 414
- Amendment 415
- Amendment 416
- Amendment 417
- Amendment 418
- Amendment 419
- Amendment 420
- Amendment 421
- Amendment 422
- Amendment 423
- Amendment 424
- Amendment 425
- Amendment 426
- Amendment 427
- Amendment 428
- Amendment 429
- Amendment 430
- Amendment 431
- Amendment 432
- Amendment 433
- Amendment 434
- Amendment 435
- Amendment 436
- Amendment 437
- Amendment 438
- Amendment 439
- Amendment 440
- Amendment 441
- Amendment 442
- Amendment 443
- Amendment 444
- Amendment 445
- Amendment 446
- Amendment 447
- Amendment 448
- Amendment 449
- Amendment 450
- Amendment 451
- Amendment 452
- Amendment 453
- Amendment 454
- Amendment 455
- Amendment 456
- Amendment 457
- Amendment 458
- Amendment 459
- Amendment 460
- Amendment 461
- Amendment 462
- Amendment 463
- Amendment 464
- Amendment 465
- Amendment 466
- Amendment 467
- Amendment 468
- Amendment 469
- Amendment 470
- Amendment 471
- Amendment 472
- Amendment 473
- Amendment 474
- Amendment 475
- Amendment 476
- Amendment 477
- Amendment 478
- Amendment 479
- Amendment 480
- Amendment 481
- Amendment 482
- Amendment 483
- Amendment 484
- Amendment 485
- Amendment 486
- Amendment 487
- Amendment 488
- Amendment 489
- Amendment 490
- Amendment 491
- Amendment 492
- Amendment 493
- Amendment 494
- Amendment 495
- Amendment 496
- Amendment 497
- Amendment 498
- Amendment 499
- Amendment 500
- Amendment 501
- Amendment 502
- Amendment 503
- Amendment 504
- Amendment 505
- Amendment 506
- Amendment 507
- Amendment 508
- Amendment 509
- Amendment 510
- Amendment 511
- Amendment 512
- Amendment 513
- Amendment 514
- Amendment 515
- Amendment 516
- Amendment 517
- Amendment 518
- Amendment 519
- Amendment 520
- Amendment 521
- Amendment 522
- Amendment 523
- Amendment 524
- Amendment 525
- Amendment 526
- Amendment 527
- Amendment 528
- Amendment 529
- Amendment 530
- Amendment 531
- Amendment 532
- Amendment 533
- Amendment 534
- Amendment 535
- Amendment 536
- Amendment 537
- Amendment 538
- Amendment 539
- Amendment 540
- Amendment 541
- Amendment 542
- Amendment 543
- Amendment 544
- Amendment 545
- Amendment 546
- Amendment 547
- Amendment 548
- Amendment 549
- Amendment 550
- Amendment 551
- Amendment 552
- Amendment 553
- Amendment 554
- Amendment 555
- Amendment 556
- Amendment 557
- Amendment 558
- Amendment 559
- Amendment 560
- Amendment 561
- Amendment 562
- Amendment 563
- Amendment 564
- Amendment 565
- Amendment 566
- Amendment 567
- Amendment 568
- Amendment 569
- Amendment 570
- Amendment 571
- Amendment 572
- Amendment 573
- Amendment 574
- Amendment 575
- Amendment 576
- Amendment 577
- Amendment 578
- Amendment 579
- Amendment 580
- Amendment 581
- Amendment 582
- Amendment 583
- Amendment 584
- Amendment 585
- Amendment 586
- Amendment 587
- Amendment 588
- Amendment 589
- Amendment 590
- Amendment 591
- Amendment 592
- Amendment 593
- Amendment 594
- Amendment 595
- Amendment 596
- Amendment 597
- Amendment 598
- Amendment 599
- Amendment 600
- Amendment 601
- Amendment 602
- Amendment 603
- Amendment 604
- Amendment 605
- Amendment 606
- Amendment 607
- Amendment 608
- Amendment 609
- Amendment 610
- Amendment 611
- Amendment 612
- Amendment 613
- Amendment 614
- Amendment 615
- Amendment 616
- Amendment 617
- Amendment 618
- Amendment 619
- Amendment 620
- Amendment 621
- Amendment 622
- Amendment 623
- Amendment 624
- Amendment 625
- Amendment 626
- Amendment 627
- Amendment 628
- Amendment 629
- Amendment 630
- Amendment 631
- Amendment 632
- Amendment 633
- Amendment 634
- Amendment 635
- Amendment 636
- Amendment 637
- Amendment 638
- Amendment 639
- Amendment 640
- Amendment 641
- Amendment 642
- Amendment 643
- Amendment 644
- Amendment 645
- Amendment 646
- Amendment 647
- Amendment 648
- Amendment 649
- Amendment 650
- Amendment 651
- Amendment 652
- Amendment 653
- Amendment 654
- Amendment 655
- Amendment 656
- Amendment 657
- Amendment 658
- Amendment 659
- Amendment 660
- Amendment 661
- Amendment 662
- Amendment 663
- Amendment 664
- Amendment 665
- Amendment 666
- Amendment 667
- Amendment 668
- Amendment 669
- Amendment 670
- Amendment 671
- Amendment 672
- Amendment 673
- Amendment 674
- Amendment 675
- Amendment 676
- Amendment 677
- Amendment 678
- Amendment 679
- Amendment 680
- Amendment 681
- Amendment 682
- Amendment 683
- Amendment 684
- Amendment 685
- Amendment 686
- Amendment 687
- Amendment 688
- Amendment 689
- Amendment 690
- Amendment 691
- Amendment 692
- Amendment 693
- Amendment 694
- Amendment 695
- Amendment 696
- Amendment 697
- Amendment 698
- Amendment 699
- Amendment 700
- Amendment 701
- Amendment 702
- Amendment 703
- Amendment 704
- Amendment 705
- Amendment 706
- Amendment 707
- Amendment 708
- Amendment 709
- Amendment 710
- Amendment 711
- Amendment 712
- Amendment 713
- Amendment 714
- Amendment 715
- Amendment 716
- Amendment 717
- Amendment 718
- Amendment 719
- Amendment 720
Text 4,414 paragraphs
Amendment 1
Alessandra Moretti
Motion for a resolution
Citation 1
| Motion for a resolution | Amendment |
|---|---|
| – having regard to Article 168 of the Treaty on the Functioning of the European Union, | – having regard to Article 168 and 191 of the Treaty on the Functioning of the European Union, |
Or. en
Amendment 2
Alessandra Moretti
Motion for a resolution
Citation 1 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the WHO Framework Convention on Tobacco Control (WHO FCTC), |
Or. en
Read the rest (4,402 paragraphs)
Amendment 3
Alessandra Moretti
Motion for a resolution
Citation 1 b (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 29 September 2021 on European Missions which sets out the EU Cancer Mission (COM(2021)609), |
Or. en
Amendment 4
Kateřina Konečná
Motion for a resolution
Citation 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 29 September 2021 on European Missions which sets out the EU Cancer Mission (COM(2021)609), |
Or. en
Amendment 5
Aurelijus Veryga
Motion for a resolution
Citation 10 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 29 September 2021 on European Missions which sets out the EU Cancer Mission (COM(2021)609, |
Or. en
Amendment 6
Alessandra Moretti
Motion for a resolution
Citation 1 c (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 20 September 2022 on strengthening prevention through early detection: A new EU approach on cancer screening (2022/0290 (NLE), |
Or. en
Amendment 7
Kateřina Konečná
Motion for a resolution
Citation 6 b (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 20 September 2022 on strengthening prevention through early detection: A new EU approach on cancer screening (2022/0290 (NLE)), which expanded screening recommendations towards lung, prostate and gastric cancer, |
Or. en
Amendment 8
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 10 b (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 20 September 2022 on strengthening prevention through early detection: A new EU approach on cancer screening (2022/0290 (NLE)), which expanded screening recommendations towards lung, prostate and gastric cancer, |
Or. en
Amendment 9
Aurelijus Veryga
Motion for a resolution
Citation 10 b (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 20 September 2022 on strengthening prevention through early detection: A new EU approach on cancer screening (2022/0290 (NLE)), which expanded screening recommendations towards lung, prostate and gastric cancer; |
Or. en
Amendment 10
Alessandra Moretti
Motion for a resolution
Citation 1 d (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 21 June 2024 on vaccine-preventable cancers; |
Or. en
Amendment 11
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 10 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 21 June 2024 on vaccine-preventable cancers (2024/0024 (NLE)), which aims to help EU Member States address cancer risks associated with hepatitis B (HBV) and human papillomavirus (HPV) infections, and which sets the objective of vaccinating at least 90% of the EU target population of girls against HPV by the age of 15, and significantly increasing HPV vaccination of boys, by 2030; |
Or. en
Amendment 12
Aurelijus Veryga
Motion for a resolution
Citation 10 c (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 21 June 2024 on vaccine-preventable cancers (2024/0024 (NLE)), which aims to help EU Member States address cancer risks associated with hepatitis B (HBV) and human papillomavirus (HPV) infections, and which sets the objective of vaccinating at least 90% of the EU target population of girls against HPV by the age of 15, and significantly increasing HPV vaccination of boys, by 2030; |
Or. en
Amendment 13
Sebastian Everding
Motion for a resolution
Citation 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 21 June 2024 on vaccine-preventable cancers (2024/0024 (NLE)), which aims to help EU Member States address cancer risks associated with hepatitis B (HBV) and human papillomavirus (HPV) infections, and which sets the objective of vaccinating at least 90% of the EU target population of girls against HPV by the age of 15, and significantly increasing HPV vaccination of boys, by 2030; |
Or. en
Amendment 14
Alessandra Moretti
Motion for a resolution
Citation 1 e (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 28 June 2021, EU strategic framework on health and safety at work 2021–2027: Occupational safety and health in a changing world of work (COM(2021)0323); |
Or. en
Amendment 15
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 10 c (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 28 June 2021, EU strategic framework on health and safety at work 2021–2027: Occupational safety and health in a changing world of work (COM(2021)0323), which, together with Europe’s Beating Cancer Plan, constitutes a key pillar underpinning the EU’s commitment to preventing and combating work-related cancer; |
Or. en
Amendment 16
Kateřina Konečná
Motion for a resolution
Citation 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 28 June 2021, EU strategic framework on health and safety at work 2021–2027: Occupational safety and health in a changing world of work (COM(2021)0323), which, together with Europe’s Beating Cancer Plan, constitutes a key pillar underpinning the EU’s commitment to preventing and combating work-related cancer; |
Or. en
Amendment 17
Alessandra Moretti
Motion for a resolution
Citation 1 f (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission’s Communication of 5 March 2026 entitled ‘Gender Equality Strategy 2026-2030’ (COM(2026)113); |
Or. en
Amendment 18
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission’s Communication of 5 March 2026 entitled ‘Gender Equality Strategy 2026-2030’ (COM(2026)113); |
Or. en
Amendment 19
Sebastian Everding
Motion for a resolution
Citation 12 c (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission’s Communication of 5 March 2026 entitled ‘Gender Equality Strategy 2026-2030’ (COM(2026)113), |
Or. en
Amendment 20
Alessandra Moretti
Motion for a resolution
Citation 1 g (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation on smoke-and aerosol-free environments replacing Council Recommendation 2009/C 296/02; |
Or. en
Amendment 21
Alessandra Moretti
Motion for a resolution
Citation 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the WHO Physical Activity Strategy for the WHO European Region; |
Or. en
Amendment 22
Aurelijus Veryga
Motion for a resolution
Citation 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Council Recommendation of 9 December 2022 on “Strengthening prevention through early detection: A new EU approach on cancer screening”; |
Or. en
Amendment 23
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the EU Zero Pollution Action Plan and its mid-term review, “Delivering clean air, oceans, freshwaters and soil,” adopted by the College on 29 January 2026, |
Or. en
Amendment 24
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 10 d (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission Communication of 14 October 2020 on the Chemicals Strategy for Sustainability (COM(2020) 667); |
Or. en
Amendment 25
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Citation 10 e (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the report of the World Health Organization (WHO) of 2020, entitled ‘Alcohol and cancer in the WHO European Region: An appeal for better prevention; |
Or. en
Amendment 26
Alessandra Moretti
Motion for a resolution
Citation 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the European Parliament resolution of 20 October 2021 with recommendations to the Commission on protecting workers from asbestos (2019/2182(INL)); |
Or. en
Amendment 27
Sebastian Everding
Motion for a resolution
Citation 12 b (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the November 2020 WHO Global Strategy to accelerate the elimination of cervical cancer as a public health problem; |
Or. en
Amendment 28
Sebastian Everding
Motion for a resolution
Citation 12 d (new)
| Motion for a resolution | Amendment |
|---|---|
| – having regard to the Commission communication of 7 November 2018 on endocrine disruptors; |
Or. en
Amendment 29
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Citation 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| – whereas under Article 168 TFEU, the responsibility for organising, financing and providing health services and medical care is primarily vested in the Member States; whereas as such, EU action in the field of cancer should serve to support, coordinate and supplement the policies of the Member States without impinging on their prerogatives, |
Or. fr
Amendment 30
Bartosz Arłukowicz
Motion for a resolution
Recital A a (new)
| Motion for a resolution | Amendment |
|---|---|
| Aa. whereas the establishment of a standing Committee on Public Health (SANT) within the European Parliament is a direct follow-up to the work carried out by the Special Committee on Beating Cancer (BECA) and reflects the growing importance of health policy at EU level; |
Or. pl
Amendment 31
Ondřej Dostál
Motion for a resolution
Recital C
| Motion for a resolution | Amendment |
|---|---|
| C. whereas there were an estimated 2.7 million new cases of cancer and 1.3 million deaths from cancer in 2022 alone; | C. whereas there were an estimated 2.7 million new cases of cancer and 1.3 million deaths from cancer in 2024 alone; |
Or. en
Amendment 32
Aurelijus Veryga
Motion for a resolution
Recital C a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ca. whereas cancer is the second leading cause of death in the European Union, accounting for nearly 1.1 million deaths each year; whereas approximately one in two EU citizens is expected to be diagnosed with cancer during their lifetime; whereas the number of new cancer cases is projected to continue increasing due to Europe’s ageing population and lifestyle-related risk factors; |
Or. en
Amendment 33
Adam Jarubas
Motion for a resolution
Recital C a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ca. whereas breast and prostate cancer remains the most common cancer respectively in women and men in the Union and continue to represent a major cause of mortality in their respective populations and show inequality in outcomes across Member States; |
Or. en
Amendment 34
Christophe Clergeau
Motion for a resolution
Recital D
| Motion for a resolution | Amendment |
|---|---|
| D. whereas by 2040, cancer cases are projected to increase by 18.3 % and deaths from cancer by 26.3 %; | D. whereas by 2040, cancer cases are projected to increase by 18.3 % and deaths from cancer by 26.3 %; whereas recent data shows that the numbers of cancer diagnoses and deaths worldwide are projected to rise substantially from 2024 to 2050, by 60,7% and 74,5%, respectively; this will result in an estimated 30,5 million new cancer diagnoses and 18,6 million deaths by 2050;1a |
| 1a GBD 2023 Cancer Collaborators. The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 2025; published online Sept 24. https://doi.org/10.1016/S0140-6736(25)01635-6. |
Or. en
Amendment 35
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Recital D a (new)
| Motion for a resolution | Amendment |
|---|---|
| Da. whereas advances in early detection, innovative treatments and comprehensive supportive care have resulted in a growing population of over 20 million cancer survivors across Europe, reflecting both significant medical progress and an urgent need for strengthened survivorship policies addressing long-term quality of life; |
Or. en
Amendment 36
Adam Jarubas
Motion for a resolution
Recital D a (new)
| Motion for a resolution | Amendment |
|---|---|
| Da. whereas cancer is not only a medical challenge but also a major societal and economic challenge requiring coordinated action across health, research, employment and industrial policy; |
Or. en
Amendment 37
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital D a (new)
| Motion for a resolution | Amendment |
|---|---|
| Da. whereas breast cancer remains the most common cancer among women in the Union and continues to represent a major cause of mortality and inequality in outcomes across Member States; |
Or. en
Amendment 38
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital D b (new)
| Motion for a resolution | Amendment |
|---|---|
| Db. whereas cancer is one of the leading causes of premature mortality among women globally, with 2.3 million women dying prematurely from cancer each year; whereas 1.5 million of those deaths could be prevented through primary prevention or early detection, and a further 800,000 deaths could be averted if all women had access to optimal cancer care; whereas systemic gender inequalities persist in cancer care, research and policymaking, influencing priorities, funding and the focus of studies, thereby perpetuating gender disparities in health outcomes; |
Or. en
Amendment 39
Monika Beňová
Motion for a resolution
Recital E
| Motion for a resolution | Amendment |
|---|---|
| E. whereas the economic impact of cancer in the EU already exceeds EUR 100 billion annually, with Member States losing the equivalent of 1.1 million full-time workers a year, and per capita expenditure on cancer care expected to grow by 59 % by 2050; | E. whereas the economic impact of cancer in the EU already exceeds EUR 100 billion annually, with Member States losing the equivalent of 1.1 million full-time workers a year, and per capita expenditure on cancer care expected to grow by 59 % by 2050; calls for the utilisation of AI in health sector to strengthen early detection measures; recalls the added value of the EU health data space in improving efficiency in the EU health system at large; calls for systematic data audits across European health sectors in order to integrate AI solutions; |
Or. en
Amendment 40
Bartosz Arłukowicz
Motion for a resolution
Recital F
| Motion for a resolution | Amendment |
|---|---|
| F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States; | F. whereas there are still large disparities in cancer incidence, detection, treatment and survival as well as in efforts to ensure that patients have equal and rapid access to the latest medical technologies, including innovative treatments, precision diagnostics and digital healthcare solutions between and within Member States; |
Or. pl
Amendment 41
Adam Jarubas
Motion for a resolution
Recital F
| Motion for a resolution | Amendment |
|---|---|
| F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States; | F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States; including in breast and prostate cancer, where inequalities in screening uptake, stage at diagnosis, access to multidisciplinary care and survival remain particularly pronounced; |
Or. en
Amendment 42
Aurelijus Veryga
Motion for a resolution
Recital F
| Motion for a resolution | Amendment |
|---|---|
| F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States; | F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States, including in breast cancer, where inequalities in screening uptake, stage at diagnosis, access to multidisciplinary care and survival remain particularly pronounced; |
Or. en
Amendment 43
Sebastian Everding
Motion for a resolution
Recital F
| Motion for a resolution | Amendment |
|---|---|
| F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States; | F. whereas there are still large disparities in cancer incidence, screening uptake and early diagnosis, referral pathways, access to multidisciplinary treatment, participation in clinical trials, survival and quality of life between and within Member States; |
Or. en
Amendment 44
András Tivadar Kulja
Motion for a resolution
Recital F
| Motion for a resolution | Amendment |
|---|---|
| F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States; | F. whereas there are still large disparities in cancer incidence, detection, treatment and survival between and within Member States, including in screening uptake, stage at diagnosis and access to multidisciplinary care; |
Or. en
Amendment 45
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital F a (new)
| Motion for a resolution | Amendment |
|---|---|
| Fa. whereas EU citizens face inequalities when it comes to cancer prevention, do not enjoy the same standard of protection against risk factors, and do not all receive the same education on healthy lifestyles; whereas following their recovery or while still in remission, they also do not enjoy the same universal ability to return to work, become financially independent or resume a well-balanced family, social and emotional life; |
Or. fr
Amendment 46
Ondřej Dostál
Motion for a resolution
Recital F a (new)
| Motion for a resolution | Amendment |
|---|---|
| Fa. whereas there remains a gap between the reimbursement for cancer care guaranteed by law and the reality experienced by patients, including unacceptable delays, across Member States; |
Or. en
Amendment 47
Marta Temido
Motion for a resolution
Recital F a (new)
| Motion for a resolution | Amendment |
|---|---|
| Fa. whereas systemic gender inequalities persist in cancer research, influencing priorities, funding and the focus of studies, thereby perpetuating gender disparities in health outcomes; |
Or. en
Amendment 48
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Recital F b (new)
| Motion for a resolution | Amendment |
|---|---|
| Fb. whereas the latest data shows that a number of Member States continue to work on the basis of out-of-date cancer action plans devised as long ago as 2008 (Belgium), 2009 (Sweden), 2014 (Austria, Finland and Lithuania), or – in the case of Greece, as of August 2025 – not at all; |
Or. fr
Amendment 49
Ondřej Dostál
Motion for a resolution
Recital F b (new)
| Motion for a resolution | Amendment |
|---|---|
| Fb. whereas inequalities in access to primary care, a key determinant of early cancer detection and effective treatment, persist within and across Member States; |
Or. en
Amendment 50
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, harmful alcohol consumption, poor nutrition, a sedentary lifestyle, obesity, environmental pollution and hazardous substances; whereas this risk factors are common to other chronic diseases and, therefore, cancer prevention and risk reduction measures have to be implemented in the context of an integrated chronic disease prevention programme, in close cooperation with the Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases; |
Or. en
Amendment 51
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco use, alcohol consumption, obesity, infections, unhealthy diets, environmental and air pollution, ultraviolet radiation exposure, and exposure to harmful materials and substances, including carcinogenic, mutagenic and reprotoxic substances, such as PFAS and endocrine disruptors; |
Or. en
Amendment 52
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Ondřej Knotek, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; whereas prevention is more effective than any cure, as well as being the most cost-effective long-term cancer control strategy; |
Or. fr
Amendment 53
Sebastian Everding
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. stresses that a significant proportion of cancers are preventable and that modifiable risk factors include not only tobacco, alcohol and environmental exposures, but also dietary patterns, including high consumption of red and processed meat and low intake of plant-based foods; emphasises that addressing overall dietary patterns is essential for effective cancer prevention policies; |
Or. en
Amendment 54
Kateřina Konečná
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40% of cancer cases can be prevented by limiting risk factors such as the smoking of combusted tobacco products, alcohol, obesity, environmental pollution, ultraviolet radiation exposure and hazardous substances; |
Or. en
Amendment 55
Alessandra Moretti
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by addressing risk factors such as tobacco, alcohol, obesity, physical inactivity, environmental pollution, ultraviolet radiation exposure and hazardous substances; |
Or. en
Amendment 56
Aurelijus Veryga
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution, ultraviolet radiation exposure, and hazardous substances; |
Or. en
Amendment 57
Ondřej Knotek
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as the smoking of combusted tobacco products, alcohol, obesity, environmental pollution and hazardous substances; |
Or. en
Amendment 58
Christophe Clergeau
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, ultraviolet radiation exposure, environmental pollution and hazardous substances; |
Or. en
Amendment 59
Tomislav Sokol
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, harmful alcohol consumption, obesity, environmental pollution and hazardous substances; |
Or. en
Amendment 60
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, harmful alcohol consumption, obesity, environmental pollution and hazardous substances; |
Or. en
Amendment 61
Pietro Fiocchi, Michele Picaro, Ruggero Razza, Carlo Fidanza
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as smoking, harmful alcohol abuse, obesity, environmental pollution and hazardous substances; |
Or. en
Amendment 62
Ondřej Krutílek
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco smoking, alcohol, obesity, environmental pollution and hazardous substances; |
Or. en
Amendment 63
Monika Beňová
Motion for a resolution
Recital G
| Motion for a resolution | Amendment |
|---|---|
| G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco, alcohol, obesity, environmental pollution and hazardous substances; | G. whereas prevention is the most cost-efficient long-term cancer control strategy; whereas 40 % of cancer cases can be prevented by limiting risk factors such as tobacco smoke, alcohol, obesity, environmental pollution and hazardous substances; |
Or. en
Amendment 64
Christophe Clergeau
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas 10% of the cancer burden in Europe is attributable to environmental risk factors especially pollution; whereas there is a significant cancer prevention potential in reducing and preventing pollution; whereas human biomonitoring shows that people are exposed daily to a multitude of toxic substances through food, drinking water, air, personal care products, and occupational settings; whereas health costs associated with endocrine disruptors-related illness alone are estimated at €163 billion annually for Europe; whereas widespread use of pesticides is a major source of pollution, contaminating water, soil and air, and posing serious risk to human health, including contributing to different types of cancer; whereas evidence suggests that the link between pesticide exposure and cancer risk is generally stronger in occupationally-exposed groups such as agricultural and forestry workers; whereas already in 2017, the societal costs, including health costs, on a European scale directly attributable to pesticides were estimated to be around €2.3 billion; whereas air pollution is linked to 0.5–1% of all cancer cases (2020) and to 7% of lung cancers in Europe (2018), causing 2% of EU cancer deaths (2020); |
Or. en
Amendment 65
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas diagnosis and early detection are key pillars of the cancer action strategy in increasing the chances of successful treatment; whereas new human-validated technologies are effective at better detecting and treating cancer; whereas all EU citizens – regardless of where they live, but especially those based in rural areas or the outermost regions – should be afforded access to effective diagnosis; |
Or. fr
Amendment 66
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. Recalls its position in the report on Europe’s Beating Cancer Plan (2020/2267(INI)), calling on the Commission to follow up on scientific evaluations of the health risks related to electronic cigarettes, heated tobacco products and other novel tobacco products, including comparative risk assessments; underlines the need to prevent access to these products by minors and non-smokers through appropriate regulatory measures, in line with the Tobacco Products Directive; |
Or. en
Amendment 67
Alessandra Moretti
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas new and emerging tobacco products, nicotine products and smoking devices are often marketed as less harmful without scientific evidence supporting those claims and in particular without taking into consideration medium or long terms effects for the use of those products; whereas the increase uptake by minors and young people, non smokers and vulnerable people is a source of major public health concern; |
Or. en
Amendment 68
Monika Beňová
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas products should not be treated as presenting identical health risks where scientific evidence indicates materially different risk profiles; whereas public health policy should therefore avoid undifferentiated approaches and instead reflect the relative level of harm associated with different products; |
Or. en
Amendment 69
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas the majority of cancer risk factors are already scientifically proven and preventable; whereas the challenge is not a lack of knowledge, but the inadequate, inconsistent and uneven implementation of existing prevention policies in the Member States; |
Or. el
Amendment 70
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas the current EU legislative framework on tobacco control has successfully contributed to the significant decline of the smoking prevalence across the European Union, as recalled in the Commission's Communication on the Safe Hearts Plan issued in December 2025; |
Or. en
Amendment 71
Nicolás González Casares
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas, according to the World Health Organization, no level of alcohol consumption is safe for human health, as alcohol is a toxic, psychoactive, and dependence-producing substance linked to a wide range of non-communicable diseases, including cancer; |
Or. en
Amendment 72
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas the Mediterranean diet is known by scientific evidences as a healthy, balanced diet that plays a protective role in the primary and secondary prevention of the main chronic degenerative diseases, including cancer; |
Or. en
Amendment 73
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas 10% of the cancer burden in Europe is attributable to environmental risk factors especially pollution; whereas there is a significant cancer prevention potential in reducing and preventing pollution; |
Or. en
Amendment 74
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital G a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ga. whereas patients and the rest of the population need to be properly informed about health if they are to change their lifestyles and understand their rights; |
Or. fr
Amendment 75
Alessandra Moretti
Motion for a resolution
Recital G b (new)
| Motion for a resolution | Amendment |
|---|---|
| Gb. whereas according to the WHO, exposure to second-hand tobacco smoke is a widespread source of mortality, morbidity and disability in the Union; whereas second-hand emissions from new and emerging tobacco and nicotine products can have potentially harmful health impacts and can expose people to potentially harmful levels of particulate matter and key toxicants; whereas recent evidence has indicated that exposure to second-hand emissions from heated tobacco products were associated with significant respiratory and cardiovascular abnormalities in bystanders and second-hand aerosols from electronic cigarettes, including both ones that do and do not contain nicotine, expose bystanders to quantifiable levels of particulate matter and key toxicants and contaminants; whereas the WHO considers that no level of side-stream exposure is safe or acceptable, so a careful approach should be taken and recommends applying tobacco control measures, including protection from exposure, to electronic cigarettes; |
Or. en
Amendment 76
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital G b (new)
| Motion for a resolution | Amendment |
|---|---|
| Gb. whereas the Mediterranean diet is recognised as a healthy, balanced diet that plays a protective role in the primary and secondary prevention of the main chronic degenerative diseases; whereas more than 620 000 deaths annually in the European Union are attributable to unhealthy diets, while more than half of adults and a growing proportion of children live with overweight or obesity; whereas children and adolescents are particularly susceptible to marketing practices that promote unhealthy food; |
Or. fr
Amendment 77
Monika Beňová
Motion for a resolution
Recital G b (new)
| Motion for a resolution | Amendment |
|---|---|
| Gb. whereas effective prevention policy must be grounded in the best available scientific evidence and should differentiate between products and patterns of consumption according to the level of risk they pose to health; whereas the nature of a product, its composition, its level of processing and the pattern of consumption are relevant factors in assessing its impact on cardiovascular and cancer related health outcomes; |
Or. en
Amendment 78
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital G b (new)
| Motion for a resolution | Amendment |
|---|---|
| Gb. whereas human biomonitoring shows that people are exposed daily to a multitude of toxic substances through food, drinking water, air, personal care products, and occupational settings; whereas increasing evidence links exposure to endocrine-disrupting chemicals (EDCs), as well as "forever chemicals" like per- and polyfluoroalkyl substances (PFAS) to an increased risk of cancer; |
Or. en
Amendment 79
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital G c (new)
| Motion for a resolution | Amendment |
|---|---|
| Gc. whereas already in 2017, the societal costs, including health costs, on a European scale directly attributable to pesticides were estimated to be around €2.3 billion; whereas air pollution is linked to 0.5–1% of all cancer cases (2020) and to 7% of lung cancers in Europe (2018), causing 2% of EU cancer deaths (2020)1a; | |
| 1a https://www.eea.europa.eu/en/analysis/publications/beating-cancer-the-role-of-europes-environment/air-pollution?utm_source=chatgpt.com |
Or. en
Amendment 80
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital G c (new)
| Motion for a resolution | Amendment |
|---|---|
| Gc. whereas the exposome approach considers the totality of environmental, chemical, physical, biological, social, commercial and behavioural exposures across an individual’s lifetime and provides a unified framework for targeted prevention; |
Or. fr
Amendment 81
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital G d (new)
| Motion for a resolution | Amendment |
|---|---|
| Gd. whereas many risk factors, including tobacco use, harmful alcohol consumption, unhealthy diets, a sedentary lifestyle and environmental exposures, are shared with other non-communicable diseases; |
Or. fr
Amendment 82
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital G d (new)
| Motion for a resolution | Amendment |
|---|---|
| Gd. whereas environmental pollution and exposure to carcinogens disproportionately affect marginalised and low-income communities; |
Or. en
Amendment 83
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; whereas new and emerging tobacco and nicotine products, including electronic cigarettes, heated tobacco products and nicotine pouches, are increasingly prevalent among young people across the Union, posing risks of addiction and long-term health effects that are not yet fully addressed by the existing legislative framework; |
Or. en
Amendment 84
Bartosz Arłukowicz
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use, and whereas the proportion of 15-16-year-olds using e-cigarettes across 34 European countries is 22 % on average, which indicates a worrying upward trend among young people and which is the highest rate of tobacco use in the world; |
Or. pl
Amendment 85
Monika Beňová
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco and nicotine related products present different risk profiles; whereas this should not lead to any weakening of public health protection, but should support proportionate and evidence based regulation, particularly with regard to preventing uptake among minors and non-smokers; |
Or. en
Amendment 86
Alessandra Moretti
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; whereas the social cost of tobacco remains significant, with smoking linked to one in seven deaths in the EU; |
Or. en
Amendment 87
Sebastian Everding
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas the social cost of tobacco remains significant, with smoking linked to one in seven deaths in the EU, tobacco causes 27 % of all cancers, while 90 % of lung cancer cases can be avoided by eliminating tobacco use; |
Or. en
Amendment 88
Ondřej Knotek
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas the smoking of combusted tobacco products causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco smoking; |
Or. en
Amendment 89
Kateřina Konečná
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas the smoking of combusted tobacco products causes 27% of all cancers, and 90% of lung cancer cases can be avoided by eliminating smoking; |
Or. en
Amendment 90
Ondřej Krutílek
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco smoking causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco smoking; |
Or. en
Amendment 91
Monika Beňová
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco smoke causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; |
Or. en
Amendment 92
Jessica Polfjärd
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas tobacco smoking causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating smoking; |
Or. en
Amendment 93
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Recital H
| Motion for a resolution | Amendment |
|---|---|
| H. whereas tobacco causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating tobacco use; | H. whereas smoking causes 27 % of all cancers, and 90 % of lung cancer cases can be avoided by eliminating smoking; |
Or. en
Amendment 94
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital H a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ha. whereas the World Health Organization does not recommend electronic cigarettes as a smoking cessation aid; Whereas the World Health Organization’s most recent global report on trends in tobacco use indicates alarmingly high levels of e-cigarette use among adolescents, estimating that 4.2 million users aged 13 to 15 live in the European Region, and that uptake of e-cigarettes among young people already exceeds that of traditional cigarettes; |
Or. en
Amendment 95
Alessandra Moretti
Motion for a resolution
Recital H a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ha. whereas tobacco and smoking continue to impose a significant economic burden on the EU and its Member States, with total healthcare costs and productivity losses due to smoking estimated at approximately EUR 130 billion annually, corresponding to around 2.5% of GDP, and resulting in substantial productivity losses, including the loss of approximately 433,000 individuals of working age; |
Or. en
Amendment 96
Aurelijus Veryga
Motion for a resolution
Recital H a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ha. whereas smoking is responsible for approximately 20% of cancer cases in Europe, causing at least 16 different types of cancer; whereas it contributes to more than 80% of all lung cancer cases and accounts for over 250,000 deaths annually from cancers of the trachea, bronchus and lung in the EU; |
Or. en
Amendment 97
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Recital H a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ha. whereas e-cigarette use among 15–16-year-olds has reached 22 % on average across 34 European countries, up from 14 % in 2019, with prevalence higher among girls (25 %) than boys (19 %); whereas this trend constitutes an emerging cancer risk requiring urgent regulatory attention;1a | |
| 1a https://www.who.int/docs/librariesprovider2/default-document-library/03_youth-prevalence_2025.pdf |
Or. en
Amendment 98
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Recital H a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ha. whereas the Commission's evaluation of the legislative framework for tobacco and related products does not sufficiently reflect Parliament's request for an evidence-based assessment of the risks of related products versus tobacco; |
Or. en
Amendment 99
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital H b (new)
| Motion for a resolution | Amendment |
|---|---|
| Hb. whereas tobacco and smoking continue to impose a significant economic burden on the EU and its Member States, with total healthcare costs and productivity losses due to smoking estimated at approximately EUR 130 billion annually, corresponding to around 2.5% of GDP, and resulting in substantial productivity losses, including the loss of approximately 433,000 individuals of working age; |
Or. en
Amendment 100
Alessandra Moretti
Motion for a resolution
Recital H b (new)
| Motion for a resolution | Amendment |
|---|---|
| Hb. whereas alcohol is a Group 1 carcinogenic and a risk factor for several types of cancer; whereas, according to WHO, there is no safe level of alcohol consumption with regard to cancer risk; |
Or. en
Amendment 101
Alessandra Moretti
Motion for a resolution
Recital H c (new)
| Motion for a resolution | Amendment |
|---|---|
| Hc. whereas the WHO Europe region will be the only WHO region not expected to meet the global target of a 30% reduction in tobacco use among women by 2025; |
Or. en
Amendment 102
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Recital I
| Motion for a resolution | Amendment |
|---|---|
| I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; | I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; whereas new scientific findings1a have shown that small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, especially for young adult, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. Therefore, the scientific evidences strongly suggest that statements, guidelines, and recommendations on the optimal level of alcohol consumption need to take into consideration the background rates of diseases and injuries for each population and that the level of alcohol consumption that minimises health loss varies significantly across populations. At the same time, small amounts of alcohol consumption are associated with improved health outcomes in populations that predominantly face a high burden of cardiovascular diseases, particularly older adults in many world regions; |
| 1a Gakidou, E. and G.A. Collaborators, Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet, 2022. 400(10347): p. 185-235. https://pmc.ncbi.nlm.nih.gov/articles/PMC9289789/pdf/main.pdf |
Or. en
Amendment 103
Monika Beňová
Motion for a resolution
Recital I
| Motion for a resolution | Amendment |
|---|---|
| I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; | I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; whereas alcohol related harm should be addressed through evidence based and proportionate public health measures, with particular attention to the protection of children, adolescents and other vulnerable groups; |
Or. en
Amendment 104
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital I
| Motion for a resolution | Amendment |
|---|---|
| I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; | I. whereas 3 in 10 alcohol-attributable deaths are due to cancer, and between 2030 and 2050 up to 1 million additional cancer cases could be prevented if alcohol consumption targets were met; |
Or. en
Amendment 105
Aurelijus Veryga
Motion for a resolution
Recital I
| Motion for a resolution | Amendment |
|---|---|
| I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; | I. whereas 3 in 10 alcohol-attributable deaths are due to cancer and between 2030 and 2050 up to 1 million additional cancer cases could be prevented if alcohol consumption targets were met; |
Or. en
Amendment 106
Pietro Fiocchi, Michele Picaro, Ruggero Razza, Carlo Fidanza
Motion for a resolution
Recital I
| Motion for a resolution | Amendment |
|---|---|
| I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; | I. whereas cancer is responsible for 3 in 10 deaths attributable to harmful alcohol abuse; |
Or. en
Amendment 107
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Recital I
| Motion for a resolution | Amendment |
|---|---|
| I. whereas 3 in 10 alcohol-attributable deaths are due to cancer; | I. whereas 3 in 10 alcohol-attributable deaths are due to cancer;1a |
| 1a https://www.who.int/docs/librariesprovider2/default-document-library/factsheet_alcoholandcancer_final.pdf |
Or. en
Amendment 108
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital I a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ia. whereas alcohol is a toxic, psychoactive and dependence-producing substance, classified decades ago by the IARC as a Group 1 carcinogen; whereas 4.1 % of all new cancer cases worldwide in 2020 were attributable to alcohol consumption ; whereas a study cited by the WHO concludes that no level of alcohol consumption is safe with regard to cancer prevention and underscores the need to reflect this evidence in the design and implementation of cancer prevention policies; |
Or. en
Amendment 109
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Recital I a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ia. whereas prevention should primarily focus on alcohol abuse, particularly among young people, by means of appropriate information, education and awareness-raising initiatives; |
Or. fr
Amendment 110
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Recital I a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ia. whereas harmful alcohol consumption is a risk factor in the development of certain types of cancer, the incidence of which depends on drinking patterns and other associated factors; |
Or. en
Amendment 111
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Recital J
| Motion for a resolution | Amendment |
|---|---|
| J. whereas 16 % of adults in the EU were living with obesity in 2019; | J. whereas obesity is linked to at least 13 types of cancer; whereas 16 % of adults in the EU were living with obesity in 2019; whereas WHO Europe estimates that obesity is likely to be directly responsible for at least 200 000 new cancer cases annually; |
Or. en
Amendment 112
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital J
| Motion for a resolution | Amendment |
|---|---|
| J. whereas 16 % of adults in the EU were living with obesity in 2019; | J. whereas obesity is linked to 13 types of cancer, and 16 % of adults in the EU were living with obesity in 2019; whereas WHO Europe estimates obesity is likely to be directly responsible for at least 200 000 new cancer cases in the region annually; |
Or. en
Amendment 113
Aurelijus Veryga
Motion for a resolution
Recital J
| Motion for a resolution | Amendment |
|---|---|
| J. whereas 16 % of adults in the EU were living with obesity in 2019; | J. whereas obesity is linked to 13 types of cancer, 16 % of adults in the EU were living with obesity in 2019 and WHO Europe estimates obesity is likely to be directly responsible for at least 200 000 new cancer cases in the region annually; |
Or. en
Amendment 114
Christophe Clergeau
Motion for a resolution
Recital J
| Motion for a resolution | Amendment |
|---|---|
| J. whereas 16 % of adults in the EU were living with obesity in 2019; | J. whereas obesity is linked to 13 types of cancer, 16 % of adults in the EU were living with obesity in 2019 and WHO Europe estimates obesity is likely to be directly responsible for at least 200 000 new cancer cases in the region annually; |
Or. en
Amendment 115
Alessandra Moretti
Motion for a resolution
Recital J
| Motion for a resolution | Amendment |
|---|---|
| J. whereas 16 % of adults in the EU were living with obesity in 2019; | J. whereas obesity is linked to 13 types of cancer and 16 % of adults in the EU were living with obesity in 2019; |
Or. en
Amendment 116
Alessandra Moretti
Motion for a resolution
Recital J a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ja. whereas over 60 % of adults in the WHO European Region are living with overweight or obesity; whereas 1 in 4 children aged 6–9 years across Europe are living with overweight or obesity, and in southern European countries nearly 1 in 5 children are living with obesity alone; whereas excess body weight at any level above healthy range increases cancer risk, and the food environments that drive overweight and obesity must therefore be addressed as a structural public health priority; |
Or. en
Amendment 117
Monika Beňová
Motion for a resolution
Recital J a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ja. whereas nutritional policy should distinguish between foods on the basis of their nutritional composition, level of processing and overall role in a balanced diet; whereas lean, unprocessed foods that are sources of essential nutrients should not be equated, without adequate scientific justification, with ultra-processed foods that are associated with higher health risks when consumed excessively; |
Or. en
Amendment 118
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital J a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ja. whereas prevailing dietary patterns, characterised by excessive consumption of foods high in fat, sugars and salt (HFSS), ultra-processed foods (UPFs) and animal-based products, as well as insufficient intake of plant-based foods, are major contributors to obesity and metabolic dysfunction, thereby increasing the risk of cancer; |
Or. en
Amendment 119
Sebastian Everding
Motion for a resolution
Recital J a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ja. whereas plant-based diets are associated with a lower risk of obesity while unhealthy dietary patterns, including high consumption of animal products and insufficient intake of plant-based foods are key drivers of obesity and metabolic dysfunction, which are major risk factors for multiple cancers; |
Or. en
Amendment 120
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital J a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ja. whereas overweight, obesity and a sedentary lifestyle from a very young age are major risk factors across people’s lives and increase the likelihood of developing a number of non-communicable diseases, including some cancers; |
Or. fr
Amendment 121
Alessandra Moretti
Motion for a resolution
Recital J b (new)
| Motion for a resolution | Amendment |
|---|---|
| Jb. whereas unhealthy diets, such as those characterised by high consumption of foods high in fat, sugars and salt (HFSS) and ultra-processed foods (UPFs) together with a low consumption of fruits, vegetables, legumes and whole grains, are an independent and major driver of cancer risk beyond obesity alone; whereas food environments across the Union do not consistently make the healthy choice the easy choice for consumers; |
Or. en
Amendment 122
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital J b (new)
| Motion for a resolution | Amendment |
|---|---|
| Jb. whereas according to the WHO and the IARC, increased consumption of plant-based foods supports cancer prevention, while the overconsumption of meat, ultra-processed foods and products high in sugars, salt and fats, as well as exposure to harmful food contaminants, should be addressed; |
Or. en
Amendment 123
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital J b (new)
| Motion for a resolution | Amendment |
|---|---|
| Jb. whereas regular physical activity and sport go a long way towards preventing overweight, obesity and a number of risk factors linked to cancer, while also improving physical and mental health; |
Or. fr
Amendment 124
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital J c (new)
| Motion for a resolution | Amendment |
|---|---|
| Jc. whereas the IARC highlights socio economic inequalities as a major determinant of cancer outcomes, both between and within countries, with lower socio economic status being associated with higher cancer mortality for many types of cancer, and current efforts to address these disparities remaining insufficient ; whereas despite progress, significant inequalities persist between and within Member States in terms of prevention, screening, early diagnosis, treatment, survivorship and palliative care; |
Or. en
Amendment 125
Alessandra Moretti
Motion for a resolution
Recital J c (new)
| Motion for a resolution | Amendment |
|---|---|
| Jc. whereas approximately 12 million women in Europe are living with cancer, and each year more than 1.2 million women in the European Union are diagnosed with cancer and nearly 600,000 die from the disease; |
Or. en
Amendment 126
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital J c (new)
| Motion for a resolution | Amendment |
|---|---|
| Jc. whereas the promotion of regular physical activity and a balanced diet from childhood onwards should be a health priority for the EU; |
Or. fr
Amendment 127
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital J d (new)
| Motion for a resolution | Amendment |
|---|---|
| Jd. whereas commercial determinants of health, including marketing and misleading claims, can undermine prevention policies and normalise harmful consumption with clear socio-economic gradients in exposure, especially among children and young people; |
Or. en
Amendment 128
Alessandra Moretti
Motion for a resolution
Recital J d (new)
| Motion for a resolution | Amendment |
|---|---|
| Jd. whereas commercial determinants of health play a decisive role in shaping consumption patterns and cancer risk; whereas such practices disproportionately affect lower-income households and children; |
Or. en
Amendment 129
Alessandra Moretti
Motion for a resolution
Recital J e (new)
| Motion for a resolution | Amendment |
|---|---|
| Je. whereas the affordability and accessibility of healthy foods are key structural determinants of diet quality and cancer prevention; whereas in many Member States fruits, vegetables, legumes and whole grains remain more expensive relative to HFSS and ultra-processed alternatives, creating socioeconomic barriers to healthy eating that public policy must address; |
Or. en
Amendment 130
Aurelijus Veryga
Motion for a resolution
Recital K
| Motion for a resolution | Amendment |
|---|---|
| K. whereas cancers caused by infections account for over 7 % of all EU cancer cases; | K. whereas cancers caused by infections account for over 7 % of all EU cancer cases; whereas Helicobacter pylori infection is the leading risk factor for gastric cancer; whereas its global prevalence is estimated at around 43.1 %, with significant variation across Member States; |
Or. en
Amendment 131
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital K a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ka. whereas Rheumatic and Musculoskeletal Diseases (RMDs) affect over 120 million people across Europe, with the prevalence of RMDs such as rheumatoid arthritis and knee osteoarthritis projected to rise by 80.2% and 74.9% respectively by 2050, whereas people living with RMDs face an elevated risk of cancer, current cancer policy frameworks fail to adequately recognize and address this link; |
Or. en
Amendment 132
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Recital K a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ka. whereas antimicrobial resistance (AMR) poses a growing threat to the safety and effectiveness of cancer care, particularly for immunocompromised patients, and risks undermining decades of progress in cancer prevention, diagnosis and treatment; |
Or. en
Amendment 133
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital K a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ka. whereas structural, socio-economic, environmental and commercial factors play a decisive role in determining the risk of cancer in the EU; |
Or. fr
Amendment 134
Alessandra Moretti
Motion for a resolution
Recital K a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ka. whereas environmental factors, in particular air quality, are major risk factors for the development of serious health conditions and diseases, including cancer; |
Or. en
Amendment 135
Alessandra Moretti
Motion for a resolution
Recital K b (new)
| Motion for a resolution | Amendment |
|---|---|
| Kb. whereas 10% of the cancer burden in Europe is attributable to environmental risk factors especially pollution; whereas there is a significant cancer prevention potential in reducing and preventing pollution; whereas increasing evidence links exposure to endocrine-disrupting chemicals (EDCs), as well as "forever chemicals" like per- and polyfluoroalkyl substances (PFAS) to an increased risk of cancer; whereas widespread use of chemicals in human activities is a major source of concern causing contamination in water, soil and air; |
Or. en
Amendment 136
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital L
| Motion for a resolution | Amendment |
|---|---|
| L. whereas rare cancers account for approximately 24 % of all new cancer cases in the EU; | L. whereas rare cancers account for approximately 24 % of all new cancer cases in the EU and are associated with delayed detection, limited treatment options, scarce clinical expertise and major cross-border inequalities; whereas addressing rare cancers requires strong EU-level coordination, dedicated funding and reinforced European Reference Networks; |
Or. en
Amendment 137
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital L
| Motion for a resolution | Amendment |
|---|---|
| L. whereas rare cancers account for approximately 24 % of all new cancer cases in the EU; | L. whereas rare cancers, including all paediatric cancers, account for approximately 24 % of all new cancer cases in the EU, and are a public health challenge in and of themselves; |
Or. fr
Amendment 138
Aurelijus Veryga
Motion for a resolution
Recital L a (new)
| Motion for a resolution | Amendment |
|---|---|
| La. whereas approximately 12 million women in Europe are living with cancer, and each year more than 1.2 million women in the European Union are diagnosed with cancer and nearly 600,000 die from the disease; |
Or. en
Amendment 139
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital M
| Motion for a resolution | Amendment |
|---|---|
| M. whereas cancer is the leading cause of death by disease in children over one year of age in the EU, with over 15 500 diagnoses and over 2 000 deaths in 2020; | M. whereas cancer is the leading cause of death by disease in children over one year of age in the EU, with over 15 500 diagnoses and over 2 000 deaths in 2020; whereas concerns have been raised in several Member States regarding potential clusters of paediatric cancers, prompting investigations by national authorities; whereas, while many such clusters may be attributable to statistical variation, their occurrence highlights the need for strengthened surveillance, improved data collection and enhanced research into potential environmental and other risk factors; |
Or. en
Amendment 140
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Recital M
| Motion for a resolution | Amendment |
|---|---|
| M. whereas cancer is the leading cause of death by disease in children over one year of age in the EU, with over 15 500 diagnoses and over 2 000 deaths in 2020; | M. whereas cancer is the leading cause of death by disease in children over one year of age in the EU, with over 15 500 diagnoses and over 2 000 deaths in 2020; whereas the last ten years have seen fewer than twenty oncology treatments receive authorisation for use in children, in stark contrast with the over 150 approvals granted for adult cancers, pointing to a chronic and still unaddressed gap in therapeutic options for younger patients; |
Or. en
Amendment 141
Alessandra Moretti
Motion for a resolution
Recital M a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ma. whereas sixty percent of all cases with cancer, and 70% of cancer-related deaths occur in patients aged 65 years and over; whereas the improvements foreseen in terms of life expectancy will result in a growing population of older people, with consequent increase also in cancer cases; whereas elderly cancer patients faces discriminations based on their age in terms of access to treatment, in particular innovative treatments and clinical trials; whereas age should not be the only factor for the evaluation of a patient health conditions, but instead a multidimensional evaluation should be prioritised, in line with the comprehensive geriatric assessment principle; |
Or. en
Amendment 142
Sebastian Everding
Motion for a resolution
Recital M a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ma. whereas all childhood cancers are rare with additional specificities and represent the leading cause of death by disease in children over one year of age in the EU, with over 15 500 diagnoses and over 2 000 deaths in 2020, and more than 400,000 European citizens are childhood cancer survivors, with an important proportion experiencing severe adverse late effects related to past tumour or treatments; |
Or. en
Amendment 143
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital M a (new)
| Motion for a resolution | Amendment |
|---|---|
| Ma. whereas the specific needs of children and adolescents with cancer require ongoing attention and support worldwide; whereas paediatric cancers should be handled differently to cancer in adults; |
Or. fr
Amendment 144
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital M b (new)
| Motion for a resolution | Amendment |
|---|---|
| Mb. whereas ageing is a major factor behind the incidence of cancer, and whereas many cancer patients are older people with specific vulnerabilities, comorbidities and care needs, which will require a more robust approach to prevention, diagnosis, treatment and follow-up for older people; |
Or. fr
Amendment 145
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital N a (new)
| Motion for a resolution | Amendment |
|---|---|
| Na. whereas informal caregivers, including family members, play a crucial role in supporting cancer patients and often face significant psychological, social and financial burdens; whereas families of children and adolescents with cancer face specific and particularly acute challenges, as parents or legal guardians are often required to reduce or suspend their professional activity in order to provide care; whereas this caregiving responsibility disproportionately affects women and may lead to substantial long-term social and economic consequences, including impacts on income, career progression and pension rights; |
Or. en
Amendment 146
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Recital N a (new)
| Motion for a resolution | Amendment |
|---|---|
| Na. whereas multiple large-scale clinical studies conducted between 2025 and 2026 have independently demonstrated that AI-supported cancer screening significantly increases detection rates while reducing clinical workload, across breast, colorectal and lung cancers; |
Or. en
Amendment 147
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Recital N b (new)
| Motion for a resolution | Amendment |
|---|---|
| Nb. whereas cancer is the leading cause of work-related mortality in the European Union, with 45.6% of all occupational deaths attributable to cancer; |
Or. en
Amendment 148
Alessandra Moretti
Motion for a resolution
Recital O a (new)
| Motion for a resolution | Amendment |
|---|---|
| Oa. whereas the current fragmented financing landscape, relying on multiple short-term programmes and grants, limits the Union’s capacity to support long-term investment in cancer prevention, screening, treatment and survivorship, and risks exacerbating inequalities between Member States; whereas ensuring adequate, dedicated, predictable and ring-fenced funding within the multiannual financial framework is essential for the effective implementation of Europe’s Beating Cancer Plan; |
Or. en
Amendment 149
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital O a (new)
| Motion for a resolution | Amendment |
|---|---|
| Oa. whereas sustained and effective funding is needed to support ambitious projects and provide stable and satisfactory working conditions for researchers in the field of cancer; whereas pharmaceutical companies, including SMEs, are key drivers of innovation in the field of cancer; |
Or. fr
Amendment 150
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Recital O a (new)
| Motion for a resolution | Amendment |
|---|---|
| Oa. whereas companies that produce medical devices, including SMEs, are key drivers of innovation in the field of cancer; |
Or. fr
Amendment 151
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital O b (new)
| Motion for a resolution | Amendment |
|---|---|
| Ob. whereas the EU is still heavily reliant on non-EU countries for the production of active pharmaceutical ingredients, anti-cancer medicines and some medical technologies; whereas in consequence, patients and European healthcare systems are susceptible to supply disruptions, strategic weaknesses and price volatility; |
Or. fr
Amendment 152
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital O c (new)
| Motion for a resolution | Amendment |
|---|---|
| Oc. whereas it is essential to strengthen Europe’s strategic autonomy in the field of cancer prevention, diagnosis and treatment in order to ensure that all patients in the EU are afforded safe, swift and fair access to medicines and medical technologies; |
Or. fr
Amendment 153
Adam Jarubas
Motion for a resolution
Recital P
| Motion for a resolution | Amendment |
|---|---|
| P. whereas the lack of a monitoring and evaluation framework with measurable indicators, baselines and targets makes it difficult to assess the Plan’s long-term effectiveness and impact; | P. whereas the lack of a monitoring and evaluation framework with measurable indicators, baselines and targets makes it difficult to assess the Plan’s long-term effectiveness and impact, and where more granular indicators are needed in order to measure inequalities between Member States and across different cancer types, including breast and prostate cancer, metastatic disease; |
Or. en
Amendment 154
Aurelijus Veryga
Motion for a resolution
Recital P
| Motion for a resolution | Amendment |
|---|---|
| P. whereas the lack of a monitoring and evaluation framework with measurable indicators, baselines and targets makes it difficult to assess the Plan’s long-term effectiveness and impact; | P. whereas the lack of a monitoring and evaluation framework with measurable indicators, baselines and targets makes it difficult to assess the Plan’s long-term effectiveness and impact; whereas more granular indicators are needed in order to measure inequalities between Member States and across different cancer types, including breast cancer and metastatic disease; |
Or. en
Amendment 155
András Tivadar Kulja
Motion for a resolution
Recital P
| Motion for a resolution | Amendment |
|---|---|
| P. whereas the lack of a monitoring and evaluation framework with measurable indicators, baselines and targets makes it difficult to assess the Plan’s long-term effectiveness and impact; | P. whereas the lack of a monitoring and evaluation framework with measurable indicators, baselines and targets makes it difficult to assess the Plan’s long-term effectiveness and impact, and where more detailed indicators are required to assess disparities among Member States and across various cancer types; |
Or. en
Amendment 156
Sebastian Everding
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas Europe’s Beating Cancer Plan set the objective of ensuring that by 2025, 90 % of the target population is offered breast, cervical and colorectal cancer screening; whereas available evidence indicates that this objective has not been achieved and that participation rates in some screening programmes are stagnating or declining, making renewed political focus on organised, population-based screening programmes urgent; |
Or. en
Amendment 157
Emmanouil Fragkos, Galato Alexandraki
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas the increasing polarisation, dramatisation and aggression in public discourse, especially in the political and journalistic arena, is burdening citizens' mental health and reinforcing chronic stress, which is associated with negative effects on physical health; whereas public opinion-forming bodies have a responsibility to promote responsible and evidence-based discourse; |
Or. el
Amendment 158
Marie-Luce Brasier-Clain, Aleksandar Nikolic, Margarita de la Pisa Carrión, Valérie Deloge, Aldo Patriciello
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas nutrition is a fundamental determinant of health and plays a key role in the prevention of non-communicable diseases, including cancer; whereas the Mediterranean diet is a model of nutritional excellence that can contribute to cancer prevention, in particular by reducing the risk of certain types of cancer and supporting overall metabolic and inflammatory balance; |
Or. en
Amendment 159
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas the Plan has not been implemented evenly across the board; whereas although tangible progress has been made with screening frameworks, HPV measures, digital infrastructure, telemedicine and some initiatives aimed at improving quality of life, efforts to provide support for survivors and reduce inequalities have continued to lag behind; |
Or. fr
Amendment 160
Alessandra Moretti
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| P a. whereas a comprehensive “Health in All Policies" approach, as anchored in Article 168 TFEU, requires the systematic integration of health considerations, including prevention and the social, environmental and commercial determinants of health, across all Union policies in line with the One Health and exposome approach; |
Or. en
Amendment 161
Aurelijus Veryga
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| P a. whereas advances in early detection, innovative treatments, and comprehensive supportive care have resulted in a growing population of over 20 million cancer survivors across Europe, reflecting both remarkable medical progress and an urgent need for continued policy support; |
Or. en
Amendment 162
Kateřina Konečná
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas advances in early detection, innovative treatments, and comprehensive supportive care have resulted in a growing population of over 20 million cancer survivors across Europe, reflecting both remarkable medical progress and an urgent need for continued policy support; |
Or. en
Amendment 163
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas some measures under the Plan have been delayed or suspended, including action in the areas of health education, tobacco, excessive alcohol consumption, childhood obesity and sunbeds; |
Or. fr
Amendment 164
Christophe Clergeau
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas approximately 12 million women in Europe are living with cancer, and each year more than 1.2 million women in the European Union are diagnosed with cancer and nearly 600,000 die from the disease1a; | |
| 1a L’Hôte M, Rubio I, Erba P, Kiss A (2024) Women & Cancer: More than 12 million reasons for actions. Policy Action Paper. European Cancer Organisation. |
Or. en
Amendment 165
Michalis Hadjipantela
Motion for a resolution
Recital P a (new)
| Motion for a resolution | Amendment |
|---|---|
| Pa. whereas malnutrition is one of the most frequent and serious complications in cancer patients and significantly affects treatment outcomes, quality of life and survival; |
Or. en
Amendment 166
Aurelijus Veryga
Motion for a resolution
Recital P b (new)
| Motion for a resolution | Amendment |
|---|---|
| Pb. whereas 5–10% of cancers are metastatic at first diagnosis, equating to around 270,000 people per year in the EU having specific needs, a substantial percentage of cancers detected early will relapse, even with access to treatment, with the total number of people in the EU living with metastatic cancer undercounted due to cancer registry limitations; |
Or. en
Amendment 167
Alessandra Moretti
Motion for a resolution
Recital P b (new)
| Motion for a resolution | Amendment |
|---|---|
| P b. whereas scientific evidence shows that a majority of cancer cases are linked to modifiable risk factors and cumulative exposures over the life course, including environmental, occupational and lifestyle-related factors, in line with the exposome and One Health approach, thereby highlighting the central role of prevention policies; |
Or. en
Amendment 168
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P b (new)
| Motion for a resolution | Amendment |
|---|---|
| Pb. whereas carers play a pivotal role throughout the cancer care pathway; whereas inequalities between the Member States remain, however, in the support that carers receive, including psychosocial support, time off and measures designed to promote a work-life balance; |
Or. fr
Amendment 169
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P b (new)
| Motion for a resolution | Amendment |
|---|---|
| Pb. whereas on average, half of the cancer medicines authorised by the European Medicines Agency are not available in the Member States, as they have not been authorised by the relevant national authority, with significant disparities across the EU; |
Or. fr
Amendment 170
Kateřina Konečná
Motion for a resolution
Recital P b (new)
| Motion for a resolution | Amendment |
|---|---|
| Pb. whereas approximately 12 million women in Europe are living with cancer, and each year more than 1.2 million women in the European Union are diagnosed with cancer and nearly 600,000 die from the disease; |
Or. en
Amendment 171
Christophe Clergeau
Motion for a resolution
Recital P b (new)
| Motion for a resolution | Amendment |
|---|---|
| Pb. whereas cancer is the leading cause of work-related mortality in the European Union, with 45.6% of all occupational deaths attributable to cancer; |
Or. en
Amendment 172
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P c (new)
| Motion for a resolution | Amendment |
|---|---|
| Pc. whereas cancer patients often have to contend with medicine shortages; whereas serious disruptions to the supply of cancer treatments are extremely detrimental to cancer patients, their carers and their families; |
Or. fr
Amendment 173
Alessandra Moretti
Motion for a resolution
Recital P c (new)
| Motion for a resolution | Amendment |
|---|---|
| Pc. whereas inequalities in cancer outcomes are closely linked to broader social and territorial inequalities, including income, education, age, gender, and access to healthcare services, and require targeted and coordinated Union action; |
Or. en
Amendment 174
Kateřina Konečná
Motion for a resolution
Recital P c (new)
| Motion for a resolution | Amendment |
|---|---|
| Pc. whereas cancer is the leading cause of work-related mortality in the European Union, with 45.6% of all occupational deaths attributable to cancer; |
Or. en
Amendment 175
Kateřina Konečná
Motion for a resolution
Recital P d (new)
| Motion for a resolution | Amendment |
|---|---|
| Pd. whereas 5–10% of cancers are metastatic at first diagnosis, equating to around 270,000 people per year in the EU having specific needs, a substantial percentage of cancers detected early will relapse, even with access to treatment, with the total number of people in the EU living with metastatic cancer undercounted due to cancer registry limitations; |
Or. en
Amendment 176
Alessandra Moretti
Motion for a resolution
Recital P d (new)
| Motion for a resolution | Amendment |
|---|---|
| Pd. whereas prevention policies must address not only individual behaviours but also commercial determinants of health, including the marketing and availability of harmful products such as tobacco, alcohol and ultra-processed foods; |
Or. en
Amendment 177
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P d (new)
| Motion for a resolution | Amendment |
|---|---|
| Pd. whereas patient-centred approaches to treatment have been shown to improve quality of life and overall survival rates for patients; |
Or. fr
Amendment 178
Alessandra Moretti
Motion for a resolution
Recital P e (new)
| Motion for a resolution | Amendment |
|---|---|
| Pe. whereas recent advances in cancer research, including the development of targeted immunotherapies and mRNA-based cancer vaccines, rely on the identification of tumour-specific neoantigens, enabling more precise and potentially personalised or semi-personalised treatments; whereas such approaches aim to trigger broader and more effective immune responses against cancer cells while limiting damage to healthy tissue; whereas these innovative therapies hold significant promise for improving outcomes but raise important challenges in terms of affordability, scalability and sustainability for public healthcare systems; |
Or. en
Amendment 179
Kateřina Konečná
Motion for a resolution
Recital P e (new)
| Motion for a resolution | Amendment |
|---|---|
| Pe. whereas the European Parliament’s 2022 report on Europe’s Beating Cancer Plan emphasised the importance of comprehensive, evidence -based prevention targeting modifiable risk factors; whereas that report highlighted the need for improved health promotion, behavioural change and effective prevention measures based on scientific evidence; |
Or. en
Amendment 180
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Recital P e (new)
| Motion for a resolution | Amendment |
|---|---|
| Pe. whereas there is tremendous potential in the use of new technologies and AI, assuming that it is overseen by humans, for improving cancer research, treatment processes and patient care; |
Or. fr
Amendment 181
Alessandra Moretti
Motion for a resolution
Recital P f (new)
| Motion for a resolution | Amendment |
|---|---|
| Pf. whereas Europe’s Beating Cancer Plan set the objective of ensuring that by 2025 90 % of the target population is offered breast, cervical and colorectal cancer screening; whereas available evidence indicates that this objective has not been achieved and that participation rates in some screening programmes are stagnating or declining, making renewed political focus on organised, population-based screening programmes urgent; |
Or. en
Amendment 182
Alessandra Moretti
Motion for a resolution
Paragraph -1 (new)
| Motion for a resolution | Amendment |
|---|---|
| -1. Stresses that access to high quality, accessible and public healthcare services is a fundamental right of every person in the EU and represents one of the most effective strategy to prevent, detect and treat cancer effectively; regrets the discriminations faced by EU citizens in the access to those services and calls for the Commission and member states to address urgently the matter; calls in this sense for legislative and regulatory measures at EU and national level to identify and guarantee minimum standards in terms of access to healthcare services for all in the EU; | |
| ;; |
Or. en
Amendment 183
Alessandra Moretti
Motion for a resolution
Paragraph 1
| Motion for a resolution | Amendment |
|---|---|
| 1. Welcomes the Plan as a groundbreaking framework addressing the entire cancer disease pathway at EU level and a cornerstone of the European Health Union; | 1. Welcomes the Plan as a groundbreaking framework addressing the entire cancer disease pathway at EU level and a cornerstone of the European Health Union; stresses that its future implementation should be guided by a "Health in All Policies" approach, ensuring that prevention and health considerations are systematically integrated across all relevant Union policies in line with the One Health and exposome approach; |
Or. en
Amendment 184
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 1
| Motion for a resolution | Amendment |
|---|---|
| 1. Welcomes the Plan as a groundbreaking framework addressing the entire cancer disease pathway at EU level and a cornerstone of the European Health Union; | 1. Welcomes the Plan as a groundbreaking framework addressing the entire cancer disease pathway at EU level and a cornerstone of the European Health Union; points out, however, that the Plan’s effectiveness hinges primarily on its being supported by the Member States and respect for national healthcare prerogatives; |
Or. fr
Amendment 185
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Ondřej Knotek, Margarita de la Pisa Carrión, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 1
| Motion for a resolution | Amendment |
|---|---|
| 1. Welcomes the Plan as a groundbreaking framework addressing the entire cancer disease pathway at EU level and a cornerstone of the European Health Union; | 1. Welcomes the Plan and regards it as a groundbreaking framework addressing the entire cancer care pathway at EU level, while noting that its effectiveness hinges primarily on its being supported by the Member States and respect for national healthcare prerogatives; |
Or. fr
Amendment 186
Alessandra Moretti
Motion for a resolution
Paragraph 1 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 1a. Stresses that health policy must be free from undue corporate influence; calls for transparency in decision-making and lobbying related to cancer and health in general; underlines the disparity of resources between industries and civil society in their relationship with public bodies and the representation of interests, in particular with the European Parliament, and calls for the Commission to support civil society with adequate funding in order to balance this gap; |
Or. en
Amendment 187
Sebastian Everding
Motion for a resolution
Paragraph 2
| Motion for a resolution | Amendment |
|---|---|
| 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than health outcomes; | 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; stresses, however, that implementation cannot be assessed primarily through process completion, but must be judged against measurable improvements in prevention, screening uptake, stage at diagnosis, waiting times for diagnosis and treatment, survival, quality of life and reductions in inequalities between and within Member States; regrets that the absence of a robust outcome-based monitoring framework has limited transparent assessment of the Plan’s real impact on patients; |
Or. en
Amendment 188
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 2
| Motion for a resolution | Amendment |
|---|---|
| 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than health outcomes; | 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than health outcomes; stresses that the assessment of these results should not be based solely on general comparisons between Member States, but should take into account factors such as demographic structure, the capacity of healthcare systems and actual access to treatment, in order to avoid oversimplified conclusions that do not reflect the actual situation in each country; |
Or. en
Amendment 189
Alessandra Moretti
Motion for a resolution
Paragraph 2
| Motion for a resolution | Amendment |
|---|---|
| 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than health outcomes; | 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than health outcomes; regrets that the absence of a robust outcome-based monitoring framework has limited transparent assessment of the Plan’s real impact on patients; |
Or. en
Amendment 190
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 2
| Motion for a resolution | Amendment |
|---|---|
| 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than health outcomes; | 2. Notes that more than 90 % of the Plan’s actions have been concluded or are ongoing; regrets the fact that measurement is based on process completion, rather than tangible health outcomes; further regrets that the absence of a robust outcome-based monitoring and evaluation framework has limited the transparent and comprehensive assessment of the Plan’s real impact on patients, including in terms of survival rates, quality of life and inequalities in access to care across Member States; |
Or. en
Amendment 191
Sebastian Everding
Motion for a resolution
Paragraph 2 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) calls on the Commission to ensure the systematic, timely and harmonized collection of comprehensive and comparable data on cancer across the Union, including on incidence, mortality, survival rates, stage at diagnosis and recurrence, to desegregate this data by age, ethnicity, sex and, where possible, gender and to update and publish such data on a regular and frequent basis in order to better monitor trends, identify disparities and support evidence-based policymaking; |
Or. en
Amendment 192
Alessandra Moretti
Motion for a resolution
Paragraph 2 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 2a. calls for the establishment of a European Breast Health Day to be marked annually on 15 October, in synergy with Breast Cancer Awareness Month, as a Union-wide initiative to strengthen prevention, awareness and early detection of breast cancer; calls on the Commission and the Member States to support and implement this initiative, including by promoting risk reduction, health literacy and timely access to preventive services, including screening, as well as equitable access to high-quality treatment and survivorship care, and by fostering coordinated action among policymakers, healthcare stakeholders and civil society, in line with the objectives of Europe’s Beating Cancer Plan; |
Or. en
Amendment 193
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 2 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 2a. Stresses that although 90 % of the Plan’s actions have been concluded or are ongoing, this should not detract from disparities in how the Plan has been implemented on the ground, including with regard to legislation on cancer prevention, access to financial services for survivors, support for carers and the reduction of regional inequalities, particularly in the outermost regions and rural areas; |
Or. fr
Amendment 194
Kateřina Konečná
Motion for a resolution
Paragraph 2 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 2a. Notes that the primary funding mechanism of Europe’s Beating Cancer Plan, and the EU Safer Hearts Plan, is the EU4Health programme, which is presently proposed to be removed in the current European Commission proposal for a new EU multiannual financial framework 2028-34; |
Or. en
Amendment 195
Adam Jarubas
Motion for a resolution
Paragraph 2 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 2a. Calls on the Commission to renew and extend the Europe’s Beating Cancer Plan until 2030, aligning it with the EU Cancer Mission, and to ensure adequate and predictable funding to support its long-term implementation. |
Or. en
Amendment 196
Peter Liese
Motion for a resolution
Paragraph 2 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 2a. Insists that the Commission concentrates its efforts on initiatives that provide direct, tangible assistance to cancer patients and improve their daily care outcomes; |
Or. en
Amendment 197
Adam Jarubas
Motion for a resolution
Paragraph 2 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 2b. Calls for an ‘all policies’ approach to cancer, ensuring coherence and alignment across relevant EU frameworks, including Pharmaceutical Legislation, Clinical Trials Regulation, HTA Regulation, Biotech Act, the European Health Data Space, AI Act, to accelerate innovation, improve patient access and strengthen health system resilience. Encourages the Commission to ensure that the design and implementation of these frameworks systematically consider their impact on cancer prevention, diagnosis, treatment and long-term care, and to strengthen coordination across policy areas where relevant. |
Or. en
Amendment 198
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 3 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 3a. Expresses concerns that the primary funding mechanism underpinning of Europe’s Beating Cancer Plan is the EU4Health programme which, under the current proposal by the European Commission for the next Multiannual Financial Framework (2028–2034), is envisaged to be discontinued; warns that the removal of this dedicated funding instrument could undermine the continuity, implementation and long-term impact of the Plan; |
Or. en
Amendment 199
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 3 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 3a. Notes the extended participation in Europe’s Beating Cancer Plan beyond the European Union, with institutions and entities from neighbouring and associated countries contributing to its implementation; emphasises that strengthened cooperation, knowledge-sharing and alignment with EU standards are essential to reducing inequalities and improving outcomes across the wider European region; |
Or. en
Amendment 200
Alessandra Moretti
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure that EU4Health is reinforced to at least EUR 10.05 billion in the 2028–2034 multiannual financial framework in current prices and maintained as a stand-alone programme; stresses that a minimum of EUR 2 billion within EU4Health should be earmarked for cancer-related actions, in order to ensure adequate and predictable funding across prevention, screening, treatment and survivorship; |
Or. en
Amendment 201
Kateřina Konečná
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission and Member States to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework to ensure the implementation and continuation of Europe’s Beating Cancer Plan throughout the period of the next EU multiannual financial framework; |
Or. en
Amendment 202
Sebastian Everding
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission and Member States to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework to ensure the implementation and continuation of Europe’s Beating Cancer Plan throughout the period of the next EU multiannual financial framework; |
Or. en
Amendment 203
Aurelijus Veryga
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission and Member States to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework to ensure the implementation and continuation of Europe’s Beating Cancer Plan throughout the period of the next EU multiannual financial framework; |
Or. en
Amendment 204
Tomislav Sokol
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; calls therefore for EUR 10.05 billion in current prices to be earmarked under the ECF for specific EU4Health priorities, including the fight against cancer; |
Or. en
Amendment 205
Christophe Clergeau
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission and Member States to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework to ensure the implementation and continuation of Europe’s Beating Cancer Plan; |
Or. en
Amendment 206
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework to ensure the implementation and continuation of Europe’s Beating Cancer Plan; |
Or. en
Amendment 207
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission and the Member States to ensure adequate, predictable and sustained funding for cancer in the 2028-2034 multiannual financial framework; |
Or. en
Amendment 208
Ruggero Razza
Motion for a resolution
Paragraph 4
| Motion for a resolution | Amendment |
|---|---|
| 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; | 4. Expresses serious concern about the EUR 1 billion cut to funding for EU4Health; calls on the Commission to ensure increased adequate and predictable funding for cancer in the 2028-2034 multiannual financial framework; |
Or. it
Amendment 209
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 4 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 4a. Calls for the final architecture of EU funding to ensure adequate and dedicated resources for cancer, with strong EU leadership, predictability for stakeholders, and funding conditions that support the effective implementation and long-term sustainability of Europe’s Beating Cancer Plan; |
Or. en
Amendment 210
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Ondřej Knotek, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 4 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 4a. Urges the Commission to reduce administrative fragmentation between EU4Health, Horizon Europe, Digital Europe, cohesion policy instruments and the Technical Support Instrument, and to provide clearer points of contact and more realistic deadlines for applicants; |
Or. fr
Amendment 211
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 4 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 4a. Recommends the development of enhanced coordination mechanisms for the implementation of Europe’s Beating Cancer Plan and the EU Cancer Mission, including consideration of a European Cancer Institute-type mechanism, in order to improve alignment and impact; |
Or. en
Amendment 212
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 4 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 4b. Calls on the Commission to establish an EU framework for National Cancer Control Plans (NCCPs), including minimum standards on governance, financing, data interoperability and implementation; stresses the need for a structured monitoring system with key performance indicators, including screening coverage, diagnostic timelines, biomarker uptake, survivorship outcomes and inequality indicators; calls for the establishment of a permanent EU support facility to assist Member States through technical assistance, capacity-building and best practice exchange, and for the meaningful involvement of patient organisations in the design, implementation and evaluation of NCCPs; |
Or. en
Amendment 213
Aurelijus Veryga
Motion for a resolution
Paragraph 4 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 4b. Notes that the primary funding mechanism for Europe’s Beating Cancer Plan is the EU4Health programme; stresses that, under the Commission’s proposal for the Multiannual Financial Framework (MFF) 2028–2034, EU4Health would be integrated into a broader European Competitiveness Fund; expresses concern that this may reduce the visibility and continuity of EU health policy; stresses that this approach risks undermining the long-term legacy of Europe’s Beating Cancer Plan by casting doubt on the sustainability of the momentum achieved and the infrastructures developed; |
Or. en
Amendment 214
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 5
| Motion for a resolution | Amendment |
|---|---|
| 5. Welcomes the close collaboration between the Plan and the EU Cancer Mission, with 898 cancer-focused projects, including 61 Cancer Mission projects, selected to receive a total of EUR 2.086 billion in funding; | 5. Welcomes the close collaboration between the Plan and the EU Cancer Mission, with 898 cancer-focused projects, including 61 Cancer Mission projects, selected to receive a total of EUR 2.086 billion in funding; stresses the importance of ensuring the continuation of the EU Cancer Mission through the recognition of cancer as one of the future EU “moonshots” towards 2030; |
Or. en
Amendment 215
Aurelijus Veryga
Motion for a resolution
Paragraph 5
| Motion for a resolution | Amendment |
|---|---|
| 5. Welcomes the close collaboration between the Plan and the EU Cancer Mission, with 898 cancer-focused projects, including 61 Cancer Mission projects, selected to receive a total of EUR 2.086 billion in funding; | 5. Welcomes the close collaboration between the Plan and the EU Cancer Mission, with 898 cancer-focused projects, including 61 Cancer Mission projects, selected to receive a total of EUR 2.086 billion in funding; stresses the strategic importance of these initiatives for delivering on the Union’s objective of improving the lives of more than 3 million people by 2030; calls on the Commission to ensure continued and dedicated support under the upcoming 2028–2034 MFF; |
Or. en
Amendment 216
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Stresses that the European Cancer Plan must be truly people-centred, effectively – and not merely formally – incorporating the participation of patients and their representatives at all stages of public policy on cancer; it emphasises that the direct experience of those living with the disease is an essential element in ensuring that actions are geared towards real needs, improving quality of life and avoiding bureaucratic approaches that are out of touch with reality. In this regard, considers it essential that the Plan strengthen stable mechanisms for participation throughout its entire cycle — from the definition of priorities to the evaluation of results — ensuring genuine involvement that contributes to a more effective, coherent and truly people-centred implementation across the Union, whilst respecting the competences of the Member States in all cases; |
Or. en
Amendment 217
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Stresses that really inclusive and transparent governance of Europe’s Beating Cancer Plan shall systematically incorporate the active participation of patients' representatives in the design, implementation and evaluation of public policies on cancer; highlights that the direct experience of people affected by cancer constitutes an essential element in steering actions towards real needs, improving quality of life and strengthening the relevance, effectiveness and legitimacy of European policies in this field; in this regard, considers it essential that Europe’s Beating Cancer Plan consolidate and reinforce stable mechanisms for patient participation throughout the entire policy and initiative cycle of the Plan, ensuring meaningful involvement that contributes to a more equitable, effective and people-centred implementation across the Union; |
Or. en
Amendment 218
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Recommends, for the future implementation of Europe’s Beating Cancer Plan and the EU Cancer Mission, the development of strengthened coordination mechanisms, such as, but not limited to, a European Cancer Institute mechanism, as previously proposed in the European Parliament’s BECA report of February 2022; emphasises that such a mechanism could enhance strategic alignment, reduce fragmentation, and improve the effectiveness of cancer research, prevention, and care across the Union; |
Or. en
Amendment 219
Peter Liese
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls on the Commission and Member States to systematically identify and remove administrative and regulatory obstacles that currently hinder the work of cancer researchers across the Union; emphasizes that the reduction of bureaucratic burden is essential to accelerate the translation of laboratory findings into clinical practice; |
Or. en
Amendment 220
Marta Temido
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Stresses that public investment in cancer research must be governed by public return objectives; mandates that all EU-funded innovations include binding provisions on affordable pricing, non-exclusive licensing where appropriate, and transparency of R&D costs to ensure that the European Health Union does not subsidize private monopolies; |
Or. en
Amendment 221
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Ondřej Knotek, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Emphasises that safe access to cancer treatment, medicines and medical technologies should be made a strategic priority for the EU in the light of increasingly stiff global competition, supply chain disruptions and geopolitical risks; |
Or. fr
Amendment 222
Gerald Hauser, Margarita de la Pisa Carrión
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Calls on the Commission to fund independent, open-ended and long-term studies into possible links between mRNA-based vaccines and changes in cancer incidence, tumour progression, immune responses and treatment outcomes in cancer patients, and to regularly present the results to Parliament; |
Or. en
Amendment 223
Victor Negrescu
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. calls for strengthened support for cancer research, including making research funding more accessible and less administratively burdensome, and highlights the important role of universities and research institutions in advancing innovation and improving patient outcomes; |
Or. en
Amendment 224
Bartosz Arłukowicz
Motion for a resolution
Paragraph 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 5a. Underlines the need to ensure better and more measurable funding of cancer research in Europe, including an increase in budgets for innovative research projects and their implementation; |
Or. pl
Amendment 225
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 5 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 5b. Stresses that in the interests of strengthening the EU’s sovereignty in the areas of health, science and industry, European investment in cancer research should, as a matter of priority, help to bring about treatments, diagnostics and innovative solutions that are produced in Europe and are of genuine benefit to patients on the continent; |
Or. fr
Amendment 226
Peter Liese
Motion for a resolution
Paragraph 5 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 5b. Stresses the need for a pragmatic and research-friendly implementation of data protection rules within the European Health Data Space (EHDS); urges that these regulations be applied in a manner that facilitates the secondary use of health data for oncology research while maintaining the highest standards of privacy and public trust; |
Or. en
Amendment 227
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 5 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 5c. Calls for better support, within the framework of existing instruments, to be given to translational research, clinical trials and partnerships between European laboratories, hospitals and research centres in order to speed up the period between a new discovery emerging and a treatment being made available to patients; |
Or. fr
Amendment 228
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 5 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 5d. Calls for greater support, within the framework of existing instruments, to be given to innovative SMEs, biotech companies, university laboratories and cancer research partnerships between hospitals across Europe in order to consolidate a genuine European ecosystem of therapeutic innovation; |
Or. fr
Amendment 229
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 6
| Motion for a resolution | Amendment |
|---|---|
| 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; | 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; stresses that adequate technology investments at European and national level is essential to ensure the availability of high-quality and comparable data, as persistent shortcomings in the deployment of digital infrastructures and interoperable information systems across Member States continue to hinder the generation of reliable data at Union level; emphasises that strengthening digital infrastructures must be accompanied by investment in data capacities, workforce training and digital literacy; further underlines that digital cancer tools must be interoperable, secure and accessible, and should contribute effectively to evidence-based policy-making and to reducing inequalities between Member States, regions and population groups; |
Or. en
Amendment 230
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 6
| Motion for a resolution | Amendment |
|---|---|
| 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; | 6. Regrets that the implementation roadmap of the Plan remains limited to monitoring functions and lacks a robust accountability framework; calls on the Commission to establish a comprehensive monitoring and evaluation framework linked to outcome-based indicators and regular accountability reporting; stresses that sustained EU support should be accompanied by clear, measurable objectives relating to screening uptake, early diagnosis, access to care, and the reduction of inequalities, in order to ensure that funding translates into tangible improvements for patients; |
Or. en
Amendment 231
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 6
| Motion for a resolution | Amendment |
|---|---|
| 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; | 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; underlines that this framework should include comparable indicators at Union level, analysis by Member State and region, and clear intermediate targets, in order to identify gaps in time and guide targeted interventions and investments; |
Or. el
Amendment 232
Alessandra Moretti
Motion for a resolution
Paragraph 6
| Motion for a resolution | Amendment |
|---|---|
| 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; | 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; stresses that sustained EU support should be accompanied by clear, measurable objectives related to screening uptake, early diagnosis, access to treatment and care and reduction of inequalities, in order to ensure that funding translates into tangible improvements for patients; |
Or. en
Amendment 233
Victor Negrescu
Motion for a resolution
Paragraph 6
| Motion for a resolution | Amendment |
|---|---|
| 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; | 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; stresses the need to move from process-based reporting to outcome-based evaluation, including indicators related to patient access and quality of care; |
Or. en
Amendment 234
Aurelijus Veryga
Motion for a resolution
Paragraph 6
| Motion for a resolution | Amendment |
|---|---|
| 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework linked to outcome indicators and regular accountability reports; | 6. Regrets the fact that the Plan’s implementation roadmap functions primarily as a tracking tool rather than an accountability mechanism; calls on the Commission to establish a comprehensive monitoring framework comprising output, result and, where feasible, impact indicators for all actions and objectives, in order to assess the progress and impact of Europe’s Beating Cancer Plan across all Member States; |
Or. en
Amendment 235
Christophe Clergeau
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls on Member States to adopt fiscal and price-based measures as powerful instruments for cancer prevention, including via own resource initiative on tobacco, but potentially also sugar-sweetened beverages (SSBs), and other health-harming and cancer-causing products; encourages that all revenues are (re)invested in health systems; |
Or. en
Amendment 236
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Underscores the importance of clear, targeted and culturally appropriate prevention campaigns, not least for young people and the most vulnerable groups, in order to raise greater awareness of preventable risk factors such as smoking, alcohol abuse, obesity, and the infections responsible for some cancers; |
Or. fr
Amendment 237
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Promotes the use of EU regional and cohesion funds to support member states to make capital investments in upgrading cancer care and control delivery mechanisms, such as vaccination and screening programmes, registry and laboratory upgrades and workforce skills and training needs; |
Or. en
Amendment 238
Bartosz Arłukowicz
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls on the European Commission to draw up an annual report evaluating how the projects which have received funding have helped to improve cancer-related care in Europe, including their impact on treatment outcomes, access to treatment and quality of life for patients; |
Or. pl
Amendment 239
Michalis Hadjipantela
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| a. Calls for the establishment of a core set of outcome-based indicators, including incidence, mortality, survival, stage at diagnosis, screening uptake and access to treatment, with clear baselines and time-bound targets. |
Or. en
Amendment 240
Adam Jarubas
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Calls for the establishment of a core set of outcome-based indicators, including incidence, mortality, survival, stage at diagnosis, screening uptake and access to treatment, with clear baselines and time-bound targets |
Or. en
Amendment 241
Jessica Polfjärd
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Recalls that healthcare remains a matter of national competence; notes that substantial disparities in cancer care between Member States remain an issue; |
Or. en
Amendment 242
Christophe Clergeau
Motion for a resolution
Paragraph 6 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 6b. Welcomes the Commission’s proposal for a tobacco excise duty own resource (TEDOR) as a fair and effective mechanism to generate EUR 11.2 billion annually in additional Union revenue, while contributing to the protection of public health and supporting efforts to reduce tobacco consumption across the European Union; |
Or. en
Amendment 243
Jessica Polfjärd
Motion for a resolution
Paragraph 6 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 6b. Calls on Member States to develop and update national cancer strategies, as appropriate, in order to improve cancer care, diagnosis and treatment, according to national circumstances; welcomes the progress that has already been achieved in this field by several Member States; |
Or. en
Amendment 244
Michalis Hadjipantela
Motion for a resolution
Paragraph 6 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 6b. Calls on the Commission and Member States to strengthen cancer registries, particularly utilising European Reference Networks, and ensure timely, comparable and interoperable data collection across the Union. |
Or. en
Amendment 245
Adam Jarubas
Motion for a resolution
Paragraph 6 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 6b. Calls on the Commission and Member States to strengthen cancer registries and ensure timely, comparable and interoperable data collection across the Union. |
Or. en
Amendment 246
Adam Jarubas
Motion for a resolution
Paragraph 6 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 6c. Calls for the structured and systematic involvement of patient in the design, implementation and monitoring of cancer policies at EU and national level, including within governance and evaluation frameworks. |
Or. en
Amendment 247
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Subheading 3 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Stresses that achieving targets on cancer prevention, including by implementing measures to reduce exposure to risk factors, such as all use of tobacco, alcohol consumption, an unhealthy diet and food-related risks, environmental contaminants, air pollutants and exposure to harmful materials and substances, such as carcinogenic, mutagenic and reprotoxic substances, including PFAS and endocrine disruptors, as well as advancing the ‘One Health’ approach and an exposome agenda, are complementary to efforts to prevent other non-communicable diseases; |
Or. en
Amendment 248
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Emphasizes that comprehensive preventive actions against cancer should be implemented across all Union policies and funding programs, notably through measures supporting the elimination or reduction of harm caused by modifiable risk factors; stresses the importance of evidence-based and proportionate approaches that take into account evolving scientific knowledge and innovation in products that may reduce exposure to harmful substances; |
Or. en
Amendment 249
Alessandra Moretti
Motion for a resolution
Paragraph 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 6a. Underlines that policy measures that restrict availability of and access to unhealthy substances have proven effective in reducing consumption, shaping consumption patterns and mitigating harm; stresses therefore the need to strengthen restrictions policies for those substances in order to protect people's health, in particular young and vulnerable people; |
Or. en
Amendment 250
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Subheading 3 b (new)
| Motion for a resolution | Amendment |
|---|---|
| Stresses that a substantial share of cancers is preventable and that the commercial determinants of health, such as aggressive marketing, pricing, and product placement strategies linked to tobacco, alcohol, energy drinks, and ultra-processed foods, significantly contribute to the cancer burden; underlines that profit-driven corporate practices can undermine public health objectives and disproportionately impact lower-income households, while children and young people are particularly exposed and vulnerable to such marketing; |
Or. en
Amendment 251
Ondřej Krutílek
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | deleted |
Or. en
Amendment 252
Dan-Ştefan Motreanu
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; stresses that any future revision of the Tobacco Products Directive should be conducted through a rigorous, thorough and transparent process, based on all available independent scientific evidence and on a comprehensive assessment of the public health, economic and social impacts across the Member States; underlines that Union legislation in this area must remain proportionate, predictable and enforceable; emphasises that it is essential to ensure a clear and evidence-based differentiation between the various categories of tobacco and nicotine products, taking into account their distinct characteristics, patterns of use and risk profiles, in order to support effective public health protection, prevent youth uptake and maintain the credibility of the European regulatory framework; |
Or. en
Amendment 253
Michalis Hadjipantela
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present a proposal for the revision of the EU’s tobacco legislation based on the available scientific evidence on the respective risk profiles and specific characteristics of each tobacco and nicotine product category, with the aim of ensuring legal certainty and strong safeguard for young people; acknowledges further that the effect of proposed measures on illicit trade and black market activities need to be carefully examined and monitored. |
Or. en
Amendment 254
Elena Nevado del Campo, Dolors Montserrat
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; calls for the Commission to present, in due time, a proposal for the revision of the EU’s tobacco legislation taking into consideration the principles of Better Regulation and the requirement for rural proofing, and ensuring that such revision is firmly based on the best available independent scientific evidence, while taking into account the impact it might have on tobacco growing regions, rural employment and agricultural supply chains; |
Or. en
Amendment 255
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation to adequately address emerging tobacco and nicotine products, such as electronic cigarettes, heated tobacco products, nicotine pouches and other novel nicotine delivery systems; calls for the extension of rules on advertising, promotion and sponsorship bans to digital and cross-border platforms; |
Or. en
Amendment 256
Christophe Clergeau
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation, including for novel tobacco products and nicotine products, extending to advertising, promotion and sponsorship bans to digital and cross-border platforms, and ensuring full implementation and enforcement of the WHO Framework Convention on Tobacco Control and its Protocol; |
Or. en
Amendment 257
Aurelijus Veryga
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation including for novel tobacco products and nicotine products, extending to advertising, promotion and sponsorship bans to digital and cross-border platforms, and ensuring full implementation and enforcement of the WHO Framework Convention on Tobacco Control and its Protocol; |
Or. en
Amendment 258
Sebastian Everding
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation including for novel tobacco products and nicotine products, extending to advertising, promotion and sponsorship bans to digital and cross-border platforms, and ensuring full implementation and enforcement of the WHO Framework Convention on Tobacco Control and its Protocol; |
Or. en
Amendment 259
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; calls on the Commission to follow up on the scientific evaluation of the health risks related to e-cigarettes, heated tobacco products, nicotine pouches and novel tobacco products, including the assessment of the risk of using these products compared to consuming other tobacco products; |
Or. en
Amendment 260
Jessica Polfjärd
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without undue delay, a proposal for the revision of the EU’s tobacco legislation, supported by an impact assessment, with evidence-based and proportionate regulation of different tobacco products, with due regard for different risk profiles; |
Or. en
Amendment 261
Kateřina Konečná
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a 'Tobacco-Free Generation' by 2040; Notes the Commission's intention to revise the legislative framework on tobacco control; Emphasizes that any revision must respect the principle of proportionality and must be based on scientific evidence and accompanied by comprehensive impact assessment. ; |
Or. en
Amendment 262
Ondřej Knotek, Margarita de la Pisa Carrión
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; Notes the Commission´s intention to revise the legislative framework on tobacco control; Emphasizes that any revision must respect the principle of proportionality and must be based on scientific evidence and accompanied by comprehensive impact assessment. |
Or. en
Amendment 263
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; points out that public policies on the consumption of tobacco or alternative tobacco products should be underpinned by reliable scientific evidence, paying particular regard to products aimed at young people; |
Or. fr
Amendment 264
Alessandra Moretti
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation, which should also properly address novel tobacco products and nicotine and smoking products; |
Or. en
Amendment 265
Monika Beňová
Motion for a resolution
Paragraph 7
| Motion for a resolution | Amendment |
|---|---|
| 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, without further delay, a proposal for the revision of the EU’s tobacco legislation; | 7. Reaffirms the goal of creating a ‘Tobacco-Free Generation’ by 2040; urges the Commission to present, a proposal for the revision of the EU’s tobacco legislation with an impact assesment and corresponding robust scientific assesment ; |
Or. en
Amendment 266
Sebastian Everding
Motion for a resolution
Paragraph 7 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) urges Member States to accelerate the phase-out of tobacco products, by adopting endgame strategies with clear timelines - such as the “Tobacco Free Generation” |
Or. en
Amendment 267
Sebastian Everding
Motion for a resolution
Paragraph 7 – point b (new)
| Motion for a resolution | Amendment |
|---|---|
| (b) urges the Commission to follow the European Parliament’s request to carry out a comparative scientific assessment of novel tobacco and nicotine products and smoking; |
Or. en
Amendment 268
Alessandra Moretti
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Emphasises the importance and urgency of strong regulatory measures to reduce the affordability, access, appeal and harmfulness of tobacco, smoking devices and all nicotine products, including heated tobacco products, e-cigarettes and nicotine pouches; calls on the Commission and member states to further extend the establishment of smoke and aerosol free environments, in line with the updated Council Recommendations; calls the Commission to urgently present legislative proposals to ban flavours, limits nicotine concentration and increase excise taxation with a view of reducing appeal and uptake, particularly for young people and non smokers; highlights the urgent need to prevent a new generation of nicotine dependent children and adolescents, including through strengthened controls on youth-appealing product features and digital marketing practices, particularly on social media platforms; |
Or. en
Amendment 269
Ondřej Knotek
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Emphasizes that regulatory measures must be proportionate under Article 5(4) TEU and based on scientific evidence regarding the respective risk profiles of different product categories; Warns that applying rules designed specifically for combustible tobacco products to fundamentally different-products would be disproportionate and calls for risk-proportionate approach where different product categories are subject to rules matching their scientifically assessed level of health risk; Calls for strict age verification and youth access prevention measures across all nicotine product categories; Notes that EU Member States retain competence over excise taxation. |
Or. en
Amendment 270
Kateřina Konečná
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Emphasizes that regulatory measures must be proportionate under Article 5(4) TEU and based on scientific evidence regarding the respective risk profiles of different product categories; Warns that applying rules designed specifically for combustible tobacco products to fundamentally different-products would be disproportionate and calls for risk-proportionate approach where different product categories are subject to rules matching their scientifically assessed level of health risk; Calls for strict age verification and youth access prevention measures across all nicotine product categories; Notes that EU Member States retain competence over excise taxation. |
Or. en
Amendment 271
Nicolás González Casares
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Encourages the Commission to implement, within its activities, rules to ensure a systemic assessment, across all directorates-general, as to whether potential meetings with tobacco industry representatives are needed according to the recommendations set out in Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC), as well as the related guidelines adopted by the parties in the third session in November 2008, of the Conference of the Parties (COP) following also the recommendations made by the European Ombudsman in her decision on case OI/6/2021/KR, ensuring their full application within the scope of its competences. |
Or. en
Amendment 272
Aurelijus Veryga
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Stresses that, despite considerable progress, smoking prevalence in the EU remains high, particularly among young people; notes that the interim objective of Europe’s Beating Cancer Plan to achieve a 30% relative reduction in tobacco use by 2025 compared with 2010 has not yet been met; underlines that the WHO European Region records the highest levels of tobacco consumption globally and is projected to remain among the worst-performing regions in the coming years; |
Or. en
Amendment 273
Victor Negrescu
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Calls on the Commission, in close cooperation with Member States, to develop and coordinate sustained and targeted EU-wide awareness-raising and information campaigns on cancer prevention, and to support mobile screening services and outreach programmes, particularly in Member States and regions with higher incidence and mortality rates, in order to improve access to early detection; |
Or. en
Amendment 274
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Urges Member States to accelerate the phase-out of tobacco products, by adopting endgame strategies with clear timelines - such as the “Tobacco Free Generation”, including significant tax increases, strict regulation on packaging, reduced retail availability; Calls for the expansion and strengthening of the EU Council Conclusions on smoke- and aerosol-free environments; |
Or. en
Amendment 275
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Stresses the need to better protect minors from exposure to tobacco and tobacco products and to guard against their consumption by discouraging marketing practices and product gimmicks liable to attract young people such as flavours or packaging formats; |
Or. fr
Amendment 276
Marta Temido
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Reaffirms that 40% of cancers are preventable; insists that prevention strategies extend beyond individual lifestyle choices to address environmental pollution; calls for the full alignment of EU air quality standards with WHO guidelines and the immediate phase-out of endocrine disruptors in consumer products; |
Or. en
Amendment 277
Ondřej Krutílek
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Emphasises the need to reflect the differing risk profiles of various categories of tobacco and nicotine products, taking into account their mode of consumption. |
Or. en
Amendment 278
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 7a. Emphasizes the importance of proportionate regulatory measures on tobacco and nicotine products based on their specific characteristics and intended use; |
Or. en
Amendment 279
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 7b. Calls for all new tobacco and nicotine-based products to undergo mandatory health impact assessments before being introduced on the market, where appropriate and in accordance with EU law; stresses, to that end, that manufacturers should be required to demonstrate the potential impact of these products on the health of individuals and the population as a whole, including the risks of addiction, dual use and the long-term effects on the cardiovascular system; |
Or. fr
Amendment 280
Alessandra Moretti
Motion for a resolution
Paragraph 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 7b. Stresses that there is no sufficient evidence that alternative smoking devices, such as e-cigarettes and heated tobacco products, are effective smoking cessation tools; stresses also that smoking cessation strategies and policies must be strictly aligned with scientific evidence and shaped in in line with the advice of the relevant scientific community; |
Or. en
Amendment 281
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 7b. Calls for the rapid and complete implementation of the WHO Framework Convention on Tobacco Control (FCTC) and the WHO Protocol to Eliminate Illicit Trade in Tobacco Products, paying specific attention to the FCTC Article 5.3 and its guidelines on protection of public health policies from the vested interests of the tobacco industry; |
Or. en
Amendment 282
Aurelijus Veryga
Motion for a resolution
Paragraph 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 7b. Urges Member States to accelerate the phase-out of tobacco products by adopting comprehensive tobacco endgame strategies with clear timelines, including measures aimed at achieving a tobacco-free generation; calls, in this context, for increased tobacco taxation, stricter regulation of packaging and reduced retail availability; |
Or. en
Amendment 283
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 7b. Urges that policy-making is grounded in the best available science, behavioural data and real-world evidence as required by the Better Regulation guidelines, in particular as regards the assessment of related products and their role in reducing smoking-related disease, disability and deaths; |
Or. en
Amendment 284
Nicolás González Casares
Motion for a resolution
Paragraph 7 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 7b. Notes with concern the increasing availability and appeal of new nicotine products, including devices designed to resemble toys, flavoured products, and oral nicotine pouches, which disproportionately attract young users; |
Or. en
Amendment 285
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 7 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 7c. Calls on the Commission to present without further delay a proposal to revise the Tobacco Advertising Directive (2003/33/EC) to extend its scope to all new and emerging tobacco and nicotine products, including electronic cigarettes, heated tobacco products and nicotine pouches; considers that the current Directive’s failure to cover such products creates an unlevel playing field and allows the tobacco and nicotine industry to circumvent cross-border advertising restrictions; stresses that any revision must include a prohibition on cross-border advertising, sponsorship and promotion of these products across all media, including digital platforms and social media; |
Or. en
Amendment 286
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 7 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 7c. Recalls its position in the report on Europe's Beating Cancer Plan (2020/2267(INI)), in which it recognises that certain alternative nicotine delivery products could allow some smokers to progressively quit smoking, and they could lower cardiovascular risks and enhance prevention strategies accelerating progress towards the EU's 2040 tobacco-free ambition; |
Or. en
Amendment 287
Alessandra Moretti
Motion for a resolution
Paragraph 7 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 7c. Stresses that the increase in uptake by non smokers, young people and women of alternative smoking devices and tools such as e-cig, heated tobacco products and pouches represents a concerning public health trend which should be properly addressed by public authorities and particularly within the urgent and needed review of the Tobacco legislation; |
Or. en
Amendment 288
Nicolás González Casares
Motion for a resolution
Paragraph 7 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 7 c. Expresses deep concern that an entire generation is at risk of nicotine addiction due to aggressive marketing and product innovation strategies deployed by the tobacco industry; |
Or. en
Amendment 289
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 7 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 7d. Calls on the Commission to ensure that the revision of the Tobacco Products Directive (2014/40/EU) addresses the full product landscape of new and emerging tobacco and nicotine products; urges in particular that the revised Directive include: (i) standardised health warnings and plain packaging requirements for electronic cigarettes, heated tobacco products and nicotine pouches; (ii) restrictions on characterising flavours that attract young consumers; (iii) mandatory reporting of ingredients, emissions and addiction potential; and (iv) a prohibition on the online sale of such products to minors, with effective age-verification mechanisms; |
Or. en
Amendment 290
Alessandra Moretti
Motion for a resolution
Paragraph 7 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 7d. Calls for all non-medicinal nicotine products, including nicotine pouches, smokeless tobacco and e-cigarettes, and any future or emerging nicotine-delivery products, to be fully included within the scope of the Tobacco Products Directive, and to be subject to the same rules on age limits, flavourings, nicotine content, packaging and marketing as other tobacco products; stresses the need for clear, comprehensive and technology-neutral definitions to ensure that Union legislation remains future-proof and prevents regulatory loopholes that may be exploited to the detriment of public health, particularly children and young people; |
Or. en
Amendment 291
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 7 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 7d. Underlines the need to prevent uptake by minors and non-smokers including through appropriate regulatory measures addressing product attractiveness and youth appealing flavours in line with the Tobacco Products Directive; |
Or. en
Amendment 292
Nicolás González Casares
Motion for a resolution
Paragraph 7 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 7d. Calls on the Commission and Member States to strengthen regulation of emerging nicotine products, including stricter controls on flavours, product design, nicotine concentration, and marketing practices; |
Or. en
Amendment 293
Alessandra Moretti
Motion for a resolution
Paragraph 7 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 7e. Calls for a comprehensive ban on advertising, promotion and sponsorship of all tobacco and nicotine products across all media and communication channels, including online platforms and social media, and for the introduction of plain packaging requirements and point-of-sale display bans in order to eliminate indirect marketing practices and reduce product appeal, particularly among minors; stresses the need to extend those bans also to any delivery and smoking tools even when it does not contain nicotine or tobacco itself; |
Or. en
Amendment 294
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 7 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 7e. Calls further for harmonised, future-proof definitions capable of capturing emerging products, the establishment of a mandatory authorisation system to prevent the placing on the market of products that appeal to young people, comprehensive bans on flavours and marketing practices that increase attractiveness; |
Or. en
Amendment 295
Nicolás González Casares
Motion for a resolution
Paragraph 7 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 7e. Urges Member States to enforce comprehensive restrictions on advertising, promotion, and sponsorship of tobacco and nicotine products, including in retail environments and public spaces; |
Or. en
Amendment 296
Nicolás González Casares
Motion for a resolution
Paragraph 7 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 7f. Calls for enhanced monitoring and data collection on youth consumption of nicotine products to support evidence-based policymaking and targeted prevention strategies, following the worrying reports of the WHO about the level of consumption in the European region; |
Or. en
Amendment 297
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 7 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 7f. Underlines that online sale of tobacco and nicotine products requires strict regulatory oversight to prevent minors accessing them and to ensure vendors comply with public health standards. |
Or. en
Amendment 298
Alessandra Moretti
Motion for a resolution
Paragraph 7 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 7f. Calls for the inclusion in the EP Rules of Procedure of the provisions established through the WHO Framework Convention on Tobacco Control, particularly for Article 5.3; |
Or. en
Amendment 299
Alessandra Moretti
Motion for a resolution
Paragraph 7 g (new)
| Motion for a resolution | Amendment |
|---|---|
| 7g. Recalls that the European Union is a Party of the WHO Framework Convention on Tobacco Control, which is a legally binding Treaty according to International Law; stresses the need to align public policies to its provisions; calls also on EU institutions and bodies to fully respect the provisions of the Convention in their internal structure, rules and procedures; |
Or. en
Amendment 300
Alessandra Moretti
Motion for a resolution
Paragraph 7 h (new)
| Motion for a resolution | Amendment |
|---|---|
| 7h. Welcomes the Commission’s proposal for a tobacco excise duty own resource (TEDOR) as a fair and effective mechanism to generate additional Union revenue, while contributing to the protection of public health and supporting efforts to reduce tobacco consumption across the European Union; |
Or. en
Amendment 301
Alessandra Moretti
Motion for a resolution
Paragraph 7 i (new)
| Motion for a resolution | Amendment |
|---|---|
| 7i. Reiterates its call for an increase and an upward convergence in minimum excise duties for all tobacco and nicotine products and their final market price; |
Or. en
Amendment 302
Alessandra Moretti
Motion for a resolution
Paragraph 7 j (new)
| Motion for a resolution | Amendment |
|---|---|
| 7j. stresses the need to implement the Council Recommendation on smoke-and aerosol-free environments as a globally recognised and proven approach to adequately protect the health of people from the effects of second-hand tobacco smoke and aerosols; |
Or. en
Amendment 303
Margarita de la Pisa Carrión, Laurent Castillo, Valérie Deloge
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | deleted |
Or. en
Amendment 304
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; emphasises that harmful alcohol consumption is a risk factor behind a number of cancers; stresses the importance of preventing harmful drinking patterns, including excessive alcohol use, as recommended by the United Nations in its political declaration of December 2025; urges the Member States to devise awareness-raising initiatives geared especially towards minors with a view to providing clear information, which should be underpinned by solid evidence, about alcohol-related behaviour, to promoting informed choices and to helping people better understand the effects of excessive alcohol consumption on their health; |
Or. fr
Amendment 305
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on labels of alcoholic beverages, while noting the Commission’s intention, as set out in the Europe’s Beating Cancer Plan, to introduce mandatory indication of the list of ingredients and the nutrition declaration on all alcoholic beverage labels; Calls on the Commission to present legislative proposals in this area without further delay, introducing mandatory, prominent, clearly visible and standardised health warning labels on all alcoholic beverages, comparable in visibility to those required for tobacco products, clearly informing consumers of the link between alcohol consumption and cancer; |
Or. en
Amendment 306
Dolors Montserrat, Elena Nevado del Campo
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Acknowledges the progress made on digital labelling by the alcohol beverages industry and the inclusion of ingredient lists of alcoholic beverages by the wine sector; regrets the limited progress made to better inform consumers by improving the labelling of alcohol beverages to include moderate and responsible drinking information and to extend the mandatory indication of the list of ingredients and nutritional information for all the alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; |
Or. en
Amendment 307
Alessandra Moretti
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; stresses that nutritional information and ingredient lists must be displayed directly on the physical product label rather than solely via digital links, in order to ensure accessibility and informed consumer choice for all citizens, including those with limited digital access; |
Or. en
Amendment 308
Monika Beňová
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay, ensuring that consumers receive clear, accurate and evidence based information and that measures are proportionate to the level of risk, while paying particular attention to the protection of children, adolescents and other vulnerable groups; |
Or. en
Amendment 309
Aurelijus Veryga
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay introducing mandatory, prominent and standardised cancer warnings on all alcoholic beverages, comparable in visibility to those required for tobacco products, clearly informing consumers of the link between alcohol consumption and cancer; |
Or. en
Amendment 310
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay introducing standardised cancer warnings on all alcoholic beverages, clearly informing consumers of the link between alcohol consumption and cancer; |
Or. en
Amendment 311
Ruggero Razza
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Notes the limited progress made on the transparency of information provided to consumers of beverages, in particular with regard to ingredient lists and health information; calls on the Commission to assess proportionate, evidence-based options, while ensuring consistency with the internal market, avoiding disproportionate administrative burdens on producers, particularly SMEs, and respecting the competences of the Member States; |
Or. it
Amendment 312
Jérémy Decerle, Vlad Vasile-Voiculescu
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay, taking into account the specificities of these products by providing for such details on the package and on the label attached thereto of the electronic means; |
Or. en
Amendment 313
Letizia Moratti
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Acknowledges the relevance of the promotion of responsible alcohol consumption based on the available scientific evidence and on a whole-of-society approach |
Or. en
Amendment 314
Aldo Patriciello
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Recalls the importance of introducing clear information on the labels of alcoholic beverages to enhance consumers’ awareness about moderate and responsible drinking, as well as nutritional information and ingredient lists according to sectorial legislation |
Or. en
Amendment 315
Pietro Fiocchi, Michele Picaro, Ruggero Razza, Carlo Fidanza
Motion for a resolution
Paragraph 8
| Motion for a resolution | Amendment |
|---|---|
| 8. Regrets the limited progress made on the mandatory inclusion of ingredient lists and health warnings on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; | 8. Acknowledges the limited progress made on the mandatory inclusion of ingredient lists on the labels of alcoholic beverages; calls on the Commission to present legislative proposals in this area without further delay; |
Or. en
Amendment 316
Dolors Montserrat, Elena Nevado del Campo
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Encourages the Commission and the Member States to promote actions to reduce and prevent alcohol-related harm within the framework of a revised EU alcohol strategy, including a European zero alcohol consumption strategy for minors, accompanied, where appropriate, by legislative proposals, while respecting the principle of subsidiarity and current national legislation on age limits on alcohol consumption; |
Or. en
Amendment 317
Aurelijus Veryga
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Welcomes the Commission’s proposal for a tobacco excise duty own resource (TEDOR) as a fair and effective mechanism to generate EUR 11.2 billion annually in additional Union revenue, while contributing to the protection of public health and supporting efforts to reduce tobacco consumption across the European Union; |
Or. en
Amendment 318
Marta Temido
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Calls for the implementation of strict firewall policies to protect health-related policy-making from the influence of commercial interests; insists that the delayed revision of the Tobacco Products Directive and alcohol labelling legislation must prioritize public health outcomes over industry profits; |
Or. en
Amendment 319
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Notes that current EU rules do not sufficiently limit the volume, placement or content of alcohol marketing; calls on the Commission to propose stronger EU-level measures to reduce exposure to alcohol marketing, including in digital environments, as part of cancer prevention efforts; |
Or. en
Amendment 320
Monika Beňová
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Stresses that public health policy should not downplay alcohol related harm on the basis of cultural or traditional considerations; calls for consumer information and prevention strategies to reflect current scientific evidence on the health risks associated with alcohol consumption; |
Or. en
Amendment 321
Alessandra Moretti
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Calls for the prohibition of alcohol advertising and sponsorship in context where it could reach minors, particularly in sport events; calls also for the prohibition of advertising of non-alcoholic beverages from brands whose main business is alcoholic products; |
Or. en
Amendment 322
Nicolás González Casares
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Calls on the Commission and Member States to recognise that there is no safe level of alcohol consumption and to reflect this principle consistently in EU public health policies and prevention strategies; |
Or. en
Amendment 323
Pietro Fiocchi, Michele Picaro, Ruggero Razza, Carlo Fidanza
Motion for a resolution
Paragraph 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 8a. Urges that policy-making is grounded in the best available science, behavioural data and real-world evidence as required by the Better Regulation guidelines; |
Or. en
Amendment 324
Sebastian Everding
Motion for a resolution
Paragraph 8 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) welcomes the Commission’s proposal for a tobacco excise duty own resource (TEDOR) as a fair and effective mechanism to generate EUR 11.2 billion annually in additional Union revenue, while contributing to the protection of public health and supporting efforts to reduce tobacco consumption across the European Union; |
Or. en
Amendment 325
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 8 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 8b. Underlines that dietary behaviours are shaped by food environments and structural factors, including availability, affordability, marketing and agricultural policy; calls for greater coherence between the Europe’s Beating Cancer Plan and EU agri-food, trade, promotion and public procurement policies in order to facilitate access to healthy, plant-based foods and reduce exposure to cancer-related dietary risks; |
Or. en
Amendment 326
Alessandra Moretti
Motion for a resolution
Paragraph 8 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 8b. Stresses the need to reduce alcohol consumption to protect public health and prevent cancer; calls the Commission and the Member States to promote actions to reduce and prevent alcohol-related harm and to present an update of the EU alcohol strategy, including a European zero alcohol consumption strategy for minors together with appropriate legislative proposals; |
Or. en
Amendment 327
Aurelijus Veryga
Motion for a resolution
Paragraph 8 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 8c. Recommends for future delivery of Europe’s Beating Cancer Plan and the EU Research Mission on Cancer the development of enhanced coordinating mechanisms, such as, but not limited to, a European Cancer Institute mechanism, as previously proposed in the European Parliament’s BECA Report February 2022. |
Or. en
Amendment 328
Aurelijus Veryga
Motion for a resolution
Paragraph 8 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 8e. Promotes the use of EU regional and cohesion funds to support member states to make capital investments in upgrading cancer care and control delivery mechanisms, such as vaccination and screening programmes, registry and laboratory upgrades and workforce skills and training needs; |
Or. en
Amendment 329
Ruggero Razza
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | deleted |
Or. it
Amendment 330
Monika Beňová
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling based on robust and independent scientific evidence, and to propose solutions to reduce the consumption of ultra-processed foods and foods with an unfavourable nutritional profile such as artificially high sugar products and or high saturated fat products or high fat products containing i.e. ultra processed seed oils especially among young people; |
Or. en
Amendment 331
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; underlines that the degree of food processing is a crucial factor for public health and should be systematically taken into account in Union policy-making; calls on the Commission to develop a coherent approach at EU level to ultra-processed foods, regardless of whether they are produced within the Union or imported, including through clearer labelling, common assessment criteria and appropriate measures to reduce their consumption; |
Or. el
Amendment 332
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, including grade of processing (e.g. Nova system ), legally binding reformulation targets for salt, sugar and saturated fats, and restrictions on the marketing of unhealthy foods, to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; Stresses that voluntary industry commitments have proven insufficient and must be replaced by enforceable regulation; Emphasises that cross-sectoral action is necessary to ensure that healthier foods are the easiest and most affordable choice for all EU citizens; |
Or. en
Amendment 333
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; stresses that all food available on the EU market, including imported food, must fully comply with Union standards on food safety and health, in particular as regards permitted levels of hazardous substances, in order to reduce citizens’ exposure to cancer risk factors; |
Or. el
Amendment 334
Pietro Fiocchi
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to propose solutions to reduce the consumption, especially among young people, of high-fat and ultra-processed foods, and urges the Commission to develop a clear and harmonised definition of ultra-processed foods based on scientific evidence,. |
Or. en
Amendment 335
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; stresses, furthermore, the importance of promoting healthy eating habits from an early age and calls on the Commission and the Member States to strengthen and expand the implementation of the EU School Fruit, Vegetables and Milk Scheme, with particular emphasis on access to fresh, local and seasonal products; |
Or. el
Amendment 336
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Underscores the fact that diet has a significant bearing on people’s health; stresses the importance of promoting healthy, evidence-based diets adapted to local availability, cultural traditions and national cuisines, as opposed to one-size-fits-all prevention policies; points out that a healthy and balanced diet plays a protective role in the primary and secondary prevention of the main chronic degenerative diseases; |
Or. fr
Amendment 337
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; stresses that labelling should provide clear information on a product’s nutritional composition, while avoiding oversimplification and ensuring that dietary habits are taken into account; |
Or. fr
Amendment 338
Letizia Moratti
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to propose measures and digital tools that raise awareness of healthy eating habits and promote a balanced diet including all essential nutrients, based on scientific evidence, particularly among young people. Calls on the Commission to oppose initiatives by individual Member States that promote overly simplistic approaches not grounded in scientific evidence and that risk fragmenting and undermining the Single Market. |
Or. en
Amendment 339
András Tivadar Kulja
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people, and to promote access to and affordability of healthy, balanced diets, addressing socioeconomic disparities and recognising nutrition as a key determinant in cancer prevention; |
Or. en
Amendment 340
Aldo Patriciello, Marie-Luce Brasier-Clain, Aleksandar Nikolic, Margarita de la Pisa Carrión, Valérie Deloge
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Stresses that labelling should provide clear information on product nutritional composition, while avoiding oversimplification and ensuring that overall dietary patterns and actual consumption behaviours are taken into account; emphasises that its objective is to enable consumers to make informed choices, especially among young people; |
Or. en
Amendment 341
Marta Temido
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling; further calls for a Union-wide ban on the marketing of ultra-processed foods and high-sugar products to children, recognizing that food environments are a primary driver of childhood obesity and future cancer risk; |
Or. en
Amendment 342
Jérémy Decerle, Vlad Vasile-Voiculescu
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people, including by proposing awareness campaigns for a healthy and varied diet; |
Or. en
Amendment 343
Jessica Polfjärd
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission and Member States, in cooperation with stakeholders, to increase efforts to provide more consumer information about nutritional contents of various food products and the importance of healthy diets, especially among young people; |
Or. en
Amendment 344
Tomislav Sokol
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory and harmonised front-of-pack nutrition labelling scheme, and to propose science-based solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; |
Or. en
Amendment 345
Alessandra Moretti
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on a mandatory front-of-pack nutrition labelling backed by scientific evidence, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; |
Or. en
999Amendment 346
Bartosz Arłukowicz
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat, ultra-processed and high-sugar food, especially among young people; |
Or. pl
Amendment 347
Dolors Montserrat, Elena Nevado del Campo
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of saturated and trans fat and ultra-processed food, especially among young people; |
Or. en
Amendment 348
Pietro Fiocchi, Michele Picaro, Ruggero Razza, Carlo Fidanza
Motion for a resolution
Paragraph 9
| Motion for a resolution | Amendment |
|---|---|
| 9. Calls on the Commission to accelerate work on mandatory front-of-pack nutrition labelling, and to propose solutions to reduce the consumption of high-fat and ultra-processed food, especially among young people; | 9. Calls on the Commission to propose solutions that incentivise healthy food consumption, including the principles of the Mediterranean Diet, especially among young people; |
Or. en
Amendment 349
Sebastian Everding
Motion for a resolution
Paragraph 9 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) calls on the Commission and Member States to promote plant-rich dietary patterns, characterised by high consumption of fruits, vegetables, legumes, whole grains, nuts and seeds, as a core component of cancer prevention strategies, while supporting a reduction in the consumption of red and processed meat in line with scientific recommendations; |
Or. en
Amendment 350
Sebastian Everding
Motion for a resolution
Paragraph 9 – point b (new)
| Motion for a resolution | Amendment |
|---|---|
| (b) underlines that dietary behaviours are shaped by food environments and structural factors, including availability, affordability, marketing and agricultural policy; calls for greater coherence between the Europe’s Beating Cancer Plan and EU agri-food, trade, promotion and public procurement policies in order to facilitate access to healthy, plant-based foods and reduce exposure to cancer-related dietary risks; |
Or. en
Amendment 351
Sebastian Everding
Motion for a resolution
Paragraph 9 – point c (new)
| Motion for a resolution | Amendment |
|---|---|
| (c) calls on the Commission to make full use of existing EU policy instruments to support healthier dietary patterns, including public procurement standards, food-based dietary guidelines, promotion programmes, labelling schemes and investment in sustainable food production, in order to facilitate a shift towards healthier, more plant-based diets and strengthen cancer prevention; |
Or. en
Amendment 352
Sebastian Everding
Motion for a resolution
Paragraph 9 – point d (new)
| Motion for a resolution | Amendment |
|---|---|
| (d) urges the European Commission to implement a more distinct definition on ultra-processed foods; |
Or. en
Amendment 353
Sebastian Everding
Motion for a resolution
Paragraph 9 – point e (new)
| Motion for a resolution | Amendment |
|---|---|
| (e) calls for reinforced action on environmental cancer risk factors, including air, water and soil pollution, PFAS, hazardous substances, UV exposure and second-hand smoke, supported by harmonised EU monitoring and enforcement; |
Or. en
Amendment 354
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Highlights that Mediterranean lifestyle patterns, combining adherence to the Mediterranean diet, regular physical activity, strong community and social cohesion, are consistently associated with improved health outcomes and reduced chronic diseases-related mortality, including cancer; recalls that large European cohort evidence has shown that the combined adoption of Mediterranean diet and healthy lifestyle factors significantly lowers cancer incidence and mortality; notes that several southern EU regions, particularly in Spain and Italy, also report among the highest life expectancy levels in the Union; calls therefore for the promotion of evidence-based Mediterranean lifestyle approaches, adapted to local socio-economic contexts, as part of comprehensive EU prevention policies, public health programmes and dietary education strategies aimed at reducing the burden of cancer and improving healthy longevity; |
Or. en
Amendment 355
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Stresses that nutrition labelling should provide clear information on the nutritional composition of products, while avoiding oversimplification and ensuring that overall dietary habits and actual eating behaviours are taken into account; |
Or. fr
Amendment 356
Kateřina Konečná
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls for reinforced action on occupational cancer risk factors as well as improved protection for workers in high-risk sectors, supported by harmonised EU monitoring and enforcement and a renewed, ambitious and updated EU Strategic Framework on Occupational Health and Safety post-2027, taking into account the growing impact of climate change on workers safety and exposure to occupational cancer risk factors. |
Or. en
Amendment 357
Aurelijus Veryga
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission to take EU-level action to address the risks of sunbed use, such as an EU-wide ban for minors, given the fragmented and inconsistent regulatory landscape across the EU27; urges the Commission to resume its work on its UV exposure recommendation without further delay; calls for EU-wide awareness campaigns on the harmful effects of sunbed use on public health; |
Or. en
Amendment 358
Christophe Clergeau
Motion for a resolution
Paragraph 9 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 9d. Calls on the Commission to take Union-wide action to address the risks of sunbed use, such as a Union-wide ban for minors, given the fragmented and inconsistent regulatory landscape across the Union; urges the Commission to resume its work on its UV exposure recommendation without further delay; calls for Union-wide awareness campaigns on the harmful effects of sunbed use on public health; |
Or. en
Amendment 359
Monika Beňová
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Emphasises that the protection of minors and other vulnerable groups must remain a central objective of prevention policy; calls for targeted measures to reduce early exposure to the most harmful products and addiction inducing products for public information campaigns enabling consumers to make informed choices on the basis of transparent and scientifically sound information; |
Or. en
Amendment 360
Friedrich Pürner
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls for a complete ban of alcohol advertising, in line with the existing ban on tobacco commercials, which often showcase alcohol as a social drink that brings relaxation and entertainment; stresses that alcohol is a proven cell poison that can cause dependency and is a significant contributing factor to the development of several diseases, including cancer. |
Or. en
Amendment 361
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission and Member States to promote plant-rich dietary patterns, characterised by high consumption of fruits, vegetables, legumes, whole grains, nuts and seeds, as part of cancer prevention strategies, while supporting a reduction in red and processed meat in line with scientific recommendations; |
Or. en
Amendment 362
Alessandra Moretti
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Stresses that to be effective prevention of cancer must start during childhood; calls for public authorities to promote and fund healthy dietary habits in all circumstances and from an early age, including schools, sporting facilities and recreational areas; |
Or. en
Amendment 363
Christophe Clergeau
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission for reinforced action on environmental cancer risk factors, including air, water and soil pollution, PFAS, hazardous substances, UV exposure and second-hand smoke, supported by harmonised monitoring and enforcement; |
Or. en
Amendment 364
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 9 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 9b. Stresses that food affordability is a key determinant of dietary choices, with healthier diets generally costing more; calls on Member States to adopt fiscal measures, including reduced or zero VAT on fruits, vegetables, legumes and whole grains, and to consider taxation on ultra-processed foods (UPFs) and foods high in salt, sugar and saturated fat (HFSS products); calls for the strategic use of public food procurement to improve equitable access to healthy meals in schools, hospitals and other public institutions. |
Or. en
Amendment 365
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 9 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 9b. Underscores the importance of an active lifestyle in reducing the incidence and recurrence of cancer, alleviating mental health issues and helping to prevent obesity; calls for greater support for physical activity, public sport facilities and health literacy initiatives as part of cancer prevention efforts, particularly for children, adolescents and socially and economically disadvantaged groups; |
Or. fr
Amendment 366
Christophe Clergeau
Motion for a resolution
Paragraph 9 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls on the Commission for reinforced action on occupational cancer risk factors as well as improved protection for workers in high-risk sectors, supported by harmonised monitoring and enforcement and a renewed, ambitious and updated Union Strategic Framework on Occupational Health and Safety post-2027, taking into account the growing impact of climate change on workers safety and exposure to occupational cancer risk factors; |
Or. en
Amendment 367
Alessandra Moretti
Motion for a resolution
Paragraph 9 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 9b. Underlines the diverse barriers to healthy dietary choices, as for example higher pricing for high quality and healthy food; stresses that this affects disproportionately low and middle income portions of population; calls for adequate pricing strategies that make healthier products more affordable; |
Or. en
Amendment 368
Friedrich Pürner
Motion for a resolution
Paragraph 9 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls on the Commission and the Member States to strengthen preventive healthcare by promoting a well-balanced diet and a more active lifestyle across all age groups; |
Or. en
Amendment 369
Christophe Clergeau
Motion for a resolution
Paragraph 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 9a. Calls on the Commission for reinforced action on environmental cancer risk factors, including air, water and soil pollution, PFAS, hazardous substances, UV exposure and second-hand smoke, supported by harmonised monitoring and enforcement; |
Or. en
Amendment 370
Alessandra Moretti
Motion for a resolution
Paragraph 9 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 9c. Calls for reinforced action to protect people from environmental cancer risk factors, including air, water and soil pollution, PFAS, hazardous substances, UV exposure and second-hand smoke, supported by harmonised EU monitoring and enforcement; |
Or. en
Amendment 371
Alessandra Moretti
Motion for a resolution
Paragraph 9 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 9d. Calls on the Commission to fully implement the Chemical Strategy for Sustainability and the Zero Pollution Action Plan by rapidly restricting the most harmful substances in line with the commitment under Europe’s Beating Cancer Plan; calls in particular for a health-centred revision of the Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation (REACH) and the implementation of a comprehensive EU-wide restriction of all PFAS (per- and polyfluoroalkyl substances), to ensure policy coherence with Europe’s Beating Cancer Plan and EU’s objectives for health-protective chemical regulation; |
Or. en
Amendment 372
Alessandra Moretti
Motion for a resolution
Paragraph 9 g (new)
| Motion for a resolution | Amendment |
|---|---|
| 9g. Calls on the Commission to address the risks of sunbed use, in particularly to protect minors; urges the Commission to resume its work on its UV exposure recommendation without further delay; calls for EU-wide awareness campaigns on the harmful effects of sunbed use on public health; |
Or. en
Amendment 373
Christophe Clergeau
Motion for a resolution
Paragraph 9 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 9c. Calls for the accelerated identification, regulation and phase-out of carcinogenic, mutagenic and reprotoxic substances, including endocrine disruptors, under EU chemicals legislation, applying the precautionary principle where scientific uncertainty persists; |
Or. en
Amendment 374
Alessandra Moretti
Motion for a resolution
Paragraph 9 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 9f. Calls for the accelerated identification, regulation and phase-out of carcinogenic, mutagenic and reprotoxic substances, including endocrine disruptors, under EU chemicals legislation, applying the precautionary principle where scientific uncertainty persists |
Or. en
Amendment 375
Kateřina Konečná
Motion for a resolution
Paragraph 9 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 9b. Calls for the accelerated identification, regulation and phase-out of carcinogenic, mutagenic and reprotoxic substances, including endocrine disruptors, under EU chemicals legislation, applying the precautionary principle where scientific uncertainty persists; |
Or. en
Amendment 376
Alessandra Moretti
Motion for a resolution
Paragraph 9 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 9e. Calls for reinforced action on occupational cancer risk factors as well as improved protection for workers in high-risk sectors; |
Or. en
Amendment 377
Christophe Clergeau
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; notes however with concern that HPV vaccination coverage rates remain critically low in several Member States, compromising the goal of eliminating cervical and other HPV-related cancers by 2030; calls on the Commission to intensify targeted support to Member States in achieving this goal; calls on the European Centre for Disease Prevention and Control (ECDC) to strengthen its monitoring of national HPV vaccination coverage rates; calls on the Commission and the Member States to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; |
Or. en
Amendment 378
Aurelijus Veryga
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus (HPV); however, notes with concern that HPV vaccination coverage rates remain critically low in several Member States, compromising the goal of eliminating cervical and other HPV-related cancers by 2030; calls on the Commission to intensify targeted support to Member States in achieving this goal; calls on the European Centre for Disease Prevention and Control (ECDC) to strengthen its monitoring of national HPV vaccination coverage rates; calls on the Commission to increase the vaccination rate for hepatitis B and improve screening and treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; |
Or. en
Amendment 379
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus (HPV); however, notes with concern that HPV vaccination coverage rates remain critically low in several Member States, compromising the goal of eliminating cervical and other HPV-related cancers by 2030; calls on the Commission to intensify targeted support to Member States in achieving this goal; calls on the European Centre for Disease Prevention and Control (ECDC) to strengthen its monitoring of national HPV vaccination coverage rates ; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; |
Or. en
Amendment 380
Sebastian Everding
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus (HPV); however, notes with concern that HPV vaccination coverage rates remain critically low in several Member States, compromising the goal of eliminating cervical and other HPV-related cancers by 2030; calls on the Commission to intensify targeted support to Member States in achieving this goal; calls on the European Centre for Disease Prevention and Control (ECDC) to strengthen its monitoring of national HPV vaccination coverage rates; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; |
Or. en
Amendment 381
Ruggero Razza
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission and the Member States to step up their efforts to increase vaccination coverage, where necessary through targeted, evidence-based strategies, and to promote equitable access to vaccination for both sexes, given that HPV infections are associated with various types of cancer affecting both women and men; further calls on the Commission to support efforts to improve vaccination rates for hepatitis B and promote effective strategies for the prevention, screening and treatment for hepatitis C and Helicobacter pylori infections in order to reduce the incidence of liver and gastric cancers; |
Or. it
Amendment 382
Alessandra Moretti
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to take concrete action to further increase the vaccination rate for human papilloma virus and hepatitis B; stresses the need to improve prevention, detection and treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; stresses the importance of a life-course approach to vaccination and equitable access across Member States; |
Or. en
Amendment 383
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; calls for strengthened EU action to support early detection strategies for high-burden cancers, including breast cancer, in particular through screening and early diagnosis; |
Or. en
Amendment 384
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; notes with concern that vaccination coverage remains insufficient in several Member States; calls on the Commission to intensify targeted support to increase vaccination uptake; further calls for increased vaccination rates for hepatitis B and improved treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; |
Or. en
Amendment 385
Adam Jarubas
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; Calls for strengthened EU action on modifiable risk factors and early detection strategies relevant to high-burden cancers, including breast and prostate cancer; |
Or. en
Amendment 386
András Tivadar Kulja
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers, and further calls for strengthened EU action on modifiable risk factors and early detection strategies relevant to high-burden cancers, including breast cancer; |
Or. en
Amendment 387
Friedrich Pürner
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; Stresses that HPV vaccination should remain on a voluntary basis and should under no circumstance be made mandatory; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; |
Or. en
Amendment 388
Monika Beňová
Motion for a resolution
Paragraph 10
| Motion for a resolution | Amendment |
|---|---|
| 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers; | 10. Welcomes the fact that EU4Health has funded several projects on vaccination against human papillomavirus; calls on the Commission to increase the vaccination rate for hepatitis B and improve treatment for hepatitis C and Helicobacter pylori infections in order to prevent liver and gastric cancers, including through targeted awareness raising and early detection strategies for at risk populations; |
Or. en
Amendment 389
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 10 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 10a. Points out that a genetic predisposition to cancer linked to mutations of specific genes has been demonstrated; highlights that methods to detect these mutations are available, either at birth for early detection of certain paediatric cancers or over the course of a lifetime, especially for breast, ovarian and colorectal cancers, and that the detection of these mutations may help to prevent or detect early-stage cancer and guide treatment choices; |
Or. fr
Amendment 390
Bartosz Arłukowicz
Motion for a resolution
Paragraph 10 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 10a. Regrets that there are still significant imbalances between the Member States of the European Union in relation to the level of human papillomavirus (HPV) vaccination, ranging from under 10 % to over 90 %, leading to inequality in cancer prevention and treatment; |
Or. pl
Amendment 391
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 10 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 10a. Calls on the Commission and Member States to strengthen early detection of liver disease and liver cancer through targeted screening initiatives, awareness campaigns and improved access to non-invasive diagnostic tools, particularly for at-risk and underserved populations; |
Or. en
Amendment 392
Aurelijus Veryga
Motion for a resolution
Paragraph 10 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 10b. calls for strengthened EU action on modifiable risk factors and early detection strategies relevant to high-burden cancers, including breast cancer; |
Or. en
Amendment 393
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 11
| Motion for a resolution | Amendment |
|---|---|
| 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; | 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; underlines, furthermore, that modern living conditions, particularly in urban environments, are characterised by increased stress, limited physical activity and reduced contact with the natural environment, factors that negatively affect overall health; stresses the importance of access to green spaces, proximity to nature and the promotion of more balanced lifestyles as elements that contribute to the prevention of chronic diseases, including cancer; |
Or. el
Amendment 394
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 11
| Motion for a resolution | Amendment |
|---|---|
| 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; | 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; underlines, furthermore, the importance of mental health, adequate rest and quality sleep as factors contributing to overall health and the prevention of chronic diseases; calls on the Commission and the Member States to integrate policies that promote healthy sleep habits and the maintenance of circadian rhythms into public health, including through public information and the promotion of balanced work-life conditions; |
Or. el
Amendment 395
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 11
| Motion for a resolution | Amendment |
|---|---|
| 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; | 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; therefore calls on the Commission to develop, building on the fifth edition of the European Code Against Cancer, a next-generation personalised digital cancer prevention tool that provides citizens with individualised risk assessments and tailored prevention guidance based on their health profile; |
Or. en
Amendment 396
Alessandra Moretti
Motion for a resolution
Paragraph 11
| Motion for a resolution | Amendment |
|---|---|
| 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; | 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; underlines the importance of health literacy and combating health misinformation as part of effective prevention strategies; |
Or. en
Amendment 397
Monika Beňová
Motion for a resolution
Paragraph 11
| Motion for a resolution | Amendment |
|---|---|
| 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool; | 11. Highlights the fifth edition of the European Code Against Cancer, with its 14 evidence-based recommendations combining individual and population-level measures, and stresses that it provides a strong scientific basis for developing a personalised digital prevention tool and for strengthening citizen oriented prevention campaigns across the Union; |
Or. en
Amendment 398
Christophe Clergeau
Motion for a resolution
Paragraph 11 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on the Commission and the Member States to make the One Health approach and an exposome-informed prevention agenda (research, health data, prevention) central to cancer policy, including by strengthening cross-sectoral collaboration and monitoring across human, animal and environmental health to better prevent and reduce cancer risks linked to cumulative exposures; calls on the Commission to adopt a horizontal common prevention pillar with a dedicated budget to address all risk factors of non-communicable diseases and to mutualise prevention effort across all existing and upcoming health sectoral plans (including cancer and cardiovascular), thus creating coherent and efficient synergies through the exposome approach; |
Or. en
Amendment 399
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 11 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 11a. Welcomes the progress made in the areas of digital cancer care, telemedicine and patient-reported outcome measures in a number of Member States; stresses that these tools should remain mutually compatible, clinically relevant and fully compliant with patient confidentiality, data protection and the ability of patients to retain control over their own health data; |
Or. fr
Amendment 400
Adam Jarubas
Motion for a resolution
Paragraph 11 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 11a. Clarifies that cancer prevention should encompass primary, secondary and tertiary prevention, including screening, early diagnosis and long-term management, recognizing that a significant proportion of cancers cannot be prevented through primary prevention alone and require timely detection and sustained care to improve outcomes and quality of life. |
Or. en
Amendment 401
Alessandra Moretti
Motion for a resolution
Paragraph 11 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on the Commission to integrate the One Health and exposome approaches into the implementation of Europe’s Beating Cancer Plan, in order to better address the cumulative impact of environmental, occupational, lifestyle and social determinants of cancer across the life course; |
Or. en
Amendment 402
Michalis Hadjipantela
Motion for a resolution
Paragraph 11 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 11a. Stresses that nutritional care services must be systematically integrated across primary, secondary and tertiary prevention, recognising the essential role of nutrition in prevention, treatment response, disease progression and long-term management of cancer conditions; |
Or. en
Amendment 403
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 11 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 11a. Calls on the Commission and Member States to accelerate research and innovation on the links between RMDs and cancer, addressing the specific needs of high-risk groups, including women, older people and socio-economically vulnerable populations; |
Or. en
Amendment 404
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 11 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 11b. Calls for strengthened action to address environmental cancer risk factors, including air, water, and soil pollution, PFAS, hazardous substances, UV exposure and second-hand smoke, while taking into account the cumulative and combined effects of exposures across the exposome, supported by harmonised EU monitoring and enforcement frameworks; |
Or. en
Amendment 405
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 11 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 11c. Welcomes the Europe’s Beating Cancer Plan’s recognition of the revision of the Ambient Air Quality Directives as a key cancer prevention opportunity; calls for the next phase of the Plan to include concrete measures on chemicals prevention; highlights the Chemical Strategy for Sustainability and the Zero Pollution Action Plan as key tools to reduce exposure to hazardous substances; calls on the Commission to fully implement both strategies by rapidly restricting the most harmful substances, including endocrine disruptors and carcinogenic, mutagenic and reprotoxic substances, and to advance a health-centred reform of REACH, including a comprehensive EU-wide restriction of PFAS, ensuring protection of human health in line with the precautionary principle and the latest scientific evidence; |
Or. en
Amendment 406
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 11 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 11d. Calls for reinforced action on occupational cancer risk factors as well as improved protection for workers in high-risk sectors, supported by harmonised EU monitoring and enforcement and a renewed, ambitious and updated EU Strategic Framework on Occupational Health and Safety post-2027, taking into account the growing impact of climate change on workers safety and exposure to occupational cancer risk factors; |
Or. en
Amendment 407
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 11 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 11e. Calls on the Commission to take EU-level action to address the risks of sunbed use, such as an EU-wide ban for minors, given the fragmented and inconsistent regulatory landscape across the EU27; urges the Commission to resume its work on its UV exposure recommendation without further delay; calls for EU-wide awareness campaigns on the harmful effects of sunbed use on public health; |
Or. en
Amendment 408
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Stresses the importance of early detection as a key tool to reduce cancer mortality and health inequalities in the Union; calls for the consolidation and strengthening of existing screening programmes, ensuring their proper implementation and homogeneous coverage across all Member States; welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; calls for the establishment of a robust monitoring and evaluation framework for the implementation of screening programmes, and urges that Union funding and technical support prioritise Member States and regions with lower screening uptake and greater access gaps, while integrating equity criteria into national plans; |
Or. en
Amendment 409
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; calls, furthermore, on the Commission and the Member States to establish minimum quality and access standards for screening programmes, to strengthen mobile and decentralised health services, particularly in rural, island and remote areas, and to make use of digital tools to improve participation and early diagnosis; |
Or. el
Amendment 410
Aurelijus Veryga
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission and Member States to urgently step up efforts to reach the 90 % screening target across all relevant cancer types, including breast, cervical and colorectal cancer; stresses that breast cancer should remain a priority in these efforts through the consistent implementation of organised, population-based screening programmes, quality assurance standards and the exchange of best practices between Member States; |
Or. en
Amendment 411
Adam Jarubas
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; stresses that breast and prostate cancer should remain a priority in these efforts through the consistent implementation of organised, population-based screening programmes, quality assurance standards and the exchange of best practices between Member States; |
Or. en
Amendment 412
Alessandra Moretti
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; regrets that the objective of offering breast, cervical and colorectal cancer screening to 90 % of the target population by 2025 has not been met; calls on the Commission and member states to urgently step up efforts to reach the 90 % screening target; |
Or. en
Amendment 413
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission and Member States to urgently step up efforts to reach the 90 % screening target; regrets that the objective of offering breast, cervical and colorectal cancer screening to 90 % of the target population by 2025 has not been met; |
Or. en
Amendment 414
Kateřina Konečná
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission and Member States to urgently step up efforts to reach the 90 % screening target across all relevant cancer types, including breast, cervical and colorectal cancer; |
Or. en
Amendment 415
Sebastian Everding
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission and Member States to urgently step up efforts to reach the 90 % screening target across all relevant cancer types, including breast, cervical and colorectal cancer; |
Or. en
Amendment 416
Christophe Clergeau
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission and Member States to urgently step up efforts to reach the 90 % screening target across all relevant cancer types including breast, cervical and cancer; |
Or. en
Amendment 417
Ruggero Razza
Motion for a resolution
Paragraph 12
| Motion for a resolution | Amendment |
|---|---|
| 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target; | 12. Welcomes the EUCanScreen joint action and the projects for lung, prostate and gastric cancer screening; calls on the Commission to urgently step up efforts to reach the 90 % screening target for the population of the Member States; |
Or. it
Amendment 418
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 12 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Stresses that AI-supported screening is a proven clinical intervention, not an experimental technology; calls on the Commission and Member States to integrate clinically validated AI tools into national cancer screening programmes without further delay, in line with the Apply AI Strategy’s commitment to AI-powered screening centres by 2027;1a | |
| 1a https://digital-strategy.ec.europa.eu/en/policies/ai-screening-centres |
Or. en
Amendment 419
Alessandra Moretti
Motion for a resolution
Paragraph 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 12a. Calls on the Commission to provide a comprehensive scientific and economic assessment of the benefits of early detection and screening, including their impact on healthcare expenditure, workforce participation and broader societal costs; stresses that earlier diagnosis significantly reduces treatment intensity and costs while improving survival and quality of life; calls on the Commission, on this basis, to present without delay a coordinated EU action plan on early detection and screening, including measurable targets, minimum quality standards, interoperable data collection and benchmarking, and dedicated support for Member States to close gaps in infrastructure, access and participation, with a view to strengthening prevention and ensuring both improved patient outcomes and the long-term sustainability of healthcare systems; |
Or. en
Amendment 420
Tomislav Sokol
Motion for a resolution
Paragraph 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 12a. Emphasises that early screening and detection are key to reducing cancer mortality, since cancers identified at an early stage are far more treatable and require fewer resources; calls for early detection to be prioritised within the European Beating Cancer Plan through targeted investment, greater public awareness, and the wider use of innovative, evidence-based diagnostic tools. |
Or. en
Amendment 421
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 12a. Calls on the Member States to leverage community pharmacies to improve screening uptake by enabling their involvement in awareness-raising, patient referral, and where appropriate, participation in screening programmes, particularly for underserved and hard-to-reach populations; |
Or. en
Amendment 422
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 12 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 12a. Underscores the importance of rolling out screening programmes for the most common kinds of cancer, including colorectal cancer, more systematically and consistently across the Member States in order to facilitate earlier diagnosis and improve survival rates; |
Or. fr
Amendment 423
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 12 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 12b. Calls on the Commission to support the Member States in working towards improving the prevention of stomach cancers, including by raising greater awareness of the risk factors, treating Helicobacter pylori infections earlier, and improving access to existing prevention programmes; |
Or. fr
Amendment 424
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 12 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 12c. Calls on the Member States to eschew general communications in favour of targeted, practical and easily accessible prevention campaigns in order to successfully raise awareness of screening, vaccination and preventable risk factors; |
Or. fr
Amendment 425
Ruggero Razza
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern the significant disparities in breast cancer screening rates across Member States, which range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; stresses the need to improve access to effective, evidence-based screening programmes, where necessary through targeted investment in healthcare infrastructure and staff, taking into account regional disparities and specific socio-economic and cultural factors; calls on the Commission to support the exchange of best practices between Member States, while fully respecting their national competences; |
Or. it
Amendment 426
András Tivadar Kulja
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach, and calls on Member States to ensure organised, population-based breast cancer screening programmes with systematic invitations for specific age groups, evidence-based, so as to reduce inequalities in access and early detection between Member States, so that every woman is offered screening in line with her screening needs, regardless of where she lives; |
Or. en
Amendment 427
Adam Jarubas
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; calls on Member States to ensure organised, population-based national breast and prostate cancer screening programmes with systematic invitations for eligible age groups, in line with evidence-based European guidelines, so as to reduce inequalities in access and early detection between Member States; |
Or. en
Amendment 428
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; calls on Member States to ensure organised, population-based breast cancer screening programmes with systematic invitations for eligible populations, in line with European guidelines, in order to reduce inequalities in access and improve early detection; |
Or. en
Amendment 429
Alessandra Moretti
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast, cervical and colorectal cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines that improving uptake requires not only investment in screening infrastructure, but also robust invitation and recall systems, timely diagnostic follow-up after positive tests, culturally sensitive outreach, health literacy measures and targeted outreach to underserved and hard-to-reach populations |
Or. en
Amendment 430
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast, cervical and colorectal cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure as well as robust invitation and recall systems, timely diagnostic follow-up after positive tests and culturally sensitive outreach, health literacy measures and targeted outreach to underserved and hard-to-reach populations; |
Or. en
Amendment 431
Kateřina Konečná
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast, cervical and colorectal cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; |
Or. en
Amendment 432
Aurelijus Veryga
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast, cervical and colorectal cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; |
Or. en
Amendment 433
Christophe Clergeau
Motion for a resolution
Paragraph 13
| Motion for a resolution | Amendment |
|---|---|
| 13. Notes with great concern that breast cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; | 13. Notes with great concern that breast and cervical cancer screening rates range from below 10 % to above 90 % across the EU, and that participation rates are stagnating or even declining; underlines the need for investment in screening infrastructure and culturally sensitive outreach; |
Or. en
Amendment 434
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 13 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Recommends that Commission and Members States support increased access to cancer predisposition testing and genetic counselling, when appropriate for children and adolescents diagnosed with cancer; |
Or. en
Amendment 435
Adam Jarubas
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Calls on the Commission and the Member States to ensure that the Union objective of offering breast cancer screening to 90 % of the eligible population is met and to further expand the share of the eligible population covered by prostate cancer screening, including prostate-specific antigen (PSA) testing and MRI scans for men up to 70, through organised national screening programmes. Calls on the Commission and the Member States to ensure that those organised national screening programmes are based on evidence-based age criteria and appropriate follow-up, so that every woman and man, respectively, is offered screening in line with screening needs, regardless of place of residence; |
Or. en
Amendment 436
Alessandra Moretti
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Expresses concern about the increasing incidence of early-onset cancers, including colorectal cancer, among younger populations; notes that many of these patients fall outside current screening strategies and clinical pathways and are therefore more likely to be diagnosed at a later stage; calls on the Commission and the Member States to support research into the causes of early-onset cancers, update legislation accordingly in order to prevent them, improve awareness among healthcare professionals and the public, and ensure that healthcare systems are better equipped to recognise and respond to cancer symptoms in younger patients; |
Or. en
Amendment 437
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Expresses concern about the increasing incidence of early-onset cancers, including colorectal cancer, among younger populations; notes that many of these patients fall outside current screening strategies and clinical pathways and are therefore more likely to be diagnosed at a later stage; calls on the Commission and the Member States to support research into the causes of early-onset cancers, improve awareness among healthcare professionals and the public, and ensure that healthcare systems are better equipped to recognise and respond to cancer symptoms in younger patients; |
Or. en
Amendment 438
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Deplores the frequent delays to and shortcomings in the early diagnosis of symptomatic cancers owing to a lack of information or missed cancer screening and detection procedures; encourages the Member States to promote screening for breast, cervical and colorectal cancers as part of population-based national and regional programmes, including in remote areas and the outermost regions, and to provide adequate resources to that end; |
Or. fr
Amendment 439
Dolors Montserrat, Elena Nevado del Campo
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Calls on the European Commission and the Member States to leverage community pharmacies to improve screening uptake by enabling their involvement in awareness-raising, patient referral, and where appropriate, participation in screening programmes, particularly for underserved and hard-to-reach populations; |
Or. en
Amendment 440
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Notes with serious concern that the majority of Member States have not yet updated their National Cancer Control Plans to reflect the 2022 Council Recommendation on lung and prostate screening; calls on the Commission to link such alignment to accessing EU4Health screening funds; |
Or. en
Amendment 441
Aurelijus Veryga
Motion for a resolution
Paragraph 13 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 13a. Urges the Commission to ensure that access to breast and gynaecological cancer screening, provided in accordance with EU guidelines, is recognised as an unequivocal right for all women and fully implemented across Member States; |
Or. en
Amendment 442
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 13 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 13b. Highlights with concern that rare cancer patients, including children, adolescents and young adults, continue to face unacceptable delays in receiving a cancer diagnosis, largely because of insufficient awareness and the ambiguous nature of early symptoms; calls on the Commission and Member States to invest in the professional development of family doctors and frontline health workers so they can more readily recognise warning signs and direct patients to appropriate specialist care; further urges the Commission and Member States to make better use of the European Reference Networks for Cancer and Comprehensive Cancer Centres as vehicles for strengthening cross-border knowledge exchange, fostering collaboration among specialists and disseminating best practices in cancer management; emphasises that scientific understanding of cancers affecting this population must be advanced through expanded research, with a focus on improving early detection and shedding light on the contribution of genetic predispositions and environmental exposures to cancer risk; |
Or. en
Amendment 443
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 13 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 13b. Emphasises that effective access to breast cancer screening remains more limited in the outermost regions owing to geographical, logistical and demographic constraints; urges the Member States to promote targeted strategies in these areas, including organising tailored awareness-raising campaigns, rolling out mobile units where appropriate, and strengthening local screening and follow-up capacities; |
Or. fr
Amendment 444
Aurelijus Veryga
Motion for a resolution
Paragraph 13 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 13b. Calls on the Commission and the Member States to ensure that the Union objective of offering breast cancer screening to 90 % of the eligible population is met through organised national screening programmes, based on evidence-based age criteria and appropriate follow-up, so that every woman is offered screening in line with her screening needs, regardless of where she lives; |
Or. en
Amendment 445
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 13 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 13b. Stresses that the effectiveness of cancer screening depends not only on offering tests, but also on timely follow-up after abnormal findings; calls on the Commission to work with Member States on common indicators for time from invitation to screening, from positive test to diagnostic confirmation, and from diagnosis to treatment initiation; |
Or. en
Amendment 446
Adam Jarubas
Motion for a resolution
Paragraph 13 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 13b. Calls on the Commission to explicitly recognize blood cancers to ensure patients affected by these types of cancers are not neglected; |
Or. en
Amendment 447
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 13 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 13c. calls on Member States to ensure organised, population-based national breast cancer screening programmes with systematic invitations for eligible age groups, in line with evidence-based European guidelines, so as to reduce inequalities in access and early detection between Member States; |
Or. en
Amendment 448
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Ondřej Knotek, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 13 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 13c. Stresses the importance of ensuring that women are better informed about the benefits of early breast cancer screening with a view to increasing participation in existing organised screening programmes; |
Or. fr
Amendment 449
Tomislav Sokol
Motion for a resolution
Subheading 5 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Emphasises the transformative potential of the European Health Data Space to enable secure, interoperable, and cross-border access to high-quality health data for research, while ensuring full compliance with data protection and ethical standards; urges the Member States to ensure the swift and effective implementation of the European Health Data Space, in order to facilitate responsible data sharing, advance personalised medicine, and accelerate innovation in cancer care across the Union; |
Or. en
Amendment 450
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 13 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 13d. Calls on the Commission to give specific attention to breast cancer, as the most common cancer among women, including by addressing persistent inequalities in access to prevention, early detection, diagnosis, treatment and survivorship support across Member States; |
Or. en
Amendment 451
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; stresses that these disparities should be reduced as a matter of priority by improving effective access to early diagnosis, proper treatment and existing care pathways; |
Or. fr
Amendment 452
Aurelijus Veryga
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; stresses that these disparities are closely linked to inequalities in early detection, timely diagnosis, access to specialised multidisciplinary care, biomarker testing and innovative treatments; |
Or. en
Amendment 453
Ruggero Razza
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern the persistent disparities in cancer survival rates across Member States, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; stresses the need to improve access to early diagnosis, high-quality treatment and integrated cancer care, taking into account regional inequalities; |
Or. it
Amendment 454
András Tivadar Kulja
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; these disparities are closely linked to inequalities in early detection, time of diagnosis, access to specialised multidisciplinary care, biomarker testing and innovative treatment; |
Or. en
Amendment 455
Adam Jarubas
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; these disparities are closely linked to inequalities in early detection, timely diagnosis, access to specialist multidisciplinary care, biomarker testing and innovative treatment; |
Or. en
Amendment 456
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern persistent disparities in cancer survival rates across Member States, with breast cancer survival rates varying by up to 20 % and colon cancer survival rates ranging from 49 % to 68 %, linked to inequalities in early detection, timely diagnosis, access to specialist multidisciplinary care, biomarker testing and innovative treatments; |
Or. en
Amendment 457
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 14
| Motion for a resolution | Amendment |
|---|---|
| 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU; | 14. Notes with concern that there are still significant disparities in cancer survival rates, with breast cancer survival rates varying by as much as 20 % from one Member State to another and colon cancer survival rates ranging from 49 % to 68 % across the EU, while paediatric cancer survival rates vary by 20% across Member States; |
Or. en
Amendment 458
Sebastian Everding
Motion for a resolution
Paragraph 14 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) highlights that these disparities are often linked to structural inequalities, particularly affecting rural populations, low-income groups, minority ethnic groups, and other disadvantaged citizens, and calls for targeted measures to address these gaps; |
Or. en
Amendment 459
Sebastian Everding
Motion for a resolution
Paragraph 14 – point b (new)
| Motion for a resolution | Amendment |
|---|---|
| (b) stresses that late diagnosis remains one of the main drivers of poor cancer outcomes across the Union; calls on the Commission and the Member States to prioritise earlier diagnosis strategies beyond organised screening programmes, including improved access to primary care, faster referral pathways, diagnostic capacity, and better recognition of symptoms, particularly for cancers that are not covered by population-based screening |
Or. en
Amendment 460
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 14 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 14a. Highlights that the shortage of healthcare professionals constitutes a structural constraint on the provision of cancer care; it emphasises the need to strengthen the capacity of national healthcare systems through measures relating to the training, retention and planning of specialist staff, whilst fully respecting the competences of the Member States; |
Or. en
Amendment 461
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 14 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 14a. Considers that a treatment's success hinges on the time it takes to get diagnosed and the length of the intervening period before being treated; calls on the Commission and the Member States to do everything they can to reduce these delays as much as possible, including by conducting a country-by-country analysis; |
Or. fr
Amendment 462
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 14 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 14a. Stresses that late diagnosis remains one of the main drivers of poor cancer outcomes across the Union; underlines that timely and equitable access to high-quality diagnostics — including pathology, molecular diagnostics and validated biomarker testing — is essential for effective and personalised cancer care; |
Or. en
Amendment 463
Ruggero Razza
Motion for a resolution
Paragraph 14 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 14a. emphasises the importance of improving the quality and timeliness of cancer care pathways, where necessary through the exchange of best practices between Member States, improved access to innovative treatments and the strengthening of the capacity of national health systems; |
Or. it
Amendment 464
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 14 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 14a. calls on the Commission and the Member States to scale up the use of molecular diagnostic testing and genomic technologies to identify actionable genomic alterations for diagnosis, prognosis and treatment selection, including through tissue and liquid biopsy approaches;” |
Or. en
Amendment 465
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 14 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 14b. Expresses concern about continued disparities in access to early diagnosis and advanced diagnostic tools; calls on the Commission and the Member States to prioritise earlier diagnosis strategies beyond organised screening programmes, including improved access to primary care, faster referral pathways, strengthened diagnostic capacity and better recognition of symptoms, particularly for cancers not covered by population-based screening; |
Or. en
Amendment 466
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Ondřej Knotek, Valérie Deloge
Motion for a resolution
Paragraph 14 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 14b. Emphasises that, in certain remote, rural or sparsely populated regions, the lack of specialist healthcare staff and delays in accessing diagnosis and treatment undermine effective equality of access to cancer care; warns of the risk that access to care may depend on place of residence; urges Member States to address these regional disparities as a priority, by strengthening care capacities and improving healthcare planning; |
Or. en
Amendment 467
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 14 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 14b. Calls on the Commission and the Member States to support the integration of appropriate and risk-adapted follow-up pathways into screening programmes; |
Or. en
Amendment 468
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 15
| Motion for a resolution | Amendment |
|---|---|
| 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; | 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; emphasises the role of Comprehensive Cancer Centres as centres of excellence for coordinated multidisciplinary care throughout the entire cancer care pathway; highlights the need to reduce fragmentation and improve coordination between levels of care; calls for their development to involve healthcare professionals and patients, as well as the use of outcomes-based tools, including Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs), in order to improve the quality and continuity of care; |
Or. en
Amendment 469
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 15
| Motion for a resolution | Amendment |
|---|---|
| 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; | 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres (CCC); underlines the need to strengthen integrated governance of Europe’s Beating Cancer Plan in order to facilitate effective cooperation across levels of care, territories and stakeholders; calls for the structured involvement of healthcare professionals, patients and civil society organisations in the design and implementation of CCC to ensure a truly people-centred approach through a care model based on universal accessibility and on outcomes-based medicine focused on health outcomes and patient experience; |
Or. en
Amendment 470
Ruggero Razza
Motion for a resolution
Paragraph 15
| Motion for a resolution | Amendment |
|---|---|
| 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; | 15. Notes the creation of the EU Network of National Comprehensive Cancer Centres; stresses, however, the need to ensure that this initiative fully respects national competences regarding the organisation of healthcare systems and provides clear added value, avoiding duplication and unnecessary administrative burdens; |
Or. it
Amendment 471
Aurelijus Veryga
Motion for a resolution
Paragraph 15
| Motion for a resolution | Amendment |
|---|---|
| 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; | 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres, notes their tangible role in raising standards of care, addressing regional cancer inequalities and their promise as a basis for enhanced research productivity and cooperation within the EU; |
Or. en
Amendment 472
Kateřina Konečná
Motion for a resolution
Paragraph 15
| Motion for a resolution | Amendment |
|---|---|
| 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; | 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres, notes their tangible role in raising standards of care, addressing regional cancer inequalities and their promise as a basis for enhanced research productivity and cooperation within the EU; |
Or. en
Amendment 473
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 15
| Motion for a resolution | Amendment |
|---|---|
| 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres; | 15. Welcomes the creation of the EU Network of National Comprehensive Cancer Centres, and notes their tangible role in raising standards of care, addressing regional inequalities in cancer care, and strengthening research capacity and cooperation across the Union; |
Or. en
Amendment 474
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 15 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Stresses that turning Europe's Beating Cancer Plan into tangible results hinges on all Member States establishing and continuously updating national cancer plans; highlights that these national frameworks must include a recognisable space for childhood cancers and rare adult cancers, with clear ties to the appropriate European Reference Networks, in order to secure well-structured referral routes, continuity of specialist knowledge and fair access to high-quality care, ensuring that no patient facing a rare cancer diagnosis is left without adequate support; |
Or. en
Amendment 475
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 15 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 15a. Recalls that Europe’s Beating Cancer Plan aims to ensure that 90 % of eligible patients have access to National Comprehensive Cancer Centres by 2030; calls on the Commission to publish regular, Member-State-specific progress updates on this objective; |
Or. en
Amendment 476
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 15 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 15a. calls on the Commission and Member States to ensure that the 2030 target of 90 % patient access to such centres is met, with adequate support for Member States with less developed infrastructure; |
Or. en
Amendment 477
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 16
| Motion for a resolution | Amendment |
|---|---|
| 16. Underlines that the European Reference Networks are essential for rare cancers, but that cross-border referral pathways remain underused; calls for sustained investment in the European Reference Networks and for measures to ensure that every patient with a rare cancer has access to multidisciplinary expertise; | 16. Underlines that the European Reference Networks are essential for rare cancers, but that cross-border referral pathways remain underused; calls for sustained investment in the European Reference Networks and for measures to ensure that every patient with a rare cancer has access to multidisciplinary expertise; further calls on the Commission to develop, in cooperation with the Member States, a framework for cross-border patient navigator services in cancer care, by building on the findings of the EU Navigate project and the European Observatory on Health Systems and Policies, and mapping such competencies to the European Qualifications Framework; |
Or. en
Amendment 478
Victor Negrescu
Motion for a resolution
Paragraph 16
| Motion for a resolution | Amendment |
|---|---|
| 16. Underlines that the European Reference Networks are essential for rare cancers, but that cross-border referral pathways remain underused; calls for sustained investment in the European Reference Networks and for measures to ensure that every patient with a rare cancer has access to multidisciplinary expertise; | 16. Underlines that the European Reference Networks are essential for rare cancers, but that cross-border referral pathways remain underused; calls for sustained investment in the European Reference Networks and for measures to ensure that every patient with a rare cancer has access to multidisciplinary expertise; calls for improved practical use of these networks to facilitate timely access to innovative treatments across borders; |
Or. en
Amendment 479
Elena Nevado del Campo, Dolors Montserrat
Motion for a resolution
Paragraph 16
| Motion for a resolution | Amendment |
|---|---|
| 16. Underlines that the European Reference Networks are essential for rare cancers, but that cross-border referral pathways remain underused; calls for sustained investment in the European Reference Networks and for measures to ensure that every patient with a rare cancer has access to multidisciplinary expertise; | 16. Underlines that the European Reference Networks are essential for rare cancers, but that cross-border referral pathways remain underused; calls for sustained investment in the European Reference Networks and for measures such as encouraging Member States to further integrate them into their national healthcare systems in order to ensure that every patient with a rare cancer has access to multidisciplinary expertise; |
Or. en
Amendment 480
Tomislav Sokol
Motion for a resolution
Paragraph 16 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 16a. Emphasises the pivotal role of National Comprehensive Cancer Centres in enhancing cancer prevention, early detection, diagnosis, treatment, and survivorship outcomes; calls on Member States and the Commission to prioritise the establishment, accreditation, and sustainable funding of such centres, ensuring equitable geographical distribution and effective cross-border accessibility; highlights that National Comprehensive Cancer Centres should serve as centres of excellence and function as integrated hubs for multidisciplinary care, research, innovation, and training, thereby accelerating the translation of scientific advances into clinical practice; stresses, furthermore, the importance of strengthening European Reference Networks and deepening cooperation among National Comprehensive Cancer Centres in order to reduce disparities in cancer care across the Union; |
Or. en
Amendment 481
Margarita de la Pisa Carrión, Laurent Castillo, Aldo Patriciello, Ondřej Knotek, Valérie Deloge
Motion for a resolution
Paragraph 16 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 16a. Stresses the essential importance of bone marrow, blood and plasma donation for the treatment of a wide range of cancer patients, in particular those suffering from haematological malignancies such as leukaemia; notes the high willingness of citizens to donate, while acknowledging that potential donors often face practical and administrative obstacles which hinder or prevent donation; emphasises the need for sufficiently broad and diverse donor registries, given the frequent lack of compatibility within families; calls on the Member States to facilitate, to the greatest extent possible, donation and registration procedures, promoting pathways that ensure a simpler, more efficient and accessible donation process; |
Or. en
Amendment 482
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 16 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 16a. Calls on the Commission to deliver on the operationalization calendar of the European Health Data Space in full and on time; further calls on the Commission to ensure continuity of cross-border access to cancer imaging data beyond the conclusion of the EUCAIM project in 2026, so that the pipeline for training and validating cancer AI systems on diverse, representative European data is not interrupted during the transition to the Health Data Space infrastructure; |
Or. en
Amendment 483
Victor Negrescu
Motion for a resolution
Paragraph 16 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 16a. Highlights the shortage of healthcare professionals, including oncology specialists, as a key barrier to the effective implementation of cancer care standards; |
Or. en
Amendment 484
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 16 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 16a. Calls on the Member States to ensure high-quality and timely access to innovative treatments and specialised care for patients with rare cancers; |
Or. en
Amendment 485
Michalis Hadjipantela
Motion for a resolution
Paragraph 17
| Motion for a resolution | Amendment |
|---|---|
| 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care; | 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care, including systematic malnutrition screening and diagnosis, access to a registered dietitian within a multi-disciplinary cancer care team, and the provision of appropriate nutritional intervention, follow-up and monitoring for cancer patients; |
Or. en
Amendment 486
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 17
| Motion for a resolution | Amendment |
|---|---|
| 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care; | 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care, including systematic malnutrition screening and diagnosis, access to a registered dietitian within a multi-disciplinary cancer care team, and the provision of appropriate nutritional intervention, follow-up and monitoring for cancer patients; |
Or. en
Amendment 487
Ruggero Razza
Motion for a resolution
Paragraph 17
| Motion for a resolution | Amendment |
|---|---|
| 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care; | 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care; calls for the integration of nutrition into multidisciplinary cancer care pathways at national level, where necessary through the training of healthcare staff and improvements in patient care; |
Or. it
Amendment 488
Aldo Patriciello, Marie-Luce Brasier-Clain, Aleksandar Nikolic, Margarita de la Pisa Carrión, Valérie Deloge, Ondřej Knotek
Motion for a resolution
Paragraph 17
| Motion for a resolution | Amendment |
|---|---|
| 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Commission to develop EU-level minimum quality standards for nutritional support in cancer care; | 17. Stresses that nutrition remains insufficiently integrated into cancer care delivery across the EU; calls on the Member States to integrate science-based minimum quality standards for nutritional support in cancer care, while respecting national dietary traditions and cultural diversity; |
Or. en
Amendment 489
Sebastian Everding
Motion for a resolution
Paragraph 17 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) encourage Member States to ensure accessibility and affordability of plant-based food options in public institutions such as schools and hospitals; |
Or. en
Amendment 490
Sebastian Everding
Motion for a resolution
Paragraph 17 – point b (new)
| Motion for a resolution | Amendment |
|---|---|
| (b) calls on the Commission to ensure that medicinal products for the treatment of cancer do not contain substances classified as carcinogenic, mutagenic or toxic for reproduction (CMR), including titanium dioxide (E171) and per- and polyfluoroalkyl substances (PFAS) |
Or. en
Amendment 491
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Ondřej Knotek, Valérie Deloge
Motion for a resolution
Paragraph 17 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 17a. Underlines that the approach to cancer must not be limited to cure or remission alone, but must also aim to ensure the patient’s full recovery and the highest attainable quality of life; stresses the need to guarantee continuity of care following treatment, including access to rehabilitation services, nutritional support, reconstructive and restorative treatments, as well as other necessary interventions to support patients’ functional and social recovery; calls on Member States to ensure the provision and accessibility of such services through the healthcare systems, guaranteeing patient support throughout the entire recovery pathway until the highest possible level of functionality is achieved; |
Or. en
Amendment 492
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 17 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 17a. Calls for the establishment of EU-level standards for nutritional assessment, monitoring and personalised nutrition interventions, ensuring continuity of care across hospital, rehabilitation and community settings; |
Or. en
Amendment 493
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 17 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 17b. Stresses the fundamental role of nutrition as a key factor in cancer prognosis, treatment response and patient recovery; highlights the need for systematic assessment of patients’ nutritional status before, during and after oncological treatment, in coordination with specialists in endocrinology and clinical nutrition; calls for guaranteed access to appropriate nutritional support, including enteral or parenteral nutrition where necessary, as well as vitamin supplementation and other supportive care measures, with a view to improving patients’ health outcomes and quality of life; |
Or. en
Amendment 494
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 17 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 17b. Calls on the Commission and the Member States to support cross-border trial models, strengthen information to patients and healthcare professionals on trial opportunities and promote a more balanced geographical distribution of clinical trial capacity; |
Or. en
Amendment 495
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 18
| Motion for a resolution | Amendment |
|---|---|
| 18. Regrets the disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; | 18. Regrets the disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; calls on the Commission and the Member States, within their competences, to ensure timely, equitable and affordable access for cancer patients to essential anti-cancer medicines, including by strengthening voluntary joint procurement mechanisms at EU level, better coordinating pricing and reimbursement policies, making use of EU financial instruments and supporting Member States, with the aim of reducing or eliminating direct financial burdens on patients; |
Or. el
Amendment 496
Alessandra Moretti
Motion for a resolution
Paragraph 18
| Motion for a resolution | Amendment |
|---|---|
| 18. Regrets the disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; | 18. Regrets the disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; stresses that equitable access depends not only on marketing authorisation, but also on commercial strategies by MHA, appropriate reimbursement decisions, availability of diagnostics and biomarkers, hospital infrastructure, workforce capacity and effective referral pathways; |
Or. en
Amendment 497
Bartosz Arłukowicz
Motion for a resolution
Paragraph 18
| Motion for a resolution | Amendment |
|---|---|
| 18. Regrets the disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; | 18. Regrets the disparities in access to cancer medicines and the latest medical technologies across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; calls for the fastest possible introduction of a pan-European joint procurement mechanism for the latest medical technologies; |
Or. pl
Amendment 498
Ruggero Razza
Motion for a resolution
Paragraph 18
| Motion for a resolution | Amendment |
|---|---|
| 18. Regrets the disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; | 18. Expresses concern about the continuing disparities in access to cancer medicines across the Member States; notes the progress made on the proposed critical medicines act and the pharmaceutical reform package, which are aimed, among other things, at reducing inequalities in access to cancer medicines; |
Or. it
Amendment 499
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Stresses that cancer treatment is inherently multimodal, requiring coordinated access to systemic and non-systemic treatment modalities, including surgery, radiotherapy, interventional radiology, nuclear medicine and emerging approaches such as radioligand therapy; calls on the Commission and Member States to ensure adequate infrastructure, workforce planning and investment across all modalities; |
Or. en
Amendment 500
Kateřina Konečná
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses that cancer treatment is inherently multimodal, requiring the coordinated use of systemic and non-systemic treatment modalities, including surgery, radiation oncology, interventional radiology and emerging approaches such as radioligand therapy; calls on the Commission and Member States to ensure adequate capacity, workforce planning and investment across all treatment modalities, in order to guarantee timely and equitable access to comprehensive cancer care; |
Or. en
Amendment 501
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses that cancer treatment is inherently multimodal, requiring the coordinated use of systemic and non-systemic treatment modalities, including surgery, radiation oncology, interventional radiology and emerging approaches such as radioligand therapy; calls on the Commission and Member States to ensure adequate capacity, workforce planning and investment across all treatment modalities, in order to guarantee timely and equitable access to comprehensive cancer care; |
Or. en
Amendment 502
Aurelijus Veryga
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Stresses that cancer treatment is inherently multimodal, requiring the coordinated use of systemic and local treatment modalities, including surgery, radiation oncology and interventional radiology, as well as emerging approaches such as radioligand therapy; calls on the Commission and Member States to ensure adequate capacity, workforce planning and investment across all treatment modalities in order to guarantee timely and equitable access to comprehensive cancer care; |
Or. en
Amendment 503
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 18 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Notes with concern the growing cancer workforce shortages across many Member States; calls on the Commission and Member States to invest in continuous education and upskilling, and to address structural challenges relating to working conditions, career development and remuneration in oncology; stresses that AI literacy must be integrated into medical education curricula across the Union; |
Or. en
Amendment 504
Ondřej Dostál
Motion for a resolution
Paragraph 18 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Regrets that the Union is not empowered to directly fund treatment; however, in the case of rare cancers, cross-border and transnational treatment approaches would be more efficient and effective than the current fragmented and administratively complex reimbursement mechanisms at Member State level. |
Or. en
Amendment 505
Sebastian Everding
Motion for a resolution
Paragraph 18 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) stresses that equitable access depends not only on marketing authorisation, but also on timely reimbursement decisions, availability of diagnostics and biomarkers, hospital infrastructure, workforce capacity and effective referral pathways; |
Or. en
Amendment 506
Sebastian Everding
Motion for a resolution
Paragraph 18 – point b (new)
| Motion for a resolution | Amendment |
|---|---|
| (b) highlights that shortages in the healthcare workforce, including oncologists, radiologists, pathologists, nurses and other specialised professionals, are a major constraint on the effective implementation of cancer policies; calls on the Commission and the Member States to address workforce capacity, training and retention as part of the next phase of Europe’s Beating Cancer Plan; |
Or. en
Amendment 507
Alessandra Moretti
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Highlights the transformative potential of next-generation cancer therapies, including neoantigen-based and mRNA cancer vaccines, which allow for targeted, personalised or semi-personalised treatment approaches; underlines that these innovations may significantly improve treatment efficacy and patient outcomes; stresses, however, that their high development and treatment costs risk creating new inequalities in access and place additional pressure on public health budgets; calls on the Commission to support research, regulatory pathways and joint European approaches to ensure equitable, timely and affordable access to such innovative therapies across the Union; |
Or. en
Amendment 508
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Ondřej Knotek, Valérie Deloge
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Highlights the strategic role of biotechnological advances in the diagnosis and treatment of cancer, particularly in personalised medicine and advanced therapies; notes that the implementation of the instruments provided for in the Biotech Act, including the recognition of strategic and high-impact projects, should contribute effectively to accelerating the transition from research to clinical practice, facilitating access to funding and production capacity, and ensuring that innovation actually reaches patients; |
Or. en
Amendment 509
Ruggero Razza
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. calls for the promotion of pragmatic solutions to improve access to cancer medicines, where necessary through the strengthening of cancer networks and diagnostic and treatment pathways at national and regional level, the reduction of regional inequalities, and improved uptake of prevention and screening programmes, with a view to ensuring better outcomes in terms of survival rates and quality of care; |
Or. it
Amendment 510
Tomislav Sokol
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Notes with serious concern the wide and persistent disparities in access to innovative oncological medicinal products across the Union, with a substantial proportion of newly authorised cancer treatments not reaching patients in many Member States; calls on the Commission to double its efforts in addressing these disparities and to ensure more timely, equitable and effective access to innovative cancer treatments across the Union; |
Or. en
Amendment 511
Dan-Ştefan Motreanu
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Recommends heightened cooperation between EU Member States in respect of ensuring access for cancer patients to precision cancer medicine. This could be more fully achieved through EU funding support for the development of necessary infrastructures such as laboratories, workforce development and training and greater transparency to patient communities of available biomarker therapies in-country. |
Or. en
Amendment 512
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls on the Commission and the Member States to encourage the production of anti-cancer medicines, active pharmaceutical ingredients and essential medical technologies in Europe in order to reduce the EU’s reliance on non-EU countries and boost the resilience of its supply chains; |
Or. fr
Amendment 513
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Stresses the need to strengthen EU-wide standards for diagnostics and biomarker testing, including clear guidance on quality, data standards and minimum service requirements; calls for equitable access to biomarker testing across all Member States; |
Or. en
Amendment 514
Victor Negrescu
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls on the Commission and the Member States to ensure timely, equitable and affordable access to innovative cancer medicines, in particular by reducing delays between marketing authorisation and patient access across the Union; |
Or. en
Amendment 515
Nicolás González Casares
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Calls on the Commission to develop a comprehensive EU strategy to close the biosimilar gap, specially in cancer treatments, ensuring timely and equitable access across all Member States; |
Or. en
Amendment 516
Aurelijus Veryga
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. calls for ensuring timely and equitable access to innovative cancer therapies across Member States, including reducing delays between EU-level approval and national implementation; |
Or. en
Amendment 517
Michalis Hadjipantela
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Acknowledges that cancer increasingly requires long-term management, integrated care pathways, long-term support and policies enabling social and labour-market reintegration. |
Or. en
Amendment 518
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Underlines the need for a robust clinical research ecosystem in Europe that enables cancer research and cancer clinical trials; calls for the expeditious conclusion of the revision of both the In Vitro Diagnostic Medical Devices Regulation (IVDR), and the Biotech Act I proposal and its targeted amendments to the Clinical Trials Regulation (CTR), to deliver an integrated framework for biomarker-driven research; underlines the importance of improving patient awareness of, and access to, clinical trials, as well as facilitating patient participation across Member States; |
Or. en
Amendment 519
Tomislav Sokol
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Highlights that rare cancers account for 24% of all new cancer diagnoses in Europe each year, representing approximately 650,000 new cases annually, and that around 5.1 million people in the EU are currently living with a rare cancer; calls therefore on the Commission and the Member States to strengthen coordinated action on rare cancers, in particular by improving early diagnosis, access to specialised care, research, and cross-border cooperation. |
Or. en
Amendment 520
Kateřina Konečná
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Recommends heightened cooperation between EU Member States in respect of ensuring access for cancer patients to precision cancer medicine. This could be more fully achieved through EU funding support for the development of necessary infrastructures such as laboratories, workforce development and training and greater transparency to patient communities of available biomarker therapies in-country; |
Or. en
Amendment 521
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Stresses that medicine shortages and supply disruptions have a direct impact on the ability of cancer patients to get swift access to treatment; calls for concerted action between the EU and Member States to forestall and manage such shortages; |
Or. fr
Amendment 522
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Calls for equitable and timely access across Member States to advanced and innovative cancer therapies, including personalised, cell-based and advanced therapy medicinal products; stresses the need for strengthened infrastructure, workforce capacity and cross-border cooperation; |
Or. en
Amendment 523
Victor Negrescu
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Calls on the Commission to ensure that publicly funded oncology research is accompanied by enforceable access conditions guaranteeing availability, affordability and timely patient access across the Union; |
Or. en
Amendment 524
Aurelijus Veryga
Motion for a resolution
Paragraph 18 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 18b. Calls for the wider implementation of precision oncology and biomarker testing across Member States in order to support optimal treatment selection and improve patient outcomes; |
Or. en
Amendment 525
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 18c. Stresses the need to foster innovation in the field of life-saving cancer treatments; calls on the Member States to bolster their research and production capacities for medicines and other health products in order to ensure access to treatment, alleviate medicine shortages and reduce their reliance on imports from non-EU countries; |
Or. fr
Amendment 526
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 18 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 18c. Underlines that telemedicine, including telemonitoring and teleconsultation, can improve the timeliness of cancer care, facilitate communication with healthcare professionals and reduce unnecessary burdens for patients, while contributing to more efficient healthcare systems; calls for their wider use to improve access to care and strengthen community-based healthcare services |
Or. en
Amendment 527
Victor Negrescu
Motion for a resolution
Paragraph 18 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 18c. Notes the persistent delays between EU-level approval of innovative cancer medicines and their availability to patients in several Member States, and calls for coordinated action to reduce these delays; |
Or. en
Amendment 528
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 18c. Stresses the urgent need to address workforce shortages across the oncology care pathway, ensuring adequate training, retention and working conditions; |
Or. en
Amendment 529
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 18d. Stresses the importance of personalised medicine including, where clinically relevant, appropriate genomic and molecular profiling in order to improve the suitability of treatment, reduce unnecessary side effects and make care more patient-centred; |
Or. fr
Amendment 530
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 18d. Stresses that antimicrobial resistance poses a direct threat to cancer care and calls for its integration into cancer strategies, health preparedness frameworks and EU medicines policies; |
Or. en
Amendment 531
Aurelijus Veryga
Motion for a resolution
Paragraph 18 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 18e. Recommends enhanced cooperation between Member States to ensure equitable access to precision oncology, including biomarker testing and targeted therapies; calls for Union support for the development of diagnostic infrastructure, workforce training and transparent patient information at national level; notes that, despite progress, access to biomarker testing and personalised treatments remains uneven across Europe, limiting patient outcomes; |
Or. en
Amendment 532
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 18e. Calls for medical oncology, paediatric oncology, geriatric oncology and surgical oncology to be fully recognised as specialist disciplines and for patients to be able to consult oncologists more readily so that they can reap the benefits of innovation and avail themselves of early-stage clinical trials of promising new medicines, healthcare technologies and centres of reference; |
Or. fr
Amendment 533
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 18e. Calls on the Commission and the European Medicines Agency to explore adaptive and patient-centred regulatory pathways for rare and hard-to-treat cancers, including the use of real-world evidence and biomarker-driven approaches, while maintaining high standards of safety, quality and efficacy; |
Or. en
Amendment 534
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 18f. Calls on the Member States, in the interests of providing access to the right treatment and care by means of an optimal care pathway followed at the expedient time, to promote and strengthen the role of general practitioners, paediatricians, nurses, primary care professionals and specialist doctors in the light of the important role they play in referring patients to diagnostic testing and oncologists; calls for the same treatment to be extended to specialist nutritionists and dietitians, psychologists and rehabilitation specialists in view of the role they play during treatment and follow-up care; |
Or. fr
Amendment 535
Aurelijus Veryga
Motion for a resolution
Paragraph 18 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 18f. calls for ensuring timely and equitable access to innovative cancer therapies across Member States, including reducing delays between EU-level approval and national implementation; |
Or. en
Amendment 536
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 18f. Calls for strengthened international regulatory cooperation to accelerate access to innovative cancer therapies while ensuring robust standards; |
Or. en
Amendment 537
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 18 g (new)
| Motion for a resolution | Amendment |
|---|---|
| 18g. Highlights the ongoing shortage of oncology professionals and welcomes initiatives such as INTERACT-EUROPE and INTERACT-EUROPE 100; calls for greater support in order to promote sustainable training pathways, keep healthcare workers in the profession and adapt national workforce planning; |
Or. fr
Amendment 538
Nikos Papandreou, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 18 g (new)
| Motion for a resolution | Amendment |
|---|---|
| 18g. Calls on Member States to remove barriers to participation in clinical trials and to ensure that patients enrolled in cancer clinical trials have access to standard-of-care treatments without financial or administrative obstacles, in order to improve equitable access to innovation across the Union; |
Or. en
Amendment 539
Friedrich Pürner
Motion for a resolution
Subheading 6 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Cancer care shall ensure respectful, clear, and empathetic communication with patients and their families at all stages, enabling informed and shared decision-making. Hospitals should proactively offer patients and their families access to a social worker early in the care pathway, on a voluntary basis. |
Or. en
Amendment 540
Adam Jarubas
Motion for a resolution
Paragraph 18 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 18a. Acknowledges that cancer increasingly requires long-term management, integrated care pathways, long-term support and policies enabling social and labour-market reintegration. |
Or. en
Amendment 541
Aurelijus Veryga
Motion for a resolution
Paragraph 18 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 18c. Underlines the need for a robust clinical research ecosystem in Europe that enables cancer research and cancer clinical trials; underlines the importance of improving patient awareness of, and access to, clinical trials, as well as facilitating patient participation across Member States; |
Or. en
Amendment 542
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 18 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 18f. Calls on the Commission and the Member States to address persistent access gaps and improve equitable access for patients to targeted and personalised cancer treatments; |
Or. en
Amendment 543
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Commission to propose concrete measures to support survivors’ return to work, such as guidance and training for employers in EU and national cancer strategies to support staff affected by cancer, covering flexible work options, stigma reduction, and workplace adjustments; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; Stresses that EU-wide ‘right to be forgotten’ laws should be anchored on an evidence-based five-year minimum remission period (MRP) to reduce unnecessary financial burdens faced by cancer survivors; Calls on the Commission to ensure EU and national cancer strategies supports staff affected by cancer, covering flexible work options, stigma reduction, and workplace adjustments; |
Or. en
Amendment 544
Christophe Clergeau
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Commission to propose concrete measures to support survivors’ return to work, such as guidance and training for employers and national cancer strategies to support staff affected by cancer, covering flexible work options, stigma reduction, and workplace adjustments; Calls on Member States and the Commission to maintain and strengthen binding legislative measures at national and Union level to protect cancer survivors from unfair financial discrimination and implement a Right to Be Forgotten; |
Or. en
Amendment 545
Ruggero Razza
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Emphasises the importance of supporting cancer survivors’ return to work, where necessary through targeted policies that take into account individual needs and health conditions; calls on the Commission to support Member States in developing effective measures to facilitate a return to work and combat discrimination; highlights the need to promote consistent approaches to the ‘right to be forgotten’, while respecting national competences and different legal systems; |
Or. it
Amendment 546
Sebastian Everding
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Commission to propose concrete measures to support survivors’ return to work, calls on the Commission to address gaps in ‘right to be forgotten’ legislation; such as guidance and training for employers in EU and national cancer strategies to support staff affected by cancer, covering flexible work options, stigma reduction, and workplace adjustments; |
Or. en
Amendment 547
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Member States to promote and apply the ‘right to be forgotten’ for cancer survivors; urges the Member States to work to enable cancer survivors to resume social activities and return to the labour market by helping adults retrain for a new career, where necessary, and children to return to school or higher education; |
Or. fr
Amendment 548
Kateřina Konečná
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Commission to propose concrete measures to support survivors’ return to work, such as guidance and training for employers in EU and national cancer strategies to support staff affected by cancer, covering flexible work options, stigma reduction, and workplace adjustments; |
Or. en
Amendment 549
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; including psychosocial care, rehabilitation, anti-discrimination measures and full implementation of the right to be forgotten; |
Or. en
Amendment 550
Marta Temido
Motion for a resolution
Paragraph 19
| Motion for a resolution | Amendment |
|---|---|
| 19. Calls on the Commission to propose concrete measures to support survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; | 19. Calls on the Commission to propose concrete measures to support people living with cancer and survivors’ return to work; calls on the Commission to address gaps in ‘right to be forgotten’ legislation; |
Or. en
Amendment 551
Sebastian Everding
Motion for a resolution
Paragraph 19 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) calls on Member States and the European Commission to maintain and strengthen binding legislative momentum at national and EU level to protect cancer survivors from unfair financial discrimination and to implement a Right to Be Forgotten; |
Or. en
Amendment 552
Tomislav Sokol
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Notes that the Consumer Credit Directive constitutes the first instance at Union level where the right to be forgotten for cancer survivors has been codified, with the objective of ending discrimination faced by cancer survivors in access to financial services; calls on the Commission to assess and propose further legislative measures to extend the codification of this right to be forgotten to other relevant Union legislation, in particular the Mortgage Credit Directive; |
Or. en
Amendment 553
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Highlights the positive impact of testimonies from patients who have overcome cancer, as sources of hope for patients and their families, contributing to a more human understanding of the disease; underlines the importance of giving visibility to these testimonies as a tool to foster resilience and promote a more positive outlook, reinforcing the value of life and human dignity at all times; |
Or. en
Amendment 554
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Calls on Member States and the European Commission to maintain and strengthen binding legislative momentum at national and EU level to protect cancer survivors from unfair financial discrimination and implement a Right to Be Forgotten; |
Or. en
Amendment 555
Kateřina Konečná
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Calls on Member States and the European Commission to maintain and strengthen binding legislative momentum at national and EU level to protect cancer survivors from unfair financial discrimination and implement a Right to Be Forgotten; |
Or. en
Amendment 556
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Urges the Commission to strengthen the quality-of-life dimension of cancer policies, including the systematic collection of Patient-Reported Outcome Measures (PROMs) and addressing long-term side effects; |
Or. en
Amendment 557
Alessandra Moretti
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Calls the Commission and member states to further strengthen legislative initiatives to protect cancer survivors from unfair financial discrimination and fully implement the Right to Be Forgotten; |
Or. en
Amendment 558
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 19 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 19a. Urges the Member States to promote the ‘right to be forgotten’ for children with cancer in order to facilitate their development and help realise their goals; |
Or. fr
Amendment 559
Laurent Castillo, Aleksandar Nikolic, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 19 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 19b. Calls on the Commission to promote legislation on the right to be forgotten, with a mere eight Member States having explicitly incorporated it within their own; |
Or. fr
Amendment 560
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers and calls for the recognition and systematic support of informal caregivers and family members of cancer patients, including through access to psychosocial support, financial protection and adequate work-life balance measure; |
| Stresses the urgent need to integrate psychosocial and mental health support, including supportive and palliative care, into standard cancer care, and to ensure access to such services at all stages of the cancer journey; calls on the Commission and Member States to systematically integrate these services into cancer control strategies; |
Or. en
Amendment 561
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; underlines the importance of medication adherence and safe use of cancer therapies, particularly in outpatient settings; calls for the systematic involvement of community pharmacists in supporting adherence, managing side effects, and providing patient-centred counselling throughout the cancer care pathway; |
Or. en
Amendment 562
Dolors Montserrat, Elena Nevado del Campo
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; underlines the importance of medication adherence and safe use of cancer therapies, particularly in outpatient settings; calls for the systematic involvement of community pharmacists in supporting adherence, managing side effects, and providing patient-centred counselling throughout the cancer care pathway; |
Or. en
Amendment 563
Aurelijus Veryga
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; Stresses the urgent need to integrate psychosocial and mental health support, including supportive and palliative care, into standard cancer care and to ensure access to supportive and palliative care at all stages of the cancer pathway; calls for specific attention to be given to the needs of persons living with advanced cancers, including metastatic cancer, throughout the care pathway; |
Or. en
Amendment 564
András Tivadar Kulja
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care, and calls for specific attention to the needs of those living with advanced cancers, to be reflected throughout care pathways including palliative care and accessible hospice care; |
Or. en
Amendment 565
Adam Jarubas
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; calls for specific attention to the needs of those living with advanced cancers, such as metastatic breast and prostate cancer, to be reflected throughout care pathways; |
Or. en
Amendment 566
Ruggero Razza
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Recognises the critical role of informal carers in the care of cancer patients; stresses the need to strengthen psychosocial and mental health support, including palliative care, within cancer care pathways, taking into account the different structures of national healthcare systems and the role of Member States; |
Or. it
Amendment 567
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care and to improve how work-life balance measures for carers are implemented in practice; |
Or. fr
Amendment 568
Kateřina Konečná
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; |
Or. en
Amendment 569
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care pathways at all stages of the disease, including survivorship; |
Or. en
Amendment 570
Michalis Hadjipantela
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate nutritional, psychosocial, and mental health support, including palliative care, into standard cancer care; |
Or. en
Amendment 571
Elena Nevado del Campo, Dolors Montserrat
Motion for a resolution
Paragraph 20
| Motion for a resolution | Amendment |
|---|---|
| 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial and mental health support, including palliative care, into standard cancer care; | 20. Underlines the critical role of informal carers; stresses the urgent need to integrate psychosocial, psychiatric and mental health support, including palliative care, into standard cancer care; |
Or. en
Amendment 572
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 20 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Calls on the Commission to address the need for stronger European coordination to fully harness the potential of precision oncology and targeted therapies; emphasizes the need to strengthen public health clinical research aimed at optimisation of treatments such as de-escalation programmes, which can significantly improve the quality of life of cancer patients. |
Or. en
Amendment 573
Sebastian Everding
Motion for a resolution
Paragraph 20 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) urges the Commission to strengthen the quality-of-life dimension of future cancer policies, by addressing broader challenges, including chronic pain, sexual health, psychosocial wellbeing, long-term side effects and supportive care; |
Or. en
Amendment 574
Alessandra Moretti
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Urges the European Commission to strengthen the quality-of-life dimension of future cancer policies, by addressing broader challenges, including chronic pain, sexual health, psychosocial wellbeing, long-term side effects, socio-economic inclusion and supportive care; |
Or. en
Amendment 575
Dan-Ştefan Motreanu
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Urges the European Commission to strengthen the quality-of-life dimension of future cancer policies, by addressing broader challenges, including chronic pain, sexual health, psychosocial wellbeing, long-term side effects and supportive care; |
Or. en
Amendment 576
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 20 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 20b. Urges the European Commission to strengthen the quality-of-life dimension of future cancer policies, by addressing broader challenges, including chronic pain, sexual health, psychosocial wellbeing, long-term side effects and supportive care; |
Or. en
Amendment 577
Kateřina Konečná
Motion for a resolution
Paragraph 20 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 20b. Urges the European Commission to strengthen the quality-of-life dimension of future cancer policies, by addressing broader challenges, including chronic pain, sexual health, psychosocial wellbeing, long-term side effects and supportive care; |
Or. en
Amendment 578
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 20 – point 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| (1) Calls on the Commission to support the integration of validated digital monitoring tools into post-treatment cancer survivorship pathways, in light of clinical evidence demonstrating that such tools can significantly reduce quality-of-life deterioration;1a | |
| 1a Cavalieri S, Vener C, LeBlanc M, Lopez-Perez L, Fico G, Resteghini C, Monzani D, Marton G, Pravettoni G, Moreira-Soares M, Filippidou DE, Almeida A, Bilbao A, Mehanna H, Singer S, Thomas S, Lacerenza L, Manfuso A, Copelli C, Mercalli F, Frigessi A, Martinelli E, Licitra L and BD4QoL Consortium (2023) A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol. Front. Oncol. 13:1048593. doi: 10.3389/fonc.2023.1048593 |
Or. en
Amendment 579
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Calls on the Member States and relevant authorities to recognise the pivotal role played by informal carers, to make them part of health and care teams, and to enable them, with the aid of healthcare professionals, to make informed choices about the support measures available; encourages the development of integrated, appropriate and accessible support schemes for cancer patients and their families, which should encompass health, community and social services; |
Or. fr
Amendment 580
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Ondřej Knotek, Valérie Deloge
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Stresses the importance of patient accompaniment and the fundamental role of the family and close environment in ensuring emotional well-being and psychological stability; emphasises that such support contributes significantly to improving patients’ quality of life and may positively influence recovery outcomes; calls for measures that facilitate and promote the presence and involvement of family members throughout the treatment process, ensuring a more humane, person-centred model of care; |
Or. en
Amendment 581
Kateřina Konečná
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Stresses the urgent need to integrate psychosocial and mental health support, including supportive and palliative care, into standard cancer care and to ensure access to supportive and palliative care at all stages of the cancer journey; |
Or. en
Amendment 582
Tomislav Sokol
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Expresses serious concern about the growing shortages in the oncology workforce across the Union, which place increasing pressure on health systems and risk compromising timely access to high-quality cancer care; |
Or. en
Amendment 583
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Urges the European Commission and Member States to promote the collection of Patient-Reported Outcome Measures as well as measurement of quality-of-life across cancer care services; |
Or. en
Amendment 584
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Calls on the Member States to promote and improve expanded, early and integrated palliative care services, including by strengthening home-based palliative care; |
Or. en
Amendment 585
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 20 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 20a. Calls for meaningful involvement of patient organisations in the design, implementation and evaluation of cancer policies; |
Or. en
Amendment 586
Margarita de la Pisa Carrión, Laurent Castillo, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 20 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 20b. Stresses the need to respect human dignity throughout the entire course of life, from birth to its natural end, where palliative care plays a fundamental role in providing a comprehensive response to patients’ needs at all stages of disease; underlines that palliative care affirms life while recognising death as a natural process, focusing on the relief of suffering and the improvement of quality of life until the end; calls for the guarantee of continuous support, humane treatment of patients and their families, as well as access to adequate pain management, psychological and social support; emphasises the holistic nature of palliative care as an essential component of patient-centred healthcare, including in the final stages of illness; |
Or. en
Amendment 587
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 20 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 20b. Calls for a more holistic approach to be taken in respect of cancer patients and survivors, which should encompass not only treatment but also nutrition, how to manage pain, mental health, comorbidities, rehabilitation, social challenges and long-term aftercare support; calls for greater coordination between oncology teams and general practitioners in how cancer patients are cared for before, during and after treatment; |
Or. fr
Amendment 588
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 20 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 20c. Encourages, where feasible and safe to do so, the use of outpatient cancer treatment in order to preserve the quality of life of patients and their families; |
Or. fr
Amendment 589
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 20 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 20d. Calls on the Member States to provide integrated, multidisciplinary palliative care services for cancer patients in order to alleviate their pain and discomfort by promoting comfort care and ensuring that nurses or carers are present, while preserving the patient’s dignity and taking their autonomy and advance care planning into account; |
Or. fr
Amendment 590
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 20 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 20e. Calls on the Member States to plan care and treatment measures designed to pay greater attention to protecting patients’ fertility, paying particular regard to paediatric and juvenile cancers; |
Or. fr
Amendment 591
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 20 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 20b. Calls on the Member States to promote and implement comprehensive cancer rehabilitation, with a view to improving patient outcomes and quality of life; |
Or. en
Amendment 592
Emmanouil Fragkos, Galato Alexandraki, Geadis Geadi
Motion for a resolution
Paragraph 21
| Motion for a resolution | Amendment |
|---|---|
| 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; | 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; stresses, furthermore, the importance of decentralising the organisation of health services and strengthening regional and local structures in order to ensure equal and timely access to prevention, diagnosis and treatment, particularly in rural, island, remote and under-served areas; |
Or. el
Amendment 593
Adam Jarubas
Motion for a resolution
Paragraph 21
| Motion for a resolution | Amendment |
|---|---|
| 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; | 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities and stresses that persistent disparities in breast cancer care across the Union also constitute a women’s equality issue, as access to timely and quality care still depends too strongly on where a woman lives; |
Or. en
Amendment 594
Alessandra Moretti
Motion for a resolution
Paragraph 21
| Motion for a resolution | Amendment |
|---|---|
| 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; | 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; underlines the need to address social, environmental and territorial determinants of health, including access to prevention and early detection services; |
Or. en
Amendment 595
Victor Negrescu
Motion for a resolution
Paragraph 21
| Motion for a resolution | Amendment |
|---|---|
| 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; | 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; stresses that unequal access to innovative cancer treatments remains a key driver of disparities in survival rates across the Union; |
Or. en
Amendment 596
Ruggero Razza
Motion for a resolution
Paragraph 21
| Motion for a resolution | Amendment |
|---|---|
| 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities; | 21. Reaffirms that cancer inequalities between and within Member States have deeper structural causes; invites the Commission to provide differentiated support to help reduce cancer inequalities, while respecting national competences; |
Or. it
Amendment 597
Sebastian Everding
Motion for a resolution
Paragraph 21 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) stresses the need to address structural disparities, including two-tier healthcare systems, and to promote equitable, solidarity-based access to timely, high-quality care for all, in particular the most vulnerable, as a means to reduce broader social inequalities; |
Or. en
Amendment 598
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 21 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 21a. Calls on the Commission and Member States to ensure that all EU citizens have equitable access to cancer diagnosis, treatment, and follow-up care regardless of their country of residence, socioeconomic background, or geographical location; |
Or. en
Amendment 599
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 21 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 21a. Stresses that improving survival rates also means setting particular store by those communities and regions where diagnosis is still lagging behind or the availability of specialist care is more limited; |
Or. fr
Amendment 600
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 21 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 21a. Stresses that persistent disparities in breast cancer care across the Union also constitute a women’s equality issue, as access to timely and quality care still depends too strongly on where a woman lives; |
Or. en
Amendment 601
Aurelijus Veryga
Motion for a resolution
Paragraph 21 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 21a. Calls on Member States to upgrade cancer registry systems to improve interoperable recording of cancer recurrence and advanced cancer diagnosis; |
Or. en
Amendment 602
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 21 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 21b. Calls attention to segments of the population that are particularly vulnerable to an increased risk of cancer through the impacts of health-harming pesticides, such as farmers who come in close contact with pesticides in their work or in their communities; calls on the Commission and Member States to ensure that decisions on phasing out pesticides are led by scientific evidence on their harmful effects, and further action is taken to implement and enforce existing pesticide legislation (the Sustainable Use of Pesticides Directive 2009/128/EC and the Regulation on Plant Protection Products No 1107/2009); |
Or. en
Amendment 603
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 21 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 21b. Regrets that cross-border healthcare remains problematic for citizens, especially regarding the financial burden for patients, including how to address upfront payments and other financial obstacles |
Or. en
Amendment 604
Adam Jarubas
Motion for a resolution
Paragraph 22
| Motion for a resolution | Amendment |
|---|---|
| 22. Welcomes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions; | 22. Welcomes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions, while working to improve the data itself with more granular and comparable data, including where possible data on stage at diagnosis, recurrence, metastatic disease and socioeconomic and geographical disparities; |
Or. en
Amendment 605
András Tivadar Kulja
Motion for a resolution
Paragraph 22
| Motion for a resolution | Amendment |
|---|---|
| 22. Welcomes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions; | 22. Welcomes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions, while improving data quality with more detailed and comparable data, including—where possible—information on stage at diagnosis, recurrence, metastatic disease, and socioeconomic and geographic disparities; |
Or. en
Amendment 606
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 22
| Motion for a resolution | Amendment |
|---|---|
| 22. Welcomes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions; | 22. Calls for action to be taken to systematically identify and replicate effective practices from the Member States and regions, including mobile screening units, network-based care models, digital dashboards for care pathways, telemedicine arrangements and back-to-work support programmes; |
Or. fr
Amendment 607
Ruggero Razza
Motion for a resolution
Paragraph 22
| Motion for a resolution | Amendment |
|---|---|
| 22. Welcomes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions; | 22. Notes the launch of the Cancer Inequalities Registry in 2022 and calls for the registry to be maintained, updated and used to guide targeted investments and policy interventions; |
Or. it
Amendment 608
Alessandra Moretti
Motion for a resolution
Paragraph 22 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 22 a. Stresses the importance of high-quality, comparable and timely data for monitoring cancer outcomes and inequalities across the Union; calls on the Commission to strengthen data collection, interoperability and use, including through the European Health Data Space, in order to support evidence-based policy-making, improve implementation of screening and treatment programmes, and identify gaps in access and outcomes; |
Or. en
Amendment 609
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 22 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 22a. Stresses the importance of high-quality, comparable and timely data for monitoring cancer outcomes and inequalities across the Union; calls on the Commission to strengthen data collection, interoperability and use, including through the European Health Data Space, in order to support evidence-based policy-making, improve implementation of screening and treatment programmes, and identify gaps in access and outcomes; |
Or. en
Amendment 610
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 22 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 22a. Calls on Member States to strengthen cancer registries, including data on recurrence and metastatic disease, and calls on the Commission to support harmonisation and funding; |
Or. en
Amendment 611
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 23
| Motion for a resolution | Amendment |
|---|---|
| 23. Calls for targeted interventions and outreach strategies to ensure that disadvantaged and marginalised groups have equitable access to cancer care; | 23. Stresses that socio-economic determinants of health, including income, employment, housing, education and environmental exposures, significantly influence cancer risk and outcomes across prevention, early detection and treatment; underlines that these factors drive persistent health inequalities within and across Member States, disproportionately affecting vulnerable populations; calls for a cross-sectoral approach to cancer prevention and care addressing these determinants in line with the ‘health in all policies’ principle, and for targeted interventions to ensure equitable access to cancer care for disadvantaged and marginalised groups. |
Or. en
Amendment 612
Kateřina Konečná
Motion for a resolution
Paragraph 23
| Motion for a resolution | Amendment |
|---|---|
| 23. Calls for targeted interventions and outreach strategies to ensure that disadvantaged and marginalised groups have equitable access to cancer care; | 23. Calls for targeted interventions and outreach strategies to ensure that disadvantaged and marginalised groups have equitable access to cancer care; encourages the Commission and the Member States to strengthen health literacy on cancer risks and determinants, in particular by developing accessible and inclusive prevention tools specifically targeting these groups; calls for the use of a wide range of prevention measures, including alcohol prevention, nutritional awareness and approaches aimed at reducing health damage and health risks and supporting individuals in lowering exposure to harmful consumption. |
Or. en
Amendment 613
Ruggero Razza
Motion for a resolution
Paragraph 23
| Motion for a resolution | Amendment |
|---|---|
| 23. Calls for targeted interventions and outreach strategies to ensure that disadvantaged and marginalised groups have equitable access to cancer care; | 23. Stresses the need to reduce inequalities in access to cancer care, particularly for the most vulnerable sections of the population, by addressing the structural causes that limit such access; calls on the Commission to support Member States in strengthening their national healthcare systems and making effective use of existing tools, while fully respecting national competences; |
Or. it
Amendment 614
Elena Nevado del Campo, Dolors Montserrat
Motion for a resolution
Paragraph 23
| Motion for a resolution | Amendment |
|---|---|
| 23. Calls for targeted interventions and outreach strategies to ensure that disadvantaged and marginalised groups have equitable access to cancer care; | 23. Calls for targeted interventions and outreach strategies to ensure that disadvantaged and marginalised groups and regions have equitable access to cancer care; |
Or. en
Amendment 615
Aurelijus Veryga
Motion for a resolution
Paragraph 23 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 23a. Expresses concern about the shortage of the oncology workforce and deteriorating working conditions across the Union; notes evidence of burnout, excessive workload and administrative burden among cancer professionals; stresses that these shortages risk undermining timely access to care, quality of treatment and patient outcomes; calls on the Commission and Member States to develop a coordinated European approach to workforce planning, including investment in education, training, retention and the wellbeing of healthcare professionals across all oncology disciplines; |
Or. en
Amendment 616
Alessandra Moretti
Motion for a resolution
Paragraph 23 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 23a. Expresses serious concern about the growing shortage and deteriorating working conditions of the oncology workforce across the Union; stresses that these shortages risk undermining timely access to diagnosis and treatment, the quality of care and patient outcomes; calls on the Commission and member states to develop a coordinated EU approach to cancer workforce planning, including investment in education, training, retention and wellbeing of healthcare professionals across all oncology disciplines; |
Or. en
Amendment 617
Kateřina Konečná
Motion for a resolution
Paragraph 23 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 23a. Stresses that cancer prevention policies must take into account social inequalities and focus on reducing the burden of disease among disadvantaged, vulnerable, socially excluded and marginalised groups; highlights the need to approach these groups with innovative and targeted prevention strategies, supporting individuals in reducing exposure to harmful consumption patterns , including approaches aimed at reducing health damage and health risks; underlines that such measures should be assessed based on their real impact on health outcomes and living conditions |
Or. en
Amendment 618
Aurelijus Veryga
Motion for a resolution
Paragraph 23 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 23c. Stresses that cancer prevention and early detection programmes should take into account the specific barriers faced by persons with rheumatic and musculoskeletal diseases (RMDs), including reduced mobility, multiple comorbidities and limited access to specialised care, in order to ensure equitable reductions in cancer morbidity and mortality across the population; |
Or. en
Amendment 619
Jessica Polfjärd
Motion for a resolution
Subheading 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Gender-related aspects |
Or. en
Amendment 620
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24
| Motion for a resolution | Amendment |
|---|---|
| 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; | 24. Stresses the importance of fully integrating sex- and gender-related differences into cancer research, prevention, screening, diagnosis and treatment; Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure, screening uptake, access to diagnosis and treatment, participation in clinical trials and survivorship outcomes, and to develop targeted strategies to reduce gender-specific disparities in cancer prevention, care, and support; |
Or. en
Amendment 621
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 24
| Motion for a resolution | Amendment |
|---|---|
| 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; | 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; access to timely diagnosis and treatment, participation in clinical trials and survivorship outcomes; stresses the importance of improving the collection and use of sex-disaggregated data and developing targeted strategies to reduce gender-based disparities in cancer prevention, care and support; |
Or. en
Amendment 622
Adam Jarubas
Motion for a resolution
Paragraph 24
| Motion for a resolution | Amendment |
|---|---|
| 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; | 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake and to give specific attention to breast and prostate cancer as the most common cancer in their respective populations, including persistent inequalities in access to prevention, early detection, diagnosis, treatment and survivorship support across Member States; |
Or. en
Amendment 623
Christophe Clergeau
Motion for a resolution
Paragraph 24
| Motion for a resolution | Amendment |
|---|---|
| 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; | 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure, screening uptake, access to diagnosis and treatment, participation in clinical trials and survivorship outcomes; calls on the Commission to develop targeted strategies to reduce gender-specific disparities in cancer prevention, care, and support; |
Or. en
Amendment 624
Alessandra Moretti
Motion for a resolution
Paragraph 24
| Motion for a resolution | Amendment |
|---|---|
| 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; | 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure, screening uptake, access to diagnosis and treatment, participation in clinical trials, and survivorship outcomes, and to develop targeted strategies to reduce gender-specific disparities in cancer prevention, care, and support; |
Or. en
Amendment 625
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 24
| Motion for a resolution | Amendment |
|---|---|
| 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake; | 24. Calls on the Commission to address the gender dimension of cancer inequalities, including differences in risk factor exposure and in screening uptake and the disproportionate caring responsibilities borne by women; stresses the need for gender-sensitive approaches across all pillars; |
Or. en
Amendment 626
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 24 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Highlights the importance of telemedicine, remote monitoring and the virtual consultation model of the European Reference Networks in reducing geographical barriers; calls for sustained investment in digital health infrastructure in underserved regions; |
Or. en
Amendment 627
Sebastian Everding
Motion for a resolution
Paragraph 24 – point a (new)
| Motion for a resolution | Amendment |
|---|---|
| (a) calls on the Commission and Member States to guarantee that all women have access to fertility preservation counselling, empowering them to make informed and autonomous decisions about their cancer treatment and reproductive future; |
Or. en
Amendment 628
Sebastian Everding
Motion for a resolution
Paragraph 24 – point c (new)
| Motion for a resolution | Amendment |
|---|---|
| (c) calls for greater scrutiny of social media advertising and beauty standards that promote or normalise harmful behaviours, including sunbed use, especially among women and girls; |
Or. en
Amendment 629
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 24 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 24a. Encourages the Member States to carry out targeted activities to raise awareness of cancer screenings in rural and remote areas and the outermost regions, including setting up mobile screening units, getting general practitioners involved and launching awareness-raising campaigns; |
Or. fr
Amendment 630
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 24a. Calls on the Commission and Member States to guarantee that all women have access to fertility preservation counselling, empowering them to make informed and autonomous decisions about their cancer treatment and reproductive future; |
Or. en
Amendment 631
Christophe Clergeau
Motion for a resolution
Paragraph 24 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 24a. Calls on the Commission and Member States to guarantee that all women have access to fertility preservation counselling, empowering them to make informed and autonomous decisions about their cancer treatment and reproductive future; |
Or. en
Amendment 632
Dan-Ştefan Motreanu
Motion for a resolution
Paragraph 24 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 24a. Calls on the Commission and Member States to guarantee that all women have access to fertility preservation counselling, empowering them to make informed and autonomous decisions about their cancer treatment and reproductive future; |
Or. en
Amendment 633
Jessica Polfjärd
Motion for a resolution
Paragraph 24 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 24a. Calls on the Commission and Member States to support increased research on sex-specific aspects of cancer and gender-related differences in diagnosis, treatment and outcomes of cancer care; |
Or. en
Amendment 634
Aurelijus Veryga
Motion for a resolution
Paragraph 24 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 24b. Urges the Commission and Member States to give specific attention to breast cancer, as the most commonly diagnosed cancer in women, including persistent inequalities in access to prevention, early detection, diagnosis, treatment and survivorship support across Member States; |
Or. en
Amendment 635
Sebastian Everding
Motion for a resolution
Paragraph 24 – point b (new)
| Motion for a resolution | Amendment |
|---|---|
| (b) urges the Commission to ensure that access to breast and gynaecological cancer screening, provided in accordance with EU guidelines, is recognised as an unequivocal right for all women and fully implemented across Member States; |
Or. en
Amendment 636
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 24b. Urges the Commission to ensure that access to breast and gynaecological cancer screening, provided in accordance with EU guidelines, is recognised as an unequivocal right for all women and fully implemented across Member States; |
Or. en
Amendment 637
Dan-Ştefan Motreanu
Motion for a resolution
Paragraph 24 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 24b. Urges the Commission to ensure that access to breast and gynaecological cancer screening, provided in accordance with EU guidelines, is recognised as an unequivocal right for all women and fully implemented across Member States; |
Or. en
Amendment 638
Jessica Polfjärd
Motion for a resolution
Paragraph 24 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 24b. Calls on the Commission and Member States to address gender inequalities in cancer care outcomes; |
Or. en
Amendment 639
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 24c. Metastatic Cancer | |
| Calls on Member States to upgrade cancer registry systems to improve interoperable recording of cancer recurrence and advanced cancer diagnosis, and for the European Commission to play a facilitating and coordinating role in achieving this improvement, including supporting countries to access appropriate EU funding for registry enhancement; |
Or. en
Amendment 640
Christophe Clergeau
Motion for a resolution
Subheading 7 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Workforce |
Or. en
Amendment 641
Christophe Clergeau
Motion for a resolution
Paragraph 24 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 24b. Expresses serious concern about the growing shortage and deteriorating working conditions of the oncology workforce across the Union; stresses that these shortages risk undermining timely access to diagnosis and treatment, the quality of care and patient outcomes; |
Or. en
Amendment 642
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 24d. Oncology Workforce | |
| Expresses serious concern about the growing shortage in the healthcare workforce, including oncologists, radiologists, pathologists, nurses and other specialised professionals, and deteriorating working conditions of the oncology workforce across the Union; notes evidence of high levels of burnout, excessive workload and administrative burden among cancer professionals; |
Or. en
Amendment 643
Christophe Clergeau
Motion for a resolution
Paragraph 24 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 24c. Calls on the Commission and Member States to develop a coordinated approach to cancer workforce planning, including investment in education, training, retention and wellbeing of healthcare professionals across all oncology disciplines; |
Or. en
Amendment 644
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 24e. Calls on the Commission and Member States to develop a coordinated European approach to cancer workforce planning, including investment in education, training, retention and wellbeing of healthcare professionals across all oncology disciplines; |
Or. en
Amendment 645
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 24 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 24f. Calls for the explicit inclusion of nuclear medicine professionals (physicians, medical physicists, radiopharmacists and technologists) within EU cancer workforce strategies, and for increased EU support for specialised education, training and harmonised high-quality standards across Member States; |
Or. en
Amendment 646
Kateřina Konečná
Motion for a resolution
Subheading 8 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Oncology Workforce | |
| Expresses serious concern about the growing shortage and deteriorating working conditions of the oncology workforce across the Union; | |
| notes evidence of high levels of burnout, excessive workload and administrative burden among cancer professionals; | |
| stresses that these shortages risk undermining timely access to diagnosis and treatment, the quality of care and patient outcomes | |
| calls on the Commission and Member States to develop a coordinated European approach to cancer workforce planning, including investment in education, training, retention and wellbeing of healthcare professionals across all oncology disciplines; |
Or. en
Amendment 647
Alessandra Moretti
Motion for a resolution
Subheading 8
| Motion for a resolution | Amendment |
|---|---|
| Childhood cancer | Childhood cancer, cancer in the elderly and women |
Or. en
Amendment 648
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 25
| Motion for a resolution | Amendment |
|---|---|
| 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients and simplify prior authorisation procedures; | 25. Stresses that paediatric cancer, while rare, is a high-burden disease and is marked by significant survival and access inequalities across Europe; calls on the Commission and the Member States to enhance EU-level cooperation on and funding for paediatric oncology research, data sharing and clinical trials, to boost drug development and access to innovation for children and adolescents with cancer, to strengthen paediatric and adolescent cancer networks and infrastructure, and to ensure timely cross-border referral to specialised centres through European Reference Networks; Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients and simplify prior authorisation procedures; |
| 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). | 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). |
Or. en
Amendment 649
Tomislav Sokol
Motion for a resolution
Paragraph 25
| Motion for a resolution | Amendment |
|---|---|
| 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients and simplify prior authorisation procedures; | 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients and simplify prior authorisation procedures; emphasises in particular the need to simplify and harmonise the regulatory framework by merging authorisation and reimbursement rules from the Cross-Border Healthcare Directive and the Regulation on Coordination of Social Security Systems, thereby ensuring more transparent, efficient and legally robust reimbursement mechanisms. |
| 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). | 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). |
Or. en
Amendment 650
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25
| Motion for a resolution | Amendment |
|---|---|
| 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients and simplify prior authorisation procedures; | 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; calls, in addition, for more targeted research, support for families and continuity of care into adulthood; |
| 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). | 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). |
Or. fr
Amendment 651
Ruggero Razza
Motion for a resolution
Paragraph 25
| Motion for a resolution | Amendment |
|---|---|
| 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients and simplify prior authorisation procedures; | 25. Calls for cross-border access to cancer care and experimental therapies to be improved as a matter of urgency; invites the Commission to revise the Cross-Border Healthcare Directive3 to include practical support for families of cancer patients throughout the treatment process, where necessary through support mechanisms already available at national level; |
| 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). | 3 Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, p. 45, ELI: http://data.europa.eu/eli/dir/2011/24/oj). |
Or. it
Amendment 652
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 25 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Stresses that up to 30 % of children affected by cancer suffer severe long-term consequences; calls for continued investment in paediatric oncology research, equitable access to paediatric clinical trials, and dedicated follow-up care programmes; |
Or. en
Amendment 653
Nicolás González Casares
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Calls on timely and equitable access to innovative therapies for paediatric cancer patients, including advanced therapy medicinal products; reminds the opportunity of making full and appropriate use of the hospital exemption pathway, as a means to deliver personalised treatments in cases of unmet medical need; while ensuring high standards of quality, safety and efficacy, and addressing existing fragmentation across member States that currently limits cross-border cooperation and patient access, as highlighted in recent scientific and regulatory analyses1a; | |
| 1a The hospital exemption pathway for the approval of advanced therapy medicinal products: an underused opportunity? The case of the CAR-T ARI-0001 https://www.nature.com/articles/s41409-021-01463-y |
Or. en
Amendment 654
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Welcomes the work carried out by initiatives and organisations providing accommodation, support and practical solutions to families of patients, particularly in cases involving children who must travel far from their place of residence to receive treatment and lack sufficient resources; highlights the importance of supporting and promoting such solidarity-based initiatives, which complement healthcare provision by facilitating family accompaniment and alleviating the economic and social burden associated with the disease; |
Or. en
Amendment 655
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Acknowledges that rare cancers in adults are a public health challenge; points out that adults with rare cancers face particular difficulties on account of the rarity and unusual nature of their condition; calls, therefore, for action to be taken to raise awareness among primary and secondary healthcare professionals of rare cancers in adults, and for the creation of the proper referral pathways to specialist multidisciplinary centres; |
Or. fr
Amendment 656
Alessandra Moretti
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25 a. Calls for the promotion of geriatric oncology as a branch that deserves special consideration and funding and that needs to be strengthened by scientific research to ascertain the best treatment and diagnostic methods for older patients; calls for appropriate consideration of the specific needs and rights of older cancer patients while shaping public health and cancer related policies; |
Or. en
Amendment 657
Aurelijus Veryga
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Recognises the progress made on adolescent and young adult (AYA) cancer through EU-supported actions, including the establishment of the EU Network of Youth Cancer Survivors; calls on the Commission to provide structured support to Member States in developing and strengthening age-appropriate AYA cancer services; |
Or. en
Amendment 658
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Further calls for enhanced research and coordinated EU-level monitoring of potential clusters of paediatric cancers, including through improved surveillance systems and investigation of possible environmental and other risk factors; |
Or. en
Amendment 659
Victor Negrescu
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Stresses that every child and adolescent in the Union, irrespective of place of residence, should benefit from timely and equitable access to innovative treatments, including participation in clinical trials where appropriate; |
Or. en
Amendment 660
Ondřej Dostál
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Notes that many inequalities remain unknown, as they are not reported and are therefore not reflected in available data; |
Or. en
Amendment 661
Friedrich Pürner
Motion for a resolution
Paragraph 25 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 25a. Calls for enhanced and sustained funding for research into paediatric and rare cancers. |
Or. en
Amendment 662
Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge
Motion for a resolution
Paragraph 25 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 25b. Highlights the fundamental role of volunteers in hospitals and healthcare centres in supporting patients, particularly children, through accompaniment, educational activities and psychosocial support; emphasises the importance of recognising and giving visibility to their commitment, which significantly contributes to improving the hospital experience, reducing feelings of isolation and complementing healthcare provision through a human and social dimension of care, bringing out the best in all those involved; |
Or. en
Amendment 663
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 25 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 25b. Adolescent and Young Adults (AYA) Cancer | |
| Recognises the progress made on adolescent and young adult (AYA) cancer through EU-supported actions, including the establishment of the EU Network of Youth Cancer Survivors; calls on the Commission to provide structured support to Member States in developing and strengthening age-appropriate AYA cancer services, ensuring that young patients and survivors receive care tailored to their specific clinical, psychological and social needs; |
Or. en
Amendment 664
Michele Picaro, Pietro Fiocchi
Motion for a resolution
Paragraph 25 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 25b. Stresses the need for a comprehensive and integrated approach across all stages of the paediatric cancer care pathway, including diagnosis and treatment, as well as palliative care, which should be made available to all children and adolescents with cancer; calls on the Member States to ensure appropriate and accessible long-term follow-up; highlights the essential role of rehabilitation in supporting school reintegration and social inclusion; |
Or. en
Amendment 665
Alessandra Moretti
Motion for a resolution
Paragraph 25 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 25b. Calls on the Commission and Member States to guarantee that all women have access to fertility preservation counselling, empowering them to make informed and autonomous decisions about their cancer treatment and reproductive future; |
Or. en
Amendment 666
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 25b. Encourages the Member States to strengthen approaches to geriatric oncology, home care and home hospital arrangements for cancer patients, particularly for older or isolated patients; |
Or. fr
Amendment 667
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 25c. Stresses the importance of ensuring that child cancer patients are swiftly referred to specialist centres staffed with the requisite expertise in order to improve their chances of survival and quality of care; |
Or. fr
Amendment 668
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25 d (new)
| Motion for a resolution | Amendment |
|---|---|
| 25d. Reiterates the vital role played by European reference networks and deems it expedient to raise greater awareness and make better use of existing schemes for children with rare or complex cancers; |
Or. fr
Amendment 669
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25 e (new)
| Motion for a resolution | Amendment |
|---|---|
| 25e. Emphasises that paediatric cancers must be handled in such a way as to take full account of the patient’s family circumstances, paying particular heed to psychological support, information, accommodation and the logistical challenges of care; |
Or. fr
Amendment 670
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 25 f (new)
| Motion for a resolution | Amendment |
|---|---|
| 25f. Stresses the need to improve the information and guidance families receive about the sorts of clinical trials and innovative treatments available for paediatric cancers, without prejudice to existing frameworks; |
Or. fr
Amendment 671
Peter Liese
Motion for a resolution
Paragraph 26
| Motion for a resolution | Amendment |
|---|---|
| 26. Calls on the Commission to develop a comprehensive, citizen-oriented communication strategy focused on the concrete results delivered by the Plan, raising citizens’ awareness of the EU’s tangible impact on cancer prevention, screening, treatment and survival; | 26. Calls on the Commission to develop a comprehensive, citizen-oriented communication strategy focused on the concrete results delivered by the Plan, raising citizens’ awareness of the EU’s tangible impact on cancer prevention, screening, treatment and survival; emphasizes that this strategy should explicitly highlight medical breakthroughs and innovative treatments achieved through EU-coordinated efforts to raise public awareness of the Union's impact; |
Or. en
Amendment 672
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 26
| Motion for a resolution | Amendment |
|---|---|
| 26. Calls on the Commission to develop a comprehensive, citizen-oriented communication strategy focused on the concrete results delivered by the Plan, raising citizens’ awareness of the EU’s tangible impact on cancer prevention, screening, treatment and survival; | 26. Calls on the Commission to develop a comprehensive, citizen-oriented communication strategy focused on the concrete results delivered by the Plan, raising citizens’ awareness of the EU’s tangible impact on cancer prevention, screening, treatment and survival, while allowing the Member States to tailor their communications to their own particular reality and public health priorities; |
Or. fr
Amendment 673
Peter Liese
Motion for a resolution
Paragraph 26 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 26a. Suggests that the EU’s communication strategy incorporates real-life patient success stories to illustrate the human impact of the Plan; proposes that, subject to the explicit, informed, and prior consent of the individuals concerned, such communication should include specific patient experiences and names to showcase the life-changing outcomes of European health initiatives; |
Or. en
Amendment 674
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 27
| Motion for a resolution | Amendment |
|---|---|
| 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy; | 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy, and to support the development of rapid-response tools and fact-checking resources specifically for cancer-related misinformation, and to fund health literacy programmes that equip citizens with the critical skills to identify and reject false health claims; |
Or. en
Amendment 675
Aurelijus Veryga
Motion for a resolution
Paragraph 27
| Motion for a resolution | Amendment |
|---|---|
| 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy; | 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy and recommends the combat of health disinformation from hostile foreign actors be an important component of both EU health emergency preparedness and EU Security initiatives; |
Or. en
Amendment 676
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 27
| Motion for a resolution | Amendment |
|---|---|
| 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy; | 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy and recommends the combat of health disinformation from hostile foreign actors be an important component of both EU health emergency preparedness and EU Security initiatives; |
Or. en
Amendment 677
Ondřej Dostál
Motion for a resolution
Paragraph 27
| Motion for a resolution | Amendment |
|---|---|
| 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy; | 27. Stresses that health-related misinformation undermines public trust and contributes to lower screening uptake, vaccine hesitancy and delayed diagnosis; calls on the Commission to address misinformation in its communication strategy, while emphasising that medical advice is to be provided individually by the treating physician on a case-by-case basis; |
Or. en
Amendment 678
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 27 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Calls on the Commission and the Member States to ensure that awareness-raising and health literacy campaigns under the EBCP actively reach disadvantaged and underserved communities; stresses that these populations face the highest cancer risk factors and lowest screening participation rates; calls for EU-funded cancer communication activities to be designed in partnership with community organisations, local patient groups, using culturally adapted and accessible materials, and to be delivered through trusted community channels rather than solely through institutional websites and traditional media; |
Or. en
Amendment 679
Tomislav Sokol
Motion for a resolution
Paragraph 27 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 27a. Recognises the essential role of patients and patient organisations in shaping effective, patient-centred cancer policies and improving health outcomes; calls for the systematic and meaningful involvement of patients and patient organisations across all stages of the cancer pathway, including in the design, implementation and evaluation of cancer policies, programmes and research activities; |
Or. en
Amendment 680
Nikos Papandreou, Vytenis Povilas Andriukaitis, Romana Jerković, Leire Pajín
Motion for a resolution
Paragraph 27 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 27a. Highlights the importance of health literacy and public awareness of cancer symptoms in achieving earlier diagnosis; calls for targeted awareness initiatives, particularly for cancers with non-specific symptoms, to support timely healthcare evaluation and referral; |
Or. en
Amendment 681
Jessica Polfjärd
Motion for a resolution
Subheading 9 a (new)
| Motion for a resolution | Amendment |
|---|---|
| Research and development |
Or. en
Amendment 682
Jessica Polfjärd
Motion for a resolution
Paragraph 27 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 27a. Recalls that research and development of new cancer cures is essential to provide for better care outcomes in the future; recognises the contributions of the European life science sector to strengthening the research capacity in the EU; emphasises the importance of this sector for both European competitiveness and future access to medicines and treatment; |
Or. en
Amendment 683
Jessica Polfjärd
Motion for a resolution
Paragraph 27 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 27b. Welcomes the Commission’s proposal for a European Biotech Act; notes that increased regulatory flexibility, simpler bureaucracy, and strong intellectual property rights are important tools to increase research and innovation in the EU, including in cancer care; |
Or. en
Amendment 684
Jessica Polfjärd
Motion for a resolution
Paragraph 27 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 27c. Calls for Member States and the Commission to promote research and innovation, mobilising public and private capital to support cancer research, strengthening public health as well as the Union's competitiveness; emphasises that research and innovation must translate to clinical use; |
Or. en
Amendment 685
Alessandra Moretti
Motion for a resolution
Paragraph 28
| Motion for a resolution | Amendment |
|---|---|
| 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 2 billion for it in the 2028-2034 multiannual financial framework; | deleted |
Or. en
Amendment 686
Victor Negrescu
Motion for a resolution
Paragraph 28
| Motion for a resolution | Amendment |
|---|---|
| 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 2 billion for it in the 2028-2034 multiannual financial framework; | 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 2 billion for it in the 2028-2034 multiannual financial framework; stresses the need to maintain a dedicated EU health funding instrument in the next Multiannual Financial Framework, ensuring its complementarity with national cancer control plans and avoiding the dilution of health funding within broader programmes; calls for the consolidation of the dedicated European funding mechanism for cancer prevention, treatment and care, ensuring long-term, predictable and equitable investment across Member States and supporting the effective implementation of national cancer control plans; |
Or. en
Amendment 687
Sebastian Everding
Motion for a resolution
Paragraph 28
| Motion for a resolution | Amendment |
|---|---|
| 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 2 billion for it in the 2028-2034 multiannual financial framework; | 28. Calls on the Commission to ensure that the next phase of Europe’s Beating Cancer Plan is continued and strengthened with predictable and adequate funding in the 2028–2034 multiannual financial framework; underlines that the EU4Health programme has been instrumental in supporting the implementation of the Plan, including through investments in cancer prevention, screening, early detection, data infrastructure, networks of expertise and patient support; stresses therefore the importance of maintaining a standalone and sufficiently funded EU health programme in the next multiannual financial framework, in order to ensure continuity, coherence and impact of EU-level cancer action; |
Or. en
Amendment 688
Aurelijus Veryga
Motion for a resolution
Paragraph 28
| Motion for a resolution | Amendment |
|---|---|
| 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 2 billion for it in the 2028-2034 multiannual financial framework; | 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 4 billion for it in the 2028-2034 multiannual financial framework; |
Or. en
Amendment 689
Friedrich Pürner
Motion for a resolution
Paragraph 28
| Motion for a resolution | Amendment |
|---|---|
| 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking at least EUR 2 billion for it in the 2028-2034 multiannual financial framework; | 28. Calls on the Commission to ensure that the Plan is continued and strengthened by earmarking adequate funding for it in the 2028-2034 multiannual financial framework; |
Or. en
Amendment 690
Romana Jerković
Motion for a resolution
Paragraph 28 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 28a. Calls for the establishment of a European Breast Health Day, to be observed annually across the Union, with the aim of raising awareness of breast health, promoting prevention and early detection, improving access to screening and care and addressing inequalities in breast cancer outcomes among Member States; |
Or. en
Amendment 691
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 28 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 28a. Calls for the Plan’s impact assessment to pay particular attention to trends in survival rates, categorised by type of cancer and by Member State where possible, in order to better evaluate real policy outcomes; |
Or. fr
Amendment 692
Ondřej Dostál
Motion for a resolution
Paragraph 28 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 28a. Calls on the Commission to support the work of grassroots organisations in raising awareness of legal entitlements and supporting their enforcement, including among socially underprivileged persons; |
Or. en
Amendment 693
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 28 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 28b. Calls for monitoring of the Plan to specifically focus on the results achieved in the field of paediatric cancers, including the availability of expertise, speed of treatment and trends in survival rates; |
Or. fr
Amendment 694
Victor Negrescu
Motion for a resolution
Paragraph 29
| Motion for a resolution | Amendment |
|---|---|
| 29. Requests that the Commission ensure that a dedicated European Investment Bank facility is made available to the National Comprehensive Cancer Centres, covering infrastructure, IT interoperability and harmonisation of clinical protocols, with priority for regions with documented deficits in cancer care; | 29. Requests that the Commission ensure that a dedicated European Investment Bank facility is made available to the National Comprehensive Cancer Centres, covering infrastructure, IT interoperability and harmonisation of clinical protocols, with priority for regions with documented deficits in cancer care; stresses that such investment should contribute to reducing territorial inequalities by strengthening oncology capacity in underserved regions, including diagnostics, radiotherapy, pathology and multidisciplinary cancer services, and should be linked to measurable targets on access, waiting times and patient outcomes; |
Or. en
Amendment 695
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 29 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 29a. Calls on the Commission and the Council to recognise health and cancer care as social investment objectives that can be achieved through investment in national recovery and resilience plans (NRRP), including support for long-term oncology infrastructure such as vaccination and screening programmes, workforce development, and robust oncology data systems; |
Or. en
Amendment 696
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 29 b (new)
| Motion for a resolution | Amendment |
|---|---|
| 29b. Calls on Member States to adopt fiscal and price-based measures as powerful instruments for cancer prevention, including via own resource initiative on tobacco and broader health-oriented pricing policies targeting foods high in fat, sugars and salt (HFSS), ultra-processed foods (UPFs) and other health-harming and cancer-causing products such as the sugar-sweetened beverages (SSBs), in line with their contribution to obesity, metabolic dysfunction and increased cancer risk; calls to ensure that all revenues generated are reinvested in health systems; |
Or. en
Amendment 697
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 29 c (new)
| Motion for a resolution | Amendment |
|---|---|
| 29c. Welcomes the Commission’s proposal for a tobacco excise duty own resource (TEDOR) as a fair and effective mechanism to generate EUR 11.2 billion annually in additional Union revenue, while contributing to the protection of public health and supporting efforts to reduce tobacco consumption across the European Union; |
Or. en
Amendment 698
Jessica Polfjärd
Motion for a resolution
Paragraph 30
| Motion for a resolution | Amendment |
|---|---|
| 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties and from the fiscal measures on ultra-processed foods established under the Safe Hearts Plan; | deleted |
Or. en
Amendment 699
Pietro Fiocchi, Michele Picaro, Ruggero Razza
Motion for a resolution
Paragraph 30
| Motion for a resolution | Amendment |
|---|---|
| 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties and from the fiscal measures on ultra-processed foods established under the Safe Hearts Plan; | deleted |
Or. en
Amendment 700
Sebastian Everding
Motion for a resolution
Paragraph 30
| Motion for a resolution | Amendment |
|---|---|
| 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties and from the fiscal measures on ultra-processed foods established under the Safe Hearts Plan; | 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties and from the fiscal measures on foods associated with increased risk of chronic diseases, in particular those with a higher cancer risk, such as foods high in saturated fats, salt and sugars, including animal based products, and other nutritionally imbalanced food categories, as established under the Safe Hearts Plan |
Or. en
Amendment 701
Dolors Montserrat
Motion for a resolution
Paragraph 30
| Motion for a resolution | Amendment |
|---|---|
| 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties and from the fiscal measures on ultra-processed foods established under the Safe Hearts Plan; | 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties included in the revision of the Tobacco Taxation Directive proposed by the Commission on 16 July 20251a; |
| 1a Proposal for a COUNCIL DIRECTIVE on the structure and rates of excise duty applied to manufactured tobacco and tobacco related products (recast) COM/2025/580 final https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM%3A2025%3A0580%3AFIN |
Or. en
Amendment 702
Ruggero Razza
Motion for a resolution
Paragraph 30
| Motion for a resolution | Amendment |
|---|---|
| 30. Calls on the Commission to ensure that a guaranteed minimum share is allocated to cancer when distributing the revenues expected from tobacco excise duties and from the fiscal measures on ultra-processed foods established under the Safe Hearts Plan; | 30. (Does not affect the English version.) |
Or. it
Amendment 703
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 30 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 30a. Calls on the Commission to work with Member States to develop harmonised reimbursement frameworks for validated AI medical devices in cancer care; further calls on the Commission to establish, without waiting for the full operationalisation of EUDAMED, a centralised, publicly accessible EU database of certified AI medical devices; |
Or. en
Amendment 704
Aleksandar Nikolic, Aldo Patriciello, Valérie Deloge, Margarita de la Pisa Carrión, Laurent Castillo, Viktória Ferenc, Marie-Luce Brasier-Clain
Motion for a resolution
Paragraph 30 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 30a. Deems it expedient to better target existing EU funding to measures that make a genuine impact in the areas of prevention, screening and effective access to care, rather than generating yet more bureaucracy; |
Or. fr
Amendment 705
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 31
| Motion for a resolution | Amendment |
|---|---|
| 31. Invites the Commission to shift, in the next phase of the Plan’s implementation, from input-based grants to outcome-linked delivery across relevant EU funding instruments; | 31. Invites the Commission to shift, in the next phase of the Plan’s implementation, from input-based grants to outcome-linked delivery across relevant EU funding instruments; calls for better leverage of EIC Horizon Prizes for low-cost screening diagnostics and AI clinical decision support tools, and to explore options such as staged competitions with milestone payments, advance purchase commitments for Member States with low screening coverage, and fast-track access to regulatory sandboxes for winning solutions; |
Or. en
Amendment 706
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 31 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Calls on the Commission to make the up-to-date National Cancer Control Plans a prerequisite for health-related investments under the European Regional Development Fund, with a tiered design that rewards measurable improvement from each Member State’s own baseline; |
Or. en
Amendment 707
Victor Negrescu
Motion for a resolution
Paragraph 31 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 31a. Raises concerns about the long-term sustainability of projects funded under the Plan and calls for continuity of successful initiatives beyond initial funding cycles; |
Or. en
Amendment 708
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 31 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 31a. Invites the Commission to encourage Member States to designate cancer screening as a priority use case for the regulatory sandboxes mandated under the AI Act; |
Or. en
Amendment 709
András Tivadar Kulja
Motion for a resolution
Paragraph 32
| Motion for a resolution | Amendment |
|---|---|
| 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation; | 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation, including data on long-term survival, health related quality of life, metastatic and recurrent cancers, in order to better assess survival outcomes and inequalities across Member States; |
Or. en
Amendment 710
Victor Negrescu
Motion for a resolution
Paragraph 32
| Motion for a resolution | Amendment |
|---|---|
| 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation; | 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation; underlines that the monitoring framework should include measurable indicators on access to innovative cancer medicines, including availability and time-to-access across Member States; |
Or. en
Amendment 711
Adam Jarubas
Motion for a resolution
Paragraph 32
| Motion for a resolution | Amendment |
|---|---|
| 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation; | 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation, which should include stage specific indicators, including data on metastatic and recurrent cancers, in order to better assess survival outcomes and inequalities across Member States; |
Or. en
Amendment 712
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 32
| Motion for a resolution | Amendment |
|---|---|
| 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation; | 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation, which should include stage specific indicators, including data on metastatic and recurrent cancers, in order to better assess survival outcomes and inequalities across Member States; |
Or. en
Amendment 713
Aurelijus Veryga
Motion for a resolution
Paragraph 32
| Motion for a resolution | Amendment |
|---|---|
| 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation; | 32. Stresses that the next phase of the Plan’s implementation must include a comprehensive monitoring and evaluation framework for assessing the quality and effectiveness of implementation, including stage-specific indicators and data on metastatic and recurrent cancers, in order to better assess survival outcomes and inequalities across Member States; |
Or. en
Amendment 714
Vlad Vasile-Voiculescu, Olivier Chastel
Motion for a resolution
Paragraph 32 – subparagraph 1 (new)
| Motion for a resolution | Amendment |
|---|---|
| Calls further on the Commission to integrate cancer-specific indicators into the European Semester process, building on the European Cancer Inequalities Registry, so as to enable systematic and comparable monitoring of Member States' performance across the full cancer pathway, from prevention and early detection to treatment and survivorship, and to use Country Specific Recommendations as an accountability tool to address persistent cancer inequalities across the Union; |
Or. en
Amendment 715
Dolors Montserrat, Elena Nevado del Campo, Letizia Moratti
Motion for a resolution
Paragraph 32 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 32a. Stresses that sustained and increased investment in cancer research is essential to ensure scientific progress and to translate research results into tangible benefits for patients across the Union; underlines the importance of establishing stable and sustainable funding frameworks to strengthen research capacity across all Member States, while explicitly integrating the reduction of inequalities as a core objective and prioritising countries and regions with lower scientific capacity; stresses that research investment should cover the entire cancer continuum, from prevention and early detection to diagnosis, treatment and survivorship; calls for the development and consolidation of European research networks and hubs that foster cooperation, knowledge exchange and scientific excellence; |
Or. en
Amendment 716
Alessandra Moretti
Motion for a resolution
Paragraph 33
| Motion for a resolution | Amendment |
|---|---|
| 33. Urges the Commission, in this regard, to establish a structured annual dialogue on the Plan’s implementation and to report to Parliament’s Committee on Public Health on the basis of a set of key performance indicators covering all pillars of the Plan, disaggregated by Member State; | 33. Urges the Commission, in this regard, to establish a structured annual dialogue on the Plan’s implementation and to report to Parliament’s Committee on Public Health on the basis of a set of key performance indicators covering all pillars of the Plan, disaggregated by Member State; calls furthermore for the structured dialogue to include a dedicated session with healthcare professionals, patients and consumer organisations, and civil society, ensuring that the perspectives of healthcare professionals and citizens are reflected in the annual accountability process; |
Or. en
Amendment 717
Victor Negrescu
Motion for a resolution
Paragraph 33
| Motion for a resolution | Amendment |
|---|---|
| 33. Urges the Commission, in this regard, to establish a structured annual dialogue on the Plan’s implementation and to report to Parliament’s Committee on Public Health on the basis of a set of key performance indicators covering all pillars of the Plan, disaggregated by Member State; | 33. Urges the Commission, in this regard, to establish a structured annual dialogue on the Plan’s implementation and to report to Parliament’s Committee on Public Health on the basis of a set of key performance indicators covering all pillars of the Plan, disaggregated by Member State; stresses that these indicators should include patient-centred outcomes and access to innovative treatments, in order to ensure effective implementation and accountability; |
Or. en
Amendment 718
Tilly Metz
on behalf of the Verts/ALE Group
Motion for a resolution
Paragraph 33 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 33a. Recommends the identification of synergies between the further implementation of Europe’s Beating Cancer Plan and the EU Cancer Mission and the emerging EU Competitiveness Agenda, including by ensuring that regulatory challenges identified by oncology professionals and researchers relating to the General Data Protection Regulation, Clinical Trials Regulation, Medical Device Regulation and In Vitro Diagnostic Regulation are adequately addressed; |
Or. en
Amendment 719
Adam Jarubas
Motion for a resolution
Paragraph 33 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 33a. Calls on the Commission to establish mechanisms to support the translation of cancer research into clinical application, including support for late-stage development, regulatory readiness and health system uptake. |
Or. en
Amendment 720
Kateřina Konečná
Motion for a resolution
Paragraph 34 a (new)
| Motion for a resolution | Amendment |
|---|---|
| 34a. Recommends synergy identification with the further implementation of Europe’s Beating Cancer Plan and the EU Research Mission on Cancer with the emergent EU Competitiveness Agenda, including to ensure regulatory challenges cited by oncology professionals and researchers relating to legislation such as the General Data Protection Regulation, Clinical Trials Regulation, Medical Device Regulation and In Vitro Device Regulation, are well addressed. |
Or. en